
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cells</journal-id><journal-id journal-id-type="iso-abbrev">Cells</journal-id><journal-id journal-id-type="publisher-id">cells</journal-id><journal-title-group><journal-title>Cells</journal-title></journal-title-group><issn pub-type="epub">2073-4409</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31450621</article-id><article-id pub-id-type="pmc">6769927</article-id><article-id pub-id-type="doi">10.3390/cells8090969</article-id><article-id pub-id-type="publisher-id">cells-08-00969</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>TGF&#x003b2;/BMP Signaling Pathway in Cartilage Homeostasis</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3245-7537</contrib-id><name><surname>Thielen</surname><given-names>Nathalie G.M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>van der Kraan</surname><given-names>Peter M.</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5473-4884</contrib-id><name><surname>van Caam</surname><given-names>Arjan P.M.</given-names></name><xref rid="c1-cells-08-00969" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-cells-08-00969">Experimental Rheumatology, Radboud University Medical Center, Geert Grooteplein 28, 6525 GA Nijmegen, The Netherlands</aff><author-notes><corresp id="c1-cells-08-00969"><label>*</label>Correspondence: <email>arjan.vancaam@radboudumc.nl</email>; Tel.: +31-24-10513; Fax: +31-24-3540403</corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>8</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2019</year></pub-date><volume>8</volume><issue>9</issue><elocation-id>969</elocation-id><history><date date-type="received"><day>02</day><month>7</month><year>2019</year></date><date date-type="accepted"><day>19</day><month>8</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Cartilage homeostasis is governed by articular chondrocytes via their ability to modulate extracellular matrix production and degradation. In turn, chondrocyte activity is regulated by growth factors such as those of the transforming growth factor &#x003b2; (TGF&#x003b2;) family. Members of this family include the TGF&#x003b2;s, bone morphogenetic proteins (BMPs), and growth and differentiation factors (GDFs). Signaling by this protein family uniquely activates SMAD-dependent signaling and transcription but also activates SMAD-independent signaling via MAPKs such as ERK and TAK1. This review will address the pivotal role of the TGF&#x003b2; family in cartilage biology by listing several TGF&#x003b2; family members and describing their signaling and importance for cartilage maintenance. In addition, it is discussed how (pathological) processes such as aging, mechanical stress, and inflammation contribute to altered TGF&#x003b2; family signaling, leading to disturbed cartilage metabolism and disease.</p></abstract><kwd-group><kwd>transforming growth factor &#x003b2;</kwd><kwd>bone morphogenetic proteins</kwd><kwd>osteoarthritis</kwd><kwd>cartilage</kwd><kwd>SMADs</kwd><kwd>aging</kwd><kwd>joint loading</kwd><kwd>inflammation</kwd><kwd>linker modifications</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-cells-08-00969"><title>1. Introduction</title><p>The transforming growth factor &#x003b2; (TGF&#x003b2;) family of polypeptide growth factors controls development and homeostasis of many tissues, including articular cartilage. Articular cartilage is the connective tissue covering joint surfaces and is a type of hyaline cartilage. This tissue is key in facilitating movement with its smooth lubricated surface, and it functions as a shock absorber to disperse forces acting upon movement with its physical properties. Articular cartilage is of mesodermal origin and, remarkably for a tissue, is neither innervated nor does it contain blood vessels to supply oxygen or nutrients [<xref rid="B1-cells-08-00969" ref-type="bibr">1</xref>,<xref rid="B2-cells-08-00969" ref-type="bibr">2</xref>]. The only cell type present in this tissue is the chondrocyte, which is surrounded by a large amount (up to 98% of cartilage volume) of extracellular matrix (ECM) [<xref rid="B1-cells-08-00969" ref-type="bibr">1</xref>,<xref rid="B3-cells-08-00969" ref-type="bibr">3</xref>]. The ECM is a highly organized network of hyaluronan, proteoglycans, and collagens. These collagens provide (tensile) strength and shape to the tissue [<xref rid="B4-cells-08-00969" ref-type="bibr">4</xref>], and they mainly are (up to 90%) collagen type II (COL2A1) fibrils [<xref rid="B5-cells-08-00969" ref-type="bibr">5</xref>]. Hyaluronan is a glycosaminoglycan (GAG) (i.e., a long, unbranched polysaccharide), which forms spontaneously aggregating networks to which other biomolecules such as proteoglycans can bind [<xref rid="B6-cells-08-00969" ref-type="bibr">6</xref>]. Proteoglycans are proteins glycosylated with sulfated GAGs. The most abundant proteoglycan (in mass) in articular cartilage is aggrecan (ACAN), and this proteoglycan forms large aggregates with hyaluronan. Because ACAN is heavily glycosylated with negatively charged sulfated GAGs, these aggregates generate a (static) charge density. This charge density generates the force required to counteract compressive forces during movement via attraction of solutes, which generate osmotic swelling pressure, and via electrostatic repulsion if aggrecan molecules come in close proximity [<xref rid="B7-cells-08-00969" ref-type="bibr">7</xref>].</p><p>Articular cartilage is a highly structured tissue in which form fits function. Five distinct zones can be observed: the lamina splendens, the superficial zone, the middle zone, the deep zone, and the calcified zone (<xref ref-type="fig" rid="cells-08-00969-f001">Figure 1</xref>). The lamina splendens consists of collagen fibrils oriented in parallel to the surface and high levels of hyaluronan and the lubricating proteoglycan lubricin (PRG4), but it contains no cells [<xref rid="B8-cells-08-00969" ref-type="bibr">8</xref>,<xref rid="B9-cells-08-00969" ref-type="bibr">9</xref>,<xref rid="B10-cells-08-00969" ref-type="bibr">10</xref>]. These characteristics provide a smooth surface with a low friction coefficient. Below the lamina splendens lies the superficial zone, which contains a relatively high number of cells with flattened morphology oriented in parallel to the surface, which produce high amounts of hyaluronan and PRG4 [<xref rid="B8-cells-08-00969" ref-type="bibr">8</xref>,<xref rid="B10-cells-08-00969" ref-type="bibr">10</xref>]. The collagen fibrils here are tightly packed and also oriented in parallel to the surface. This orientation counteracts osmotic swelling pressure of the tissue below [<xref rid="B9-cells-08-00969" ref-type="bibr">9</xref>]. Beneath the superficial zone lies the middle zone, which represents 40%&#x02013;60% of articular cartilage [<xref rid="B2-cells-08-00969" ref-type="bibr">2</xref>]. Chondrocytes in this zone are rounded but sparse. The collagen fibers are oriented isotropically to the cartilage surface [<xref rid="B9-cells-08-00969" ref-type="bibr">9</xref>], which allows for efficient collapse of the tissue upon compression to dissipate the energy of the impact. The collapse of this layer is accompanied by displacement and loss of water. The more this layer is compacted, the more resistance to further collapse is increased [<xref rid="B1-cells-08-00969" ref-type="bibr">1</xref>]. This resistance to further compression is due to an increase in electrostatic repulsion between proteoglycans and also to an increase in hyaluronan viscosity because of an increase in concentration of this molecule [<xref rid="B11-cells-08-00969" ref-type="bibr">11</xref>]. Underneath the middle zone lies the deep zone (&#x000b1;30%). In the deep zone, chondrocytes are organized in columns placed between collagen fibrils oriented perpendicular to the cartilage surface [<xref rid="B6-cells-08-00969" ref-type="bibr">6</xref>,<xref rid="B9-cells-08-00969" ref-type="bibr">9</xref>]. Furthermore, this zone contains relatively the highest levels of aggrecan of all zones [<xref rid="B1-cells-08-00969" ref-type="bibr">1</xref>]. The high levels of aggrecan restrict water flow and thereby increase the compressive stiffness of cartilage. The collagen fibers are oriented to withstand the swelling pressure generated by these proteoglycans and to withstand sheer stresses generated by compression of the layers above. Part of the deep zone, below the tidemark, contains calcium salts in the ECM and is, thus, called the calcified zone [<xref rid="B2-cells-08-00969" ref-type="bibr">2</xref>]. The calcified zone forms the interface between bone and cartilage and anchors cartilage to the bone. This zone contains hypertrophic-like chondrocytes which resemble chondrocytes undergoing endochondral ossification [<xref rid="B12-cells-08-00969" ref-type="bibr">12</xref>].</p><p>The importance of articular cartilage for joint function is illustrated by the effects of its loss, which leads to disability and pain, for example, in the word&#x02019;s most common joint disease osteoarthritis (OA). Degeneration and loss of articular cartilage are the consequence of an imbalance in anabolic (e.g., ECM production) and catabolic (e.g., ECM degradation) processes. Chondrocytes, as the only cell type present, are essential for balancing these processes. Therefore, chondrocyte metabolism is a key regulator of cartilage homeostasis and joint health. Many factors can regulate chondrocyte homeostasis, like hydrostatic pressure, tensile strain, and proinflammatory cytokines, but various growth factors, including those of the TGF&#x003b2; family, play a key role in this. Growth factors modulate chondrocyte metabolism, differentiation, proliferation, and survival, and they regulate ECM production and turnover. This review will address the pivotal role of the TGF&#x003b2; family in chondrocyte (and thus cartilage) biology by listing several TGF&#x003b2; family members and describing their importance. We will discuss how these members signal and how this signaling impacts cartilage. Furthermore, we will address how (pathological) processes such as aging, mechanical stress, and inflammation influence TGF&#x003b2; signaling in chondrocytes, leading to an altered metabolism and disease.</p></sec><sec id="sec2-cells-08-00969"><title>2. The Transforming Growth Factor &#x00392; (TGF&#x003b2;) Family and Its Signaling</title><p>The TGF&#x003b2; family consists of over 30 members, including the TGF&#x003b2;s, activins, bone morphogenetic proteins (BMPs), and growth/differentiation factors (GDFs). These factors share a characteristic quaternary dimer structure [<xref rid="B13-cells-08-00969" ref-type="bibr">13</xref>] and signal via formation of heteromeric complexes between two types (type I and type II) of serine threonine-protein kinase receptors [<xref rid="B14-cells-08-00969" ref-type="bibr">14</xref>].</p><p>There are seven type I and five type II receptors (<xref ref-type="fig" rid="cells-08-00969-f002">Figure 2</xref>). Because every growth factor recruits a specific, but not necessarily unique, receptor complex, this choice in receptors allows for differences in growth factor sensitivity. In addition, multiple type III receptors have been characterized that facilitate the interaction between ligand and receptor and can stabilize receptor complexes. For example, for TGF&#x003b2; betaglycan [<xref rid="B15-cells-08-00969" ref-type="bibr">15</xref>,<xref rid="B16-cells-08-00969" ref-type="bibr">16</xref>] and endoglin [<xref rid="B17-cells-08-00969" ref-type="bibr">17</xref>], and for BMPs the repulsive guidance molecule (RGM) family members, RGM domain family member A (RGMA), dragon, and hemojuvelin have been identified as co-receptors [<xref rid="B18-cells-08-00969" ref-type="bibr">18</xref>]. Also, inhibitory (pseudo) receptors have been identified, which bind ligands but do not initiate signaling (e.g., CD109 for TGF&#x003b2; signaling [<xref rid="B19-cells-08-00969" ref-type="bibr">19</xref>] and BMP and activin membrane bound inhibitor (BAMBI) for BMP and activin signaling [<xref rid="B20-cells-08-00969" ref-type="bibr">20</xref>]). After formation of functional receptor complexes, TGF&#x003b2; family members can activate multiple intracellular signaling pathways, which are categorized as either receptor SMAD (R-SMAD)-dependent or -independent, but R-SMAD-dependent signaling is regarded as the unique and canonical signaling pathway of TGF&#x003b2; family members.</p><sec id="sec2dot1-cells-08-00969"><title>2.1. R-SMAD-Dependent Signaling</title><p>R-SMADs are proteins approximately 50 kDa in size that, upon receptor-mediated activation by carboxy terminal phosphorylation, migrate to the nucleus and function as transcription factors. Two groups of R-SMADs can be distinguished based upon structural and functional homology: one group consisting of SMAD1, SMAD5, and SMAD9 (also known as SMAD8) and one group containing SMAD2 and SMAD3 [<xref rid="B14-cells-08-00969" ref-type="bibr">14</xref>]. Upon receptor type I activation, these R-SMADs are directly phosphorylated on two serines at their C-terminal SXS motif. Specific ALKs phosphorylate specific SMADs: ALK1, 2, 3, and 6 phosphorylate SMAD1, 5, and 9, whereas ALK4, 5, and 7 phosphorylate SMAD2 and SMAD3. This phosphorylation facilitates complexation of R-SMADs with the common SMAD (co-SMAD), SMAD4, which promotes nuclear entry and accumulation. Inside the nucleus, this SMAD complex directly binds DNA, although with low affinity, and recruits transcription factors for \high-affinity interactions with DNA. The location where SMAD complexes bind DNA is dependent on characteristic SMAD-binding motifs present in the DNA sequence, which differ for SMAD3/4 and SMAD1/5/9 (e.g., GTCTAGAC for SMAD2/3/4 complexes [<xref rid="B21-cells-08-00969" ref-type="bibr">21</xref>] and GCCGnCGC for SMAD1/5/9/4 complexes [<xref rid="B22-cells-08-00969" ref-type="bibr">22</xref>]). Furthermore, the interaction between SMADs and DNA is regulated by the presence of master regulator transcription factors [<xref rid="B23-cells-08-00969" ref-type="bibr">23</xref>]. Master regulators vary per tissue, and an important master regulator of chondrocyte phenotype is SRY-box9 (SOX9), for example, which closely interacts with SMAD3/4 on the collagen type II promotor [<xref rid="B24-cells-08-00969" ref-type="bibr">24</xref>].</p><p>Two important target genes of R-SMAD signaling are the inhibitory-SMADs (I-SMAD): <italic>SMAD6</italic> and <italic>SMAD7</italic> [<xref rid="B25-cells-08-00969" ref-type="bibr">25</xref>,<xref rid="B26-cells-08-00969" ref-type="bibr">26</xref>]. These I-SMADs function as inhibitors of R-SMAD signaling on multiple levels by inhibiting C-terminal R-SMAD phosphorylation by inducing receptor dephosphorylation and degradation, by inhibiting R-SMAD DNA binding, and by inhibiting complex formation between SMAD4 and R-SMADs. In this way, SMAD6 predominantly inhibits SMAD1/5/9, and SMAD7 predominantly inhibits SMAD2/3 signaling, and both I-SMADs provide cells with an important negative feedback mechanism to inactivate R-SMAD signaling.</p><p>A (simplified) overview of the SMAD-dependent signaling pathway is depicted in <xref ref-type="fig" rid="cells-08-00969-f002">Figure 2</xref>.</p></sec><sec id="sec2dot2-cells-08-00969"><title>2.2. SMAD-Dependent Signaling in Chondrocytes and Cartilage Biology</title><p>SMAD signaling is essential for the formation and maintenance of healthy cartilage. Both in vivo and in vitro experiments point towards essential, but distinct, roles for SMAD2/3 versus SMAD1/5/9 signaling in chondrocyte biology.</p><p>In humans, genetic variation in <italic>SMAD3</italic> is associated with hip and knee OA and total burden of the disease [<xref rid="B27-cells-08-00969" ref-type="bibr">27</xref>,<xref rid="B28-cells-08-00969" ref-type="bibr">28</xref>]. Dominant nonsense, missense, or frameshift mutations in <italic>SMAD3</italic> lead to aneurysms-OA syndrome, a severe condition characterized by cardiovascular anomalies and early onset of OA in multiple joints [<xref rid="B29-cells-08-00969" ref-type="bibr">29</xref>,<xref rid="B30-cells-08-00969" ref-type="bibr">30</xref>]. Mice with a <italic>Smad3</italic> null mutation (<italic>Smad3</italic><sup>&#x00394;exon8/</sup><sup>&#x00394;exon8</sup>) develop normal articular cartilage, but this starts to rapidly degrade one month after birth, resulting in severe OA [<xref rid="B31-cells-08-00969" ref-type="bibr">31</xref>]. This rapid degradation is linked to an increased number of hypertrophic chondrocytes present in both articular and epiphyseal cartilage [<xref rid="B31-cells-08-00969" ref-type="bibr">31</xref>]. These hypertrophic chondrocytes are unable to maintain a healthy articular cartilage matrix and produce collagen type 10 (COL10A1) and matrix metalloprotease 13 (MMP13), a potent cartilage-degrading enzyme. Increased chondrocyte hypertrophy and accelerated cartilage degeneration are also observed in chondrocyte-specific <italic>Smad3</italic>-null mice (<italic>Smad3</italic><sup>&#x00394;exon2 + 3/</sup><sup>&#x00394;exon2 + 3</sup>), which have been made using <italic>Col2-Cre</italic> and floxed <italic>Smad3</italic> to circumvent systemic effects of <italic>Smad3</italic> deletion, confirming the direct role of SMAD3 in these processes [<xref rid="B32-cells-08-00969" ref-type="bibr">32</xref>]. In vitro studies using overexpression or knockout of <italic>SMAD3</italic> also support a role for SMAD3 in inhibiting chondrocyte terminal differentiation, by showing an inhibitory or stimulating effect on chondrocyte hypertrophy, respectively [<xref rid="B33-cells-08-00969" ref-type="bibr">33</xref>,<xref rid="B34-cells-08-00969" ref-type="bibr">34</xref>,<xref rid="B35-cells-08-00969" ref-type="bibr">35</xref>,<xref rid="B36-cells-08-00969" ref-type="bibr">36</xref>]. The anti-hypertrophic effect of SMAD3 is attributed to its interaction with core-binding factor subunit &#x003b1; 1 (CBFA1), also known as runt-related transcription factor 2 (RUNX2) [<xref rid="B32-cells-08-00969" ref-type="bibr">32</xref>,<xref rid="B37-cells-08-00969" ref-type="bibr">37</xref>,<xref rid="B38-cells-08-00969" ref-type="bibr">38</xref>]. RUNX2 is a potent regulator of chondrocyte maturation [<xref rid="B39-cells-08-00969" ref-type="bibr">39</xref>]. For example, overexpression of <italic>Runx2</italic> in the murine teratoma-derived ATDC5 chondrocyte-like cell line induces chondrocyte hypertrophy, whereas inhibition of RUNX2 achieves the opposite [<xref rid="B32-cells-08-00969" ref-type="bibr">32</xref>,<xref rid="B38-cells-08-00969" ref-type="bibr">38</xref>,<xref rid="B40-cells-08-00969" ref-type="bibr">40</xref>,<xref rid="B41-cells-08-00969" ref-type="bibr">41</xref>]. SMAD3 counteracts RUNX2 function by directly binding this transcription factor and recruiting silencing histone class II deacetylases to RUNX2 responsive genes [<xref rid="B37-cells-08-00969" ref-type="bibr">37</xref>] such as <italic>MMP13</italic>, <italic>COL10A1,</italic> and alkaline phosphatase (<italic>ALPL</italic>).</p><p>The role of SMAD2 in cartilage biology is less clear than that of SMAD3. In humans, there is no known association between genetic variation in <italic>SMAD2</italic> and OA. <italic>Smad2</italic> knockout animals or hypomorphs are not viable and die early during embryogenesis (&#x02264;embryonic day 9 [<xref rid="B42-cells-08-00969" ref-type="bibr">42</xref>,<xref rid="B43-cells-08-00969" ref-type="bibr">43</xref>,<xref rid="B44-cells-08-00969" ref-type="bibr">44</xref>,<xref rid="B45-cells-08-00969" ref-type="bibr">45</xref>]), before the formation of articular joints [<xref rid="B46-cells-08-00969" ref-type="bibr">46</xref>], and are thus not usable to study the role of SMAD2 in articular cartilage. Animals with only one genetic copy of <italic>Smad2</italic> (<italic>Smad2</italic><sup>+/&#x02212;</sup>) can be viable [<xref rid="B42-cells-08-00969" ref-type="bibr">42</xref>,<xref rid="B47-cells-08-00969" ref-type="bibr">47</xref>], but no cartilage phenotype has been reported. Cartilage-specific <italic>Smad2</italic> knockout mice (<italic>Smad2<sup>fx/fx</sup>;Col2a1Cre)</italic> have recently been studied [<xref rid="B48-cells-08-00969" ref-type="bibr">48</xref>], and such mice have an elongated hypertrophic zone in their growth plate. This last observation indicates a similar anti-hypertrophic effect of SMAD2 as SMAD3. An in vitro study supports a role for SMAD2 similar to that of SMAD3, because overexpression of a dominant negative variant of <italic>Smad2</italic> enhances, whereas overexpression of wildtype <italic>Smad2</italic> protects against chondrocyte hypertrophy, although less potent than SMAD3 [<xref rid="B33-cells-08-00969" ref-type="bibr">33</xref>].</p><p>SMAD1 and SMAD5 seem to have an important, but interchangeable, role in cartilage biology. In contrast, SMAD9 seems to be of little importance for cartilage formation or maintenance. In humans, no association has been reported between genetic variations in <italic>SMAD1</italic>, <italic>SMAD5,</italic> or <italic>SMAD9</italic> and OA, possibly due to redundant roles in cartilage. Like <italic>Smad2</italic> knockout mice, <italic>Smad1</italic> [<xref rid="B49-cells-08-00969" ref-type="bibr">49</xref>] or <italic>Smad5</italic> [<xref rid="B50-cells-08-00969" ref-type="bibr">50</xref>] knockout mice die before the formation of articular joints. Knockout of <italic>Smad9</italic> is not embryonically lethal yet does not seem to affect (epiphyseal) cartilage biology [<xref rid="B51-cells-08-00969" ref-type="bibr">51</xref>]. To study SMAD1 and SMAD5 in chondrogenesis, cartilage-specific knockouts have been made using <italic>Col2-cre</italic> and floxed <italic>Smad1</italic> or <italic>Smad5</italic> [<xref rid="B51-cells-08-00969" ref-type="bibr">51</xref>]. Cartilage-specific removal of either <italic>Smad1</italic> or <italic>Smad5</italic> does not result in a phenotype, nor in combination with whole body <italic>Smad9</italic> knockout. Only when both <italic>Smad1</italic> and <italic>Smad5</italic> are ablated, severe chondrodysplasia can be observed [<xref rid="B51-cells-08-00969" ref-type="bibr">51</xref>]. Additional removal of <italic>Smad9</italic> does not add much to this severe phenotype. Together, these observations indicate that SMAD1 and SMAD5 have an important, but redundant, role in cartilage formation, whereas the role of SMAD9 seems limited [<xref rid="B51-cells-08-00969" ref-type="bibr">51</xref>]. The severe chondrodysplasia is, in part, due to a lack of hypertrophic chondrocytes in the growth plates, suggesting that SMAD1/5 signaling regulates chondrocyte maturation. In vitro studies support a stimulatory role of SMAD1/5 in chondrocyte maturation. For example, overexpression of <italic>Smad6</italic>, an inhibitor of SMAD1/5/9, results in inhibited chondrogenesis in the ATDC5 cell line [<xref rid="B52-cells-08-00969" ref-type="bibr">52</xref>] and delayed chondrocyte hypertrophy [<xref rid="B53-cells-08-00969" ref-type="bibr">53</xref>]. The stimulatory effects of SMAD1/5 on chondrocyte maturation most likely are due to a stimulation of RUNX2 function. Such a stimulatory role of SMAD1/5 on RUNX2 function has been described to be essential for BMP2-induced osteoblast differentiation [<xref rid="B54-cells-08-00969" ref-type="bibr">54</xref>,<xref rid="B55-cells-08-00969" ref-type="bibr">55</xref>,<xref rid="B56-cells-08-00969" ref-type="bibr">56</xref>,<xref rid="B57-cells-08-00969" ref-type="bibr">57</xref>]. Furthermore, in pre-hypertrophic chondrocytes, SMAD1/5-RUNX2 interaction induces the activation of a reporter construct based on the <italic>Col10a1</italic> promoter, the expression of which is an important phenotypic marker of hypertrophy [<xref rid="B38-cells-08-00969" ref-type="bibr">38</xref>,<xref rid="B58-cells-08-00969" ref-type="bibr">58</xref>]. How exactly SMAD1 and SMAD5 stimulate RUNX2 function is yet unclear.</p></sec><sec id="sec2dot3-cells-08-00969"><title>2.3. SMAD-Independent Signaling</title><p>As mentioned, TGF&#x003b2; family members can also activate R-SMAD-independent pathways. Two examples are signaling via mitogen-activated protein kinase (MAPK) pathways involving TGF&#x003b2;-activated kinase 1 (TAK1) or extracellular signal-regulated kinase 1 and 2 (ERK1/2, also known as MAPK3/1). The SMAD-independent signaling pathways are depicted in <xref ref-type="fig" rid="cells-08-00969-f002">Figure 2</xref>. Of note, these pathways are not unique for TGF&#x003b2; family signaling but are important signaling mediators of many other growth factors and cytokines as well.</p><p>Activation of MAPKs by TGF&#x003b2; family members relies on adaptor proteins to bridge receptor activity to pathway activation&#x02014;for example, SHC adaptor protein 1 (SHC1) for ERK [<xref rid="B59-cells-08-00969" ref-type="bibr">59</xref>] and tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6) for TAK1 activation [<xref rid="B60-cells-08-00969" ref-type="bibr">60</xref>,<xref rid="B61-cells-08-00969" ref-type="bibr">61</xref>]. Receptor-mediated phosphorylation of SHC1 triggers a MAPK signaling cascade via GRB2/SOS, RAS, RAF, and MAP2K1, resulting in activation of ERK1/2 [<xref rid="B59-cells-08-00969" ref-type="bibr">59</xref>]. TRAF6 is activated differently: upon receptor type I/type II complex formation, TRAF6 oligomerization and auto-ubiquitination occurs, triggering complex formation between TAK1 and TGF&#x003b2;-activated kinase 1/MAP3K7 binding protein 1 (TAB1) via poly-ubiquitination, which allows TAK1 auto-phosphorylation and activity [<xref rid="B61-cells-08-00969" ref-type="bibr">61</xref>]. Alternatively, TAK1 can be activated by E3 ubiquitin-protein ligase XIAP (in complex with TAB1), the expression of which is stabilized by interaction with BMP (and TGF&#x003b2;) receptors [<xref rid="B62-cells-08-00969" ref-type="bibr">62</xref>,<xref rid="B63-cells-08-00969" ref-type="bibr">63</xref>]. Ultimately, activation of MAPK signaling by TGF&#x003b2; family members results in activation of JNK and p38 kinases, which directly regulate gene expression by modulating transcription factors such as Jun proto-oncogene (c-JUN), MYC proto-oncogene (c-MYC), activating transcription factor 2 (ATF2), and CCAAT/enhancer-binding protein &#x003b2; (C/EBP-&#x003b2;) [<xref rid="B64-cells-08-00969" ref-type="bibr">64</xref>].</p><p>Both ERK and TAK1 contribute to TGF&#x003b2; family signaling in chondrocytes. Functional inhibition of ERK1 in ATDC5 cells via inhibition of its activating kinase MAP2K1 with the inhibitor U0126 reduces TGF&#x003b2;-induced <italic>Acan</italic> expression [<xref rid="B65-cells-08-00969" ref-type="bibr">65</xref>]. Functional inhibition of ERK1 in rat chondrocytes with the use of the MAP2K1 inhibitor PD98059 reduces TGF&#x003b2;-induced proliferation and <italic>Acan</italic> and <italic>Col2a1</italic> expression [<xref rid="B66-cells-08-00969" ref-type="bibr">66</xref>,<xref rid="B67-cells-08-00969" ref-type="bibr">67</xref>]. Furthermore, in both human and bovine primary chondrocytes, use of PD98059 lowers TGF&#x003b2;-induced mRNA and protein expression of the metallopeptidase inhibitor TIMP3 [<xref rid="B68-cells-08-00969" ref-type="bibr">68</xref>], indicating that ERK activity is a cartilage-protective component of TGF&#x003b2; signaling in mature chondrocytes. In contrast, during TGF&#x003b2;-induced chondrogenesis in vitro, use of PD98059 increases <italic>Col2a1</italic> and <italic>Sox9</italic> expression and proteoglycan synthesis in rat, chicken, and human mesenchymal stem cells [<xref rid="B69-cells-08-00969" ref-type="bibr">69</xref>,<xref rid="B70-cells-08-00969" ref-type="bibr">70</xref>,<xref rid="B71-cells-08-00969" ref-type="bibr">71</xref>], indicating that ERK1/2 is an inhibitory component of TGF&#x003b2; signaling during TGF&#x003b2;-induced chondrogenesis.</p><p>Functional inhibition of TAK1 using a dominant negative form of <italic>Tak1</italic> greatly diminishes the ability of TGF&#x003b2; and BMP2 to induce <italic>Col2a1</italic> expression in rabbit articular chondrocytes [<xref rid="B72-cells-08-00969" ref-type="bibr">72</xref>]. In <italic>Col2-Cre;Tak1<sup>fl/fl</sup></italic> mice, <italic>Tak1</italic> deletion in <italic>Col2a1</italic>-expressing cells during embryogenesis results in runting and severe chondrodysplasia because of the reduced chondrocyte proliferation and delayed maturation [<xref rid="B73-cells-08-00969" ref-type="bibr">73</xref>], and these mice die shortly before [<xref rid="B73-cells-08-00969" ref-type="bibr">73</xref>] or after birth [<xref rid="B74-cells-08-00969" ref-type="bibr">74</xref>]. This severe phenotype resembles the phenotype of mice lacking BMP receptor/SMAD(1/5) signaling. Indeed, these mice show impaired BMP-induced R-SMAD and p38 MAPK/JNK/ERK signaling [<xref rid="B73-cells-08-00969" ref-type="bibr">73</xref>,<xref rid="B74-cells-08-00969" ref-type="bibr">74</xref>], confirming that TAK1 is an important component of BMP signaling in cartilage. Postnatal deletion of <italic>Tak1</italic> using inducible <italic>Col2a1-CreER<sup>T2</sup>;Tak1<sup>fl/fl</sup></italic> mice also results in growth retardation, and these mice have profoundly decreased proteoglycan and COL2A1 production in their articular cartilage [<xref rid="B75-cells-08-00969" ref-type="bibr">75</xref>]. This last observation shows that the importance of TAK1 in cartilage biology is not limited to embryogenesis.</p><p>A possible role of TAK1 signaling in chondrocytes is the regulation of SOX9 production. In chondrocytes, deletion of <italic>Tak1</italic> inhibits endogenous and BMP2-induced <italic>Sox9</italic> mRNA expression and protein production, whereas overexpression of <italic>Tak1</italic> enhances SOX9 levels [<xref rid="B75-cells-08-00969" ref-type="bibr">75</xref>]. This observation is reflected in vivo: both articular and epiphyseal chondrocytes from <italic>Col2a1-CreER<sup>T2</sup>;Tak1<sup>fl/fl</sup></italic> mice show lower SOX9 protein production after deletion of <italic>Tak1</italic> compared to control animals [<xref rid="B75-cells-08-00969" ref-type="bibr">75</xref>]. The induction of <italic>Sox9</italic> expression by TAK1 involves binding of activating transcription factor 2 (ATF2), a downstream target of TAK1 via p38 MAPK, to the <italic>Sox9</italic> promoter [<xref rid="B75-cells-08-00969" ref-type="bibr">75</xref>]. Furthermore, p38 MAPK signaling has also been shown to stabilize <italic>SOX9</italic> mRNA in human chondrocytes, further strengthening the importance of this MAPK pathway in SOX9 regulation [<xref rid="B76-cells-08-00969" ref-type="bibr">76</xref>].</p><p>TGF&#x003b2; family members can also signal via phosphoinositide 3-kinase (PI3K) or via the GTPase RhoA [<xref rid="B64-cells-08-00969" ref-type="bibr">64</xref>], but it is unclear how and to what extent this occurs in chondrocytes. Activation of PI3Ks leads to phosphorylation and activation of AKT serine/threonine kinase 1/2/3 (AKT1/2/3) and of mechanistic target of rapamycin (MTOR) [<xref rid="B77-cells-08-00969" ref-type="bibr">77</xref>]. Recently, it has been shown that mechanistic target of rapamycin complex 1 (mTORC1) activity is required for chondroblast growth and proliferation in the epiphyseal plate of mice, but that its inactivation is required for chondrocyte differentiation [<xref rid="B78-cells-08-00969" ref-type="bibr">78</xref>]. In articular cartilage, MTOR is upregulated during OA [<xref rid="B79-cells-08-00969" ref-type="bibr">79</xref>] and is an inhibitor of chondroprotective autophagy [<xref rid="B79-cells-08-00969" ref-type="bibr">79</xref>,<xref rid="B80-cells-08-00969" ref-type="bibr">80</xref>,<xref rid="B81-cells-08-00969" ref-type="bibr">81</xref>]. In vivo, intra-articular or intra-peritoneal injection of rapamycin (i.e., an inhibitor of MTOR) increases autophagy and reduces cartilage damage in the DMM (surgical destabilization of the medial meniscus) model of OA [<xref rid="B80-cells-08-00969" ref-type="bibr">80</xref>,<xref rid="B81-cells-08-00969" ref-type="bibr">81</xref>]. Furthermore, cartilage-specific <italic>Mtor</italic> knockout mice (<italic>Col2-rt-TA-Cre</italic>; <italic>Mtor</italic><sup>fl/fl</sup>) are protected against DMM-induced OA [<xref rid="B79-cells-08-00969" ref-type="bibr">79</xref>], confirming that MTOR signaling is deleterious in OA conditions.</p><p>In chondrocytes, RhoA activates rho-associated coiled-coil containing protein kinase 1 (ROCK1) [<xref rid="B82-cells-08-00969" ref-type="bibr">82</xref>,<xref rid="B83-cells-08-00969" ref-type="bibr">83</xref>]. In primary human chondrocytes, ROCK inhibition induces <italic>SOX9</italic>, <italic>COL2A1,</italic> and <italic>ACAN</italic> mRNA expressions [<xref rid="B76-cells-08-00969" ref-type="bibr">76</xref>], while in primary murine chondrocytes, ROCK inhibition enhances the output of a SOX9-responsive luciferase assay along with <italic>Col2a1</italic> and <italic>Acan</italic> mRNA expression [<xref rid="B83-cells-08-00969" ref-type="bibr">83</xref>]. Therefore, these studies indicate a negative effect of RhoA/ROCK signaling on chondrocyte phenotype. However, in murine mesenchymal cells during chondrogenic differentiation and chondrocytes cultured in 3D, ROCK1 inhibition negatively affects SOX9 function [<xref rid="B83-cells-08-00969" ref-type="bibr">83</xref>]. This effect has been attributed to direct phosphorylation of SOX9 by ROCK1, leading to nuclear accumulation and transcriptional activity of SOX9 [<xref rid="B84-cells-08-00969" ref-type="bibr">84</xref>]; thus, in contrast to the previous studies, this indicates a positive effect of Rhoa/ROCK signaling on chondrocyte phenotype.</p><p>A (simplified) overview of the SMAD-independent signaling pathways is depicted in <xref ref-type="fig" rid="cells-08-00969-f003">Figure 3</xref>.</p></sec></sec><sec id="sec3-cells-08-00969"><title>3. TGF&#x003b2; Family Members in Cartilage</title><sec id="sec3dot1-cells-08-00969"><title>3.1. TGF&#x003b2;1, TGF&#x003b2;2, and TGF&#x003b2;3</title><p>The importance of TGF&#x003b2; in cartilage biology was first observed in 1985 when two proteins were extracted from bone that were capable of inducing chondrogenesis in rat embryonic mesenchymal cells, and therefore were called cartilage inducing factor A and B [<xref rid="B85-cells-08-00969" ref-type="bibr">85</xref>]. Later research revealed that these proteins were identical to TGF&#x003b2;1 and TGF&#x003b2;2 [<xref rid="B86-cells-08-00969" ref-type="bibr">86</xref>,<xref rid="B87-cells-08-00969" ref-type="bibr">87</xref>].</p><p>In mammals, three TGF&#x003b2;s exist&#x02014;TGF&#x003b2;1, TGF&#x003b2;2, and TGF&#x003b2;3&#x02014;encoded by three different genes&#x02014;<italic>TGFB1</italic>, <italic>TGFB2</italic> and <italic>TGFB3</italic>&#x02014;and these homologs share a high percentage of amino acid identity (71%&#x02013;79%). All three TGF&#x003b2;s are produced in inactive forms as homodimers (or more rarely as heterodimers [<xref rid="B88-cells-08-00969" ref-type="bibr">88</xref>]) bound by latency-associated peptide (LAP) and latent TGF&#x003b2; binding protein (LTBP) [<xref rid="B89-cells-08-00969" ref-type="bibr">89</xref>]. This production in the inactive form separates secretion from activity, an important concept in TGF&#x003b2; biology. All three forms of TGF&#x003b2; are produced by chondrocytes [<xref rid="B90-cells-08-00969" ref-type="bibr">90</xref>,<xref rid="B91-cells-08-00969" ref-type="bibr">91</xref>,<xref rid="B92-cells-08-00969" ref-type="bibr">92</xref>] and a large amount (60&#x02013;200 ng/mL) of inactive TGF&#x003b2; is bound to the ECM of cartilage [<xref rid="B93-cells-08-00969" ref-type="bibr">93</xref>,<xref rid="B94-cells-08-00969" ref-type="bibr">94</xref>]. Because TGF&#x003b2; is produced in the inactive form, activation is a crucial step in TGF&#x003b2; signaling. For this, the noncovalent bond between LAP and TGF&#x003b2; has to be disrupted. This can occur enzymatically by degradation of LAP by, for example, MMP3 [<xref rid="B95-cells-08-00969" ref-type="bibr">95</xref>], or nonenzymatically by a conformational change in the tertiary structure of LAP. Shearing stress [<xref rid="B96-cells-08-00969" ref-type="bibr">96</xref>] or chemical modification of LAP by reactive oxygen species [<xref rid="B97-cells-08-00969" ref-type="bibr">97</xref>] can induce such a conformational change. In addition, mechanical force as produced by compressive loading was also shown to be an important physiological activator of ECM-bound TGF&#x003b2; in cartilage [<xref rid="B98-cells-08-00969" ref-type="bibr">98</xref>].</p><p>In chondrocytes, TGF&#x003b2; induces both SMAD2/3 and SMAD1/5/9-dependent signaling via ALK5 and ALK1, respectively, in addition to SMAD-independent signaling [<xref rid="B99-cells-08-00969" ref-type="bibr">99</xref>,<xref rid="B100-cells-08-00969" ref-type="bibr">100</xref>]. Which pathway is activated by TGF&#x003b2; depends on receptor level expression, co-receptor expression (i.e., endoglin enhances signaling via ALK1), and dose of TGF&#x003b2;. In chondrocytes, a low dose of TGF&#x003b2; predominantly signals via pSMAD2/3, whereas at high dosages, pSMAD1/5 signaling becomes more pronounced. Importantly, both pathways have been described to antagonize each other in chondrocytes [<xref rid="B99-cells-08-00969" ref-type="bibr">99</xref>,<xref rid="B100-cells-08-00969" ref-type="bibr">100</xref>].</p><p>TGF&#x003b2; signaling is associated with cartilage ECM production and maintenance. In mice, a single intra-articular injection of rhTGF&#x003b2;1 or rhTGF&#x003b2;2 increases proteoglycan synthesis twofold after four days, as measured by <sup>35</sup>S-sulfate incorporation in patellar articular cartilage [<xref rid="B101-cells-08-00969" ref-type="bibr">101</xref>,<xref rid="B102-cells-08-00969" ref-type="bibr">102</xref>]. Also in vitro, TGF&#x003b2; enhances proteoglycan production in both chondrocytes and cartilage explants on both mRNA and protein level [<xref rid="B103-cells-08-00969" ref-type="bibr">103</xref>,<xref rid="B104-cells-08-00969" ref-type="bibr">104</xref>,<xref rid="B105-cells-08-00969" ref-type="bibr">105</xref>,<xref rid="B106-cells-08-00969" ref-type="bibr">106</xref>], together with production of other ECM components like COL2A1 [<xref rid="B106-cells-08-00969" ref-type="bibr">106</xref>,<xref rid="B107-cells-08-00969" ref-type="bibr">107</xref>], cartilage oligomeric matrix protein (COMP) [<xref rid="B108-cells-08-00969" ref-type="bibr">108</xref>,<xref rid="B109-cells-08-00969" ref-type="bibr">109</xref>], perlecan [<xref rid="B110-cells-08-00969" ref-type="bibr">110</xref>], fibronectin [<xref rid="B111-cells-08-00969" ref-type="bibr">111</xref>], and hyaluronan [<xref rid="B112-cells-08-00969" ref-type="bibr">112</xref>]. Furthermore, TGF&#x003b2; is a potent inducer of lubricin (PRG4) in chondrocytes [<xref rid="B113-cells-08-00969" ref-type="bibr">113</xref>], a key lubricating component of synovial fluid. However, in contrast to the previously mentioned studies, inhibitory effects of TGF&#x003b2; on chondrocyte proliferation, proteoglycan synthesis, and COL2A1 production have also been described both in vitro and in vivo [<xref rid="B107-cells-08-00969" ref-type="bibr">107</xref>,<xref rid="B114-cells-08-00969" ref-type="bibr">114</xref>,<xref rid="B115-cells-08-00969" ref-type="bibr">115</xref>,<xref rid="B116-cells-08-00969" ref-type="bibr">116</xref>,<xref rid="B117-cells-08-00969" ref-type="bibr">117</xref>,<xref rid="B118-cells-08-00969" ref-type="bibr">118</xref>,<xref rid="B119-cells-08-00969" ref-type="bibr">119</xref>]. Possibly, different receptor signals play a role in these apparently contradictory observations.</p><p>Furthermore, TGF&#x003b2; signaling has important anti-inflammatory effects in cartilage. TGF&#x003b2;1 counteracts proinflammatory IL-1 signaling in vivo [<xref rid="B120-cells-08-00969" ref-type="bibr">120</xref>,<xref rid="B121-cells-08-00969" ref-type="bibr">121</xref>,<xref rid="B122-cells-08-00969" ref-type="bibr">122</xref>] and in vitro [<xref rid="B123-cells-08-00969" ref-type="bibr">123</xref>], and it helps cartilage proteoglycan content recover after inflammation induced depletion [<xref rid="B90-cells-08-00969" ref-type="bibr">90</xref>,<xref rid="B124-cells-08-00969" ref-type="bibr">124</xref>]. How TGF&#x003b2; exerts its anti-inflammatory effects is not fully elucidated yet, but in primary rabbit articular chondrocytes, both TGF&#x003b2;1 and TGF&#x003b2;3 downregulate IL-1 receptor (IL1R1) expression approximately 50% on protein and mRNA level [<xref rid="B123-cells-08-00969" ref-type="bibr">123</xref>,<xref rid="B125-cells-08-00969" ref-type="bibr">125</xref>]. Furthermore, proinflammatory IL-6 signaling is also counteracted by TGF&#x003b2; by downregulation of IL-6 receptor levels in human and bovine chondrocytes [<xref rid="B126-cells-08-00969" ref-type="bibr">126</xref>]. In macrophages, TGF&#x003b2; signaling can also stabilize NF&#x003ba;B inhibitor alpha (NFKBIA, also known as I&#x003ba;B&#x003b1;), which is a potent inhibitor of NF&#x003ba;B, but this mechanism has not been described for chondrocytes yet [<xref rid="B127-cells-08-00969" ref-type="bibr">127</xref>]. Another possible mechanism is the competition between SMAD3 and NF&#x003ba;B for co-activating transcription factors like CREB binding protein, as has been described in endothelial cells [<xref rid="B128-cells-08-00969" ref-type="bibr">128</xref>]. Additionally, many inflammatory genes counteracted by TGF&#x003b2; contain both SMAD3 and NF&#x003ba;b binding sites, leaving room for epigenetic regulation as a mechanism.</p><p>An especially important role for TGF&#x003b2; signaling lies in regulation of chondrocyte hypertrophy. TGF&#x003b2;-induced pSMAD2/3 signaling blocks hypertrophy and terminal differentiation of chondrocytes [<xref rid="B31-cells-08-00969" ref-type="bibr">31</xref>,<xref rid="B33-cells-08-00969" ref-type="bibr">33</xref>,<xref rid="B35-cells-08-00969" ref-type="bibr">35</xref>,<xref rid="B100-cells-08-00969" ref-type="bibr">100</xref>,<xref rid="B129-cells-08-00969" ref-type="bibr">129</xref>]. In contrast, TGF&#x003b2;-induced pSMAD1/5 via ALK1 is associated with chondrocyte hypertrophy [<xref rid="B99-cells-08-00969" ref-type="bibr">99</xref>,<xref rid="B100-cells-08-00969" ref-type="bibr">100</xref>]. Both effects of TGF&#x003b2; on hypertrophy can be observed in vivo. Removal of TGF&#x003b2; signaling in cartilage of two-week-old <italic>Col2-CreER;Tgfbr2<sup>flox/flox</sup></italic> mice results in an OA-like phenotype within 6 months via RUNX2-mediated <italic>Mmp13</italic> and <italic>Adamts5</italic> expression [<xref rid="B130-cells-08-00969" ref-type="bibr">130</xref>]. Furthermore, expression of a kinase-deficient dominant negative form of <italic>Tgfbr2</italic> in mice induces chondrocyte hypertrophy and osteoarthritis [<xref rid="B131-cells-08-00969" ref-type="bibr">131</xref>]. In contrast, removal of TGF&#x003b2; signaling in the hypertrophic chondrocytes of <italic>Col10a1-Cre;Tgfbr2<sup>flox/flox</sup></italic> mice delays terminal differentiation in the epiphyseal plate [<xref rid="B132-cells-08-00969" ref-type="bibr">132</xref>], and removal of TGF&#x003b2; signaling in cartilage of eight-week-old <italic>AgcCreERT2<sup>+/&#x02212;</sup>;Tgfbr2<sup>flox/flox</sup></italic> mice results in less hypertrophic chondrocytes after 12 months [<xref rid="B133-cells-08-00969" ref-type="bibr">133</xref>]. Because efficient removal of TGFBR2 was demonstrated in both the <italic>Col2-CreER;Tgfbr2<sup>flox/flox</sup></italic> and <italic>AgcCreERT2<sup>+/&#x02212;</sup>;Tgfbr2<sup>flox/flox</sup></italic> models, their different outcomes illustrate that age of TGF&#x003b2; signaling depletion (2 vs 8 weeks) and, thus, chondrocyte maturation status greatly affect the outcome and impact of TGF&#x003b2; signaling in chondrocytes.</p><p>Other family members which can induce (chondro-protective) SMAD2/3 signaling in chondrocytes are the activins. However, little is known regarding their role and importance. Activin A, activin AB, and activin B signal via ACVR2A/ACVR2B and ALK4/ALK7 to induce SMAD2/3 [<xref rid="B134-cells-08-00969" ref-type="bibr">134</xref>]. Expression of the activin A subunit inhibin &#x003b2; A (<italic>INHBA</italic>) and activin A itself are upregulated in OA cartilage [<xref rid="B135-cells-08-00969" ref-type="bibr">135</xref>,<xref rid="B136-cells-08-00969" ref-type="bibr">136</xref>] but also expression of its inhibitor follistatin is upregulated [<xref rid="B137-cells-08-00969" ref-type="bibr">137</xref>,<xref rid="B138-cells-08-00969" ref-type="bibr">138</xref>]. A possible role, which has been demonstrated in vitro, is the inhibition of IL-1-induced ADAMTS4/5 activity [<xref rid="B136-cells-08-00969" ref-type="bibr">136</xref>], which would indicate an anti-inflammatory role similar to the TGF&#x003b2;s. However, a lack of response of adult cartilage tissue to activin A has been observed in multiple studies [<xref rid="B109-cells-08-00969" ref-type="bibr">109</xref>,<xref rid="B139-cells-08-00969" ref-type="bibr">139</xref>,<xref rid="B140-cells-08-00969" ref-type="bibr">140</xref>]; for example, activin A slightly induces proteoglycan synthesis (i.e., <sup>35</sup>S-incorporation) in immature (1&#x02013;3 months old) but not in mature (&#x0003e;18 months old) bovine articular cartilage explants [<xref rid="B140-cells-08-00969" ref-type="bibr">140</xref>]. Even less is known regarding the role in cartilage of the activin antagonists, the inhibins, and only one study reports that inhibin inhibits both proteoglycan synthesis (i.e., <sup>35</sup>S-incorporation) and DNA synthesis in bovine chondrocytes [<xref rid="B140-cells-08-00969" ref-type="bibr">140</xref>], which would indicate that activin signaling contributes to both these processes, again similar to the TGF&#x003b2;s.</p></sec><sec id="sec3dot2-cells-08-00969"><title>3.2. Bone Morphogenetic Proteins (BMPs)</title><p>Multiple BMPs play an important role in chondrocyte biology, including BMP2, BMP7 (OP1), BMP4, BMP6, BMP9 (GDF2), and BMP14 (GDF5) [<xref rid="B141-cells-08-00969" ref-type="bibr">141</xref>,<xref rid="B142-cells-08-00969" ref-type="bibr">142</xref>]. Chondrocytes express the BMP type I receptors ALK1, ALK2, ALK3, and ALK6 and the type II receptors BMPR2, ACVR2A, and ACVR2B. Genetic variation in either of these factors is not yet associated with OA. Like the TGF&#x003b2;s, BMPs are produced as a dimer, but not only as homodimers; heterodimers of BMP2/6, BMP2/7, and BMP4/7 have been described both in vitro and in vivo [<xref rid="B143-cells-08-00969" ref-type="bibr">143</xref>]. In contrast to TGF&#x003b2; activity, BMP activity is not thought to be controlled via reassembly of BMPs with their prodomain to form a latency complex [<xref rid="B143-cells-08-00969" ref-type="bibr">143</xref>]. BMPs do reassemble with their prodomain to facilitate ECM binding, but this does not seem to confer latency because it does not impair receptor type I and II binding [<xref rid="B89-cells-08-00969" ref-type="bibr">89</xref>,<xref rid="B143-cells-08-00969" ref-type="bibr">143</xref>,<xref rid="B144-cells-08-00969" ref-type="bibr">144</xref>]. Instead, antagonistic scavenger proteins (e.g., gremlin, noggin, and sclerostin) and decoy receptors like BAMBI play an important role in modulating BMP activity, all of which are produced by chondrocytes. Additionally, BMPs can antagonize each other via competition for receptor type II binding [<xref rid="B145-cells-08-00969" ref-type="bibr">145</xref>].</p><p>In both healthy and OA cartilage, <italic>Bmp2</italic> mRNA expression can be detected [<xref rid="B146-cells-08-00969" ref-type="bibr">146</xref>]. BMP2 signaling induces ECM production and proliferation. In ex vivo juvenile cartilage, BMP2 induces proteoglycan content and COL2A1 production, as measured by <sup>3</sup>H-proline incorporation assays [<xref rid="B147-cells-08-00969" ref-type="bibr">147</xref>], whereas in vivo intra-articular injection of BMP2 in murine knee joints enhances proteoglycan synthesis 2.5-fold (i.e., <sup>35</sup>S-incorporation) in patellar cartilage within two days [<xref rid="B102-cells-08-00969" ref-type="bibr">102</xref>]. Furthermore, intra-articular overexpression of BMP2 in the murine knee joint using adenoviruses also enhances cartilage proteoglycan content [<xref rid="B148-cells-08-00969" ref-type="bibr">148</xref>]. In in vitro mesenchymal stromal cells and chondrocyte-like cell lines, and in in vivo epiphyseal chondrocytes, BMP2 is a well-known inducer of chondrocyte maturation and hypertrophy [<xref rid="B149-cells-08-00969" ref-type="bibr">149</xref>]. However, in mice with cartilage-specific, tamoxifen-inducible overexpression of BMP2 (<italic>Col2 rTA; TRE-Bmp2</italic>), increased hypertrophy is not observed in articular cartilage after six weeks of prolonged exposure to tamoxifen [<xref rid="B150-cells-08-00969" ref-type="bibr">150</xref>]. Furthermore, in the DMM model of experimental OA, the presence of excessive BMP2 signaling does not negatively, nor positively, affect cartilage damage but does induce very extensive osteophyte formation [<xref rid="B150-cells-08-00969" ref-type="bibr">150</xref>]. These observations might indicate that, in vivo, articular cartilage is not very sensitive to BMP2 signaling compared to osteophyte-forming tissues like periosteum. Possibly, signaling of hyaluronan, an important structural component of cartilage, via CD44 plays a role in this, as it has been demonstrated that this inhibits BMP2-induced pSMAD1/5 signaling in the murine bone marrow-derived ST2 stromal cell line [<xref rid="B151-cells-08-00969" ref-type="bibr">151</xref>]. Alternatively, GDF5 has recently been shown to be a context-dependent inhibitor of BMP2 signaling, via a yet unknown mechanism, possibly involving receptor competition [<xref rid="B152-cells-08-00969" ref-type="bibr">152</xref>], and GDF5 is present in cartilage [<xref rid="B153-cells-08-00969" ref-type="bibr">153</xref>,<xref rid="B154-cells-08-00969" ref-type="bibr">154</xref>,<xref rid="B155-cells-08-00969" ref-type="bibr">155</xref>].</p><p><italic>BMP7</italic> mRNA and protein expression can be detected in both immature and mature articular cartilage. Immunohistochemically, mature BMP7 can predominantly be detected in chondrocytes of the superficial zone, whereas its pro-form is mainly detected in deep zone chondrocytes [<xref rid="B156-cells-08-00969" ref-type="bibr">156</xref>,<xref rid="B157-cells-08-00969" ref-type="bibr">157</xref>]. To signal, BMP7 can use ALK2, ALK3, and ALK6, and the type II receptors BMPR2, ACVR2A, and ACVR2B, to induce SMAD1/5 phosphorylation and SMAD-independent signaling [<xref rid="B143-cells-08-00969" ref-type="bibr">143</xref>]. In contrast to BMP2, a positive interaction of CD44 with BMP7 signaling has been described. Without CD44, chondrocytes are not able to induce pSMAD1/5 in response to BMP7 [<xref rid="B158-cells-08-00969" ref-type="bibr">158</xref>,<xref rid="B159-cells-08-00969" ref-type="bibr">159</xref>,<xref rid="B160-cells-08-00969" ref-type="bibr">160</xref>]. In chondrocytes, BMP7 signaling induces ECM production. Both proteoglycan and <italic>COL2A1</italic> production are induced in vitro in juvenile and adult human primary chondrocytes [<xref rid="B139-cells-08-00969" ref-type="bibr">139</xref>] and ex vivo in juvenile bovine explants [<xref rid="B147-cells-08-00969" ref-type="bibr">147</xref>]. Furthermore, inhibition of endogenous BMP7 production with antisense oligonucleotides in cartilage explants lowers aggrecan production [<xref rid="B161-cells-08-00969" ref-type="bibr">161</xref>]. In vitro, BMP7 also induces the expression of cartilage oligomeric matrix protein [<xref rid="B109-cells-08-00969" ref-type="bibr">109</xref>] and hyaluronan synthase 2, resulting in more hyaluronan production by chondrocytes, possibly facilitating deposition of aggrecan in the ECM [<xref rid="B162-cells-08-00969" ref-type="bibr">162</xref>]. In addition, BMP7 can counteract an IL-1- or LPS-induced inhibition of proteoglycan synthesis in chondrocytes [<xref rid="B163-cells-08-00969" ref-type="bibr">163</xref>,<xref rid="B164-cells-08-00969" ref-type="bibr">164</xref>,<xref rid="B165-cells-08-00969" ref-type="bibr">165</xref>], and partly inhibit IL-1-induced <italic>MMP13</italic> expression, especially in the presence of IGF1 [<xref rid="B166-cells-08-00969" ref-type="bibr">166</xref>]. The positive effects of BMP7 in vitro are reflected in vivo: conditional deletion of <italic>Bmp7</italic> from limb mesenchyme in <italic>Prx-Cre;Bmp7<sup>flox/flox</sup></italic> mice results in proteoglycan loss (at 8 weeks old) and enhanced <italic>Mmp13</italic> expression (at 24 weeks old) [<xref rid="B167-cells-08-00969" ref-type="bibr">167</xref>]. Of note, joint and cartilage formation were not detectably affected in these mice, but <italic>Bmp7</italic> deletion did result in synovial inflammation, making it difficult to exclude indirect effects. Administration of BMP7 is beneficial for cartilage in OA [<xref rid="B168-cells-08-00969" ref-type="bibr">168</xref>,<xref rid="B169-cells-08-00969" ref-type="bibr">169</xref>]. Osteoarthritic cartilage is still responsive to BMP7 [<xref rid="B155-cells-08-00969" ref-type="bibr">155</xref>], and weekly injections of BMP7 diminish cartilage damage in the rabbit ACLT model of OA [<xref rid="B170-cells-08-00969" ref-type="bibr">170</xref>]. Furthermore, BMP7 increases the quantity and quality of cartilage repair tissue in rabbits with a full thickness cartilage defect [<xref rid="B171-cells-08-00969" ref-type="bibr">171</xref>]. Remarkably, although BMP7 can induce ectopic bone formation [<xref rid="B172-cells-08-00969" ref-type="bibr">172</xref>], excessive osteophyte formation was not observed in these studies, nor was excessive osteophyte formation observed in humans after a single injection of BMP7 in a Phase 1 study done in symptomatic knee OA patients [<xref rid="B173-cells-08-00969" ref-type="bibr">173</xref>]. Although BMP7 induces SMAD1/5 phosphorylation, its signaling is not associated with chondrocyte hypertrophy. Bovine articular chondrocytes do not undergo hypertrophy when cultured with BMP7 [<xref rid="B174-cells-08-00969" ref-type="bibr">174</xref>], and BMP7 blocks hypertrophy in the ATDC5 cell line [<xref rid="B175-cells-08-00969" ref-type="bibr">175</xref>]. In long bone formation ex vivo, BMP7 does stimulate the formation of pre-hypertrophic chondrocytes in the epiphyseal plate but blocks the transition towards hypertrophy [<xref rid="B176-cells-08-00969" ref-type="bibr">176</xref>]. This anti-hypertrophic effect of BMP7 has contributed to its ability to induce the transcription factor BAPX-1/NKX-3.2, a potent modulator of chondrocyte hypertrophy [<xref rid="B177-cells-08-00969" ref-type="bibr">177</xref>]. However, BMP7 does induce ALPL activity and osteogenesis in primary fetal chondrocytes [<xref rid="B178-cells-08-00969" ref-type="bibr">178</xref>], and chick sternum chondrocytes do undergo hypertrophy when cultured with BMP7 [<xref rid="B179-cells-08-00969" ref-type="bibr">179</xref>], indicating that BMP7 can induce chondrocyte hypertrophy, but, like TGF&#x003b2;, it is in a context-dependent manner.</p><p>Two other BMPs well known for their positive effect on chondrogenesis and cartilage formation are BMP4 and BMP6, which both signal via ALK2 and ALK3 to induce pSMAD1/5 and SMAD-independent signaling. However, very little is known regarding their role in mature articular cartilage. In bovine chondrocytes and cartilage explants, BMP4 enhances proteoglycan synthesis, COL2A1 production, and proliferation [<xref rid="B140-cells-08-00969" ref-type="bibr">140</xref>], and BMP4 has similar effects in human chondrocytes cultured in alginate [<xref rid="B164-cells-08-00969" ref-type="bibr">164</xref>]. BMP6 mRNA and protein are expressed in both healthy and OA articular cartilage [<xref rid="B141-cells-08-00969" ref-type="bibr">141</xref>]. In human chondrocytes, BMP6 induces proteoglycan synthesis [<xref rid="B164-cells-08-00969" ref-type="bibr">164</xref>,<xref rid="B180-cells-08-00969" ref-type="bibr">180</xref>], but with advancing age, chondrocyte response to BMP6 decreases [<xref rid="B180-cells-08-00969" ref-type="bibr">180</xref>]. However, in the epiphyseal plate, BMP6 is especially expressed in the hypertrophic zone [<xref rid="B181-cells-08-00969" ref-type="bibr">181</xref>] where it has a stimulatory role on chondrocyte maturation. Furthermore, a pro-hypertrophic effect of BMP6 has also been observed in ATDC5 cells [<xref rid="B182-cells-08-00969" ref-type="bibr">182</xref>]. These studies indicate that BMP6 signaling could be detrimental for articular cartilage</p><p>A BMP that has more recently come to attention is BMP9, also known as GDF2. This BMP signals via type II receptors ACVR2A/ACVR2B and BMPR2 and type I receptors ALK1, and/or ALK2 to induce SMAD1/5 and SMAD-independent signaling. Production of BMP9 could not be detected in chondrocytes [<xref rid="B141-cells-08-00969" ref-type="bibr">141</xref>], but BMP9 circulates in high levels in blood [<xref rid="B183-cells-08-00969" ref-type="bibr">183</xref>]. In juvenile bovine cartilage, BMP9 enhances the production of proteoglycans and does so more potently than BMP2 [<xref rid="B147-cells-08-00969" ref-type="bibr">147</xref>]. However, BMP9 can also induce ECM mineralization when chondrocytes are seeded in biodegradable polyglycolic acid (PGA) scaffolds [<xref rid="B184-cells-08-00969" ref-type="bibr">184</xref>]. Additionally, also in mesenchymal progenitor cells, BMP9 is a potent inducer of chondrogenesis accompanied by hypertrophy [<xref rid="B185-cells-08-00969" ref-type="bibr">185</xref>]. Therefore, BMP9 possibly has a detrimental effect on chondrocyte homeostasis. Indeed, increased hypertrophy was observed in primary bovine chondrocytes stimulated with this BMP, but remarkably, this was efficiently blocked via a synergy with TGF&#x003b2;1 on SMAD2/3 phosphorylation [<xref rid="B186-cells-08-00969" ref-type="bibr">186</xref>].</p><p>BMP14, better known as GDF5, is a very important initiator of joint formation and patterning. The importance of GDF5 in cartilage biology is illustrated by the observations that mutations in <italic>GDF5</italic> can lead to chondrodysplasias, and that a genetic SNP in the core promotor of <italic>GDF5,</italic> resulting in reduced GDF5 protein levels, is associated with OA development [<xref rid="B187-cells-08-00969" ref-type="bibr">187</xref>]. However, regarding the role of GDF5 in mature cartilage, relatively little is known. In chondrocytes, GDF5 predominantly signals via ALK6 [<xref rid="B178-cells-08-00969" ref-type="bibr">178</xref>] but can also signal via ALK2 and ALK3 [<xref rid="B152-cells-08-00969" ref-type="bibr">152</xref>] to induce SMAD1/5 phosphorylation and SMAD-independent signaling [<xref rid="B188-cells-08-00969" ref-type="bibr">188</xref>]. <italic>GDF5</italic> is expressed in (im)mature cartilage, but its expression is not affected by OA [<xref rid="B141-cells-08-00969" ref-type="bibr">141</xref>,<xref rid="B154-cells-08-00969" ref-type="bibr">154</xref>,<xref rid="B155-cells-08-00969" ref-type="bibr">155</xref>]. In cartilage, GDF5 induces proteoglycan synthesis [<xref rid="B154-cells-08-00969" ref-type="bibr">154</xref>,<xref rid="B178-cells-08-00969" ref-type="bibr">178</xref>] and <italic>COMP</italic> expression [<xref rid="B109-cells-08-00969" ref-type="bibr">109</xref>] but neither <italic>COL2A1</italic> synthesis nor chondrocyte proliferation [<xref rid="B154-cells-08-00969" ref-type="bibr">154</xref>]. Notably, OA chondrocytes do not respond consistently to GDF5 [<xref rid="B188-cells-08-00969" ref-type="bibr">188</xref>]; that is, large variations can be observed between OA patients on gene expression of targets like <italic>ACAN</italic> and <italic>SOX9</italic> after addition of GDF5. Possibly, a yet undiscovered co-receptor plays a role in this. Such a co-receptor has been postulated to explain how GDF5 can function as a downstream BMP2 antagonist in ATDC5 cells even though it uses the same type I and type II receptors [<xref rid="B152-cells-08-00969" ref-type="bibr">152</xref>]. Identification of such a co-receptor would greatly help in understanding GDF5 signaling in chondrocytes and how it differs from BMP signaling using the same receptors.</p><p><xref ref-type="fig" rid="cells-08-00969-f004">Figure 4</xref> summarizes the effects of the different TGF&#x003b2; family members on cartilage biology and OA development.</p></sec></sec><sec id="sec4-cells-08-00969"><title>4. Changes in TGF&#x003b2; Family Signaling as Cause for Disease</title><sec id="sec4dot1-cells-08-00969"><title>4.1. Age-Related Changes in TGF&#x003b2; Signaling</title><p>In view of the aforementioned importance of TGF&#x003b2; family members in chondrocyte and cartilage homeostasis, it is not surprising that alterations in their signaling affect cartilage biology and can lead to pathology. Alterations can occur because of various reasons, for example due to aging. Aging affects TGF&#x003b2; family signaling on multiple levels in the signaling cascade. For example, ligand and receptor expression can be affected, just as intracellular signaling and regulation of gene transcription [<xref rid="B90-cells-08-00969" ref-type="bibr">90</xref>,<xref rid="B121-cells-08-00969" ref-type="bibr">121</xref>,<xref rid="B189-cells-08-00969" ref-type="bibr">189</xref>,<xref rid="B190-cells-08-00969" ref-type="bibr">190</xref>,<xref rid="B191-cells-08-00969" ref-type="bibr">191</xref>].</p><p>A prime example of how aging affects ligand expression is BMP7. In human cartilage, BMP7 gene and protein levels decline with advancing age. This decrease has been attributed to increased methylation of its promoter, resulting in silencing of its expression [<xref rid="B192-cells-08-00969" ref-type="bibr">192</xref>,<xref rid="B193-cells-08-00969" ref-type="bibr">193</xref>]. In contrast, mRNA expressions of <italic>BMP2</italic>, <italic>BMP6,</italic> and <italic>BMP9</italic> do not seem to be affected by aging [<xref rid="B141-cells-08-00969" ref-type="bibr">141</xref>,<xref rid="B146-cells-08-00969" ref-type="bibr">146</xref>,<xref rid="B156-cells-08-00969" ref-type="bibr">156</xref>,<xref rid="B190-cells-08-00969" ref-type="bibr">190</xref>]. In mice, protein expression levels of TGF&#x003b2;2 and TGF&#x003b2;3 (but not TGF&#x003b2;1) decreased with age [<xref rid="B90-cells-08-00969" ref-type="bibr">90</xref>], whereas in cows, a drop in <italic>Tgfb1</italic> mRNA expression was observed [<xref rid="B142-cells-08-00969" ref-type="bibr">142</xref>].</p><p>Also, receptor expression is impacted by aging. Of type I receptors, a profound drop in ALK5 expression has been observed in humans, mice, guinea pigs, and cows on gene expression and protein level [<xref rid="B100-cells-08-00969" ref-type="bibr">100</xref>,<xref rid="B142-cells-08-00969" ref-type="bibr">142</xref>,<xref rid="B194-cells-08-00969" ref-type="bibr">194</xref>], indicating that this occurs consistently across species. In addition, on gene expression levels, loss of <italic>Alk2</italic>, <italic>Alk3,</italic> and <italic>Alk4</italic> has also been observed in bovine cartilage [<xref rid="B90-cells-08-00969" ref-type="bibr">90</xref>,<xref rid="B142-cells-08-00969" ref-type="bibr">142</xref>]. Notably, loss of receptor expression can not only lead to loss of the growth factor response but also alters the signaling of ligands able to use multiple receptors. For example, this has been demonstrated for TGF&#x003b2; signaling because aging affects <italic>Alk5</italic> expression more than <italic>Alk1</italic> expression, and TGF&#x003b2; induces relatively more SMAD1/5 phosphorylation in old cartilage, with all due effects [<xref rid="B142-cells-08-00969" ref-type="bibr">142</xref>,<xref rid="B194-cells-08-00969" ref-type="bibr">194</xref>]. Next to these differences in type I receptor expression, an age-related decrease in <italic>Bmpr2</italic> has also been observed [<xref rid="B142-cells-08-00969" ref-type="bibr">142</xref>]. This could possibly explain the age-related loss in the BMP7 response of chondrocytes that has been observed [<xref rid="B190-cells-08-00969" ref-type="bibr">190</xref>]. However, how age-related changes affect BMP signaling (besides BMP7) in chondrocyte homeostasis has not yet been sufficiently investigated.</p><p>Changes in receptor expression can affect intracellular signaling. As mentioned, an age-related change in receptor type I expression towards relatively more ALK1 shifts the balance from protective signaling (SMAD2/3) into deleterious signaling (SMAD1/5/9). The loss of protective SMAD2/3 signaling could explain the relation between aging and OA development [<xref rid="B12-cells-08-00969" ref-type="bibr">12</xref>,<xref rid="B195-cells-08-00969" ref-type="bibr">195</xref>]. Indeed, the changing ALK1/ALK5 ratio in aging correlates with <italic>Mmp13</italic> expression and OA development [<xref rid="B89-cells-08-00969" ref-type="bibr">89</xref>]. Computational modeling supports a direct effect, especially TGF&#x003b2; signaling via ALK1, which can explain <italic>Mmp13</italic> expression and cartilage damage in aged cartilage [<xref rid="B196-cells-08-00969" ref-type="bibr">196</xref>]. Possibly, these effects run via decreased modulation of RUNX2 activity. SMADs interact with RUNX2 to modulate chondrocyte differentiation, where interaction of SMAD3 with RUNX2 inhibits RUNX2 functioning and SMAD1/5 stimulates it [<xref rid="B36-cells-08-00969" ref-type="bibr">36</xref>,<xref rid="B53-cells-08-00969" ref-type="bibr">53</xref>,<xref rid="B197-cells-08-00969" ref-type="bibr">197</xref>,<xref rid="B198-cells-08-00969" ref-type="bibr">198</xref>].</p></sec><sec id="sec4dot2-cells-08-00969"><title>4.2. Joint Loading-Related Changes in TGF&#x003b2; Signaling</title><p>Next to aging, another factor able to modulate TGF&#x003b2; family signaling is (mechanical) loading. For example, mechanical joint loading has been shown to play a crucial role in activation of SMAD2/3 signaling [<xref rid="B97-cells-08-00969" ref-type="bibr">97</xref>,<xref rid="B199-cells-08-00969" ref-type="bibr">199</xref>,<xref rid="B200-cells-08-00969" ref-type="bibr">200</xref>]. In bovine articular cartilage explants, mechanical compression quickly induced SMAD2/3 signaling, most likely due to mechanical activation of latent TGF&#x003b2; bound to the ECM of cartilage, as cartilage contains high levels of this. This loading-induced pSMAD2/3 signaling induced a positive feedback loop, by stimulating expression of <italic>Tgfb1</italic> and <italic>Alk5</italic>. In contrast, unloading rapidly induced loss of SMAD2/3 signaling from articular cartilage (&#x0003c;2 h), possibly due to sequestering of available TGF&#x003b2; [<xref rid="B201-cells-08-00969" ref-type="bibr">201</xref>]. As a consequence of this, prolonged (2 weeks) unloading of cartilage resulted in dramatically increased <italic>Col10a1</italic> expression, a marker of chondrocyte hypertrophy. However, repeated loading of cartilage every third day efficiently blocked this increase in <italic>Col10a1</italic> expression. These observations show the importance of cartilage loading for maintenance of SMAD2/3 signaling and cartilage homeostasis. In view of the effects of SMAD3 signaling in cartilage, this mechanism possibly also explains the observations that reduced joint loading contributes to cartilage degeneration and production of the proteolytic enzymes MMP8 and MMP13 [<xref rid="B202-cells-08-00969" ref-type="bibr">202</xref>,<xref rid="B203-cells-08-00969" ref-type="bibr">203</xref>]. Importantly, old cartilage, compared to young cartilage, has a strongly reduced capacity for this loading-mediated SMAD2/3 signaling, which possibly makes it more vulnerable to OA development [<xref rid="B201-cells-08-00969" ref-type="bibr">201</xref>,<xref rid="B204-cells-08-00969" ref-type="bibr">204</xref>]. Interestingly, a sedentary lifestyle was recently hypothesized to be the cause for the doubled OA prevalence in current populations compared to those from the 1800s to early 1900s after correction for age and BMI [<xref rid="B205-cells-08-00969" ref-type="bibr">205</xref>]; thus, possibly these observations are linked. Loading also induces BMP levels; BMP2, BMP4, BMP6, and BMPR2 are increased by moderate exercise and suppresses post-traumatic OA [<xref rid="B206-cells-08-00969" ref-type="bibr">206</xref>]. However, excessive loading has been shown to lead to collagen damage, proteoglycan loss, and OA progression, and these effects have been attributed to induction of gremlin-1, a BMP antagonist [<xref rid="B207-cells-08-00969" ref-type="bibr">207</xref>,<xref rid="B208-cells-08-00969" ref-type="bibr">208</xref>]. Together, these studies show the impact of loading on TGF&#x003b2; family signaling.</p></sec><sec id="sec4dot3-cells-08-00969"><title>4.3. Inflammation-Related Changes in TGF&#x003b2; Signaling</title><p>Previously, cartilage breakdown during OA was considered to be a simple wear and tear process. However, nowadays, OA is regarded as a whole joint disease, with inflammation strongly implicated in its pathogenesis [<xref rid="B209-cells-08-00969" ref-type="bibr">209</xref>,<xref rid="B210-cells-08-00969" ref-type="bibr">210</xref>]. In over 50% of patients, synovitis (i.e., inflammation of the synovium or joint capsule) can be observed [<xref rid="B211-cells-08-00969" ref-type="bibr">211</xref>,<xref rid="B212-cells-08-00969" ref-type="bibr">212</xref>,<xref rid="B213-cells-08-00969" ref-type="bibr">213</xref>,<xref rid="B214-cells-08-00969" ref-type="bibr">214</xref>,<xref rid="B215-cells-08-00969" ref-type="bibr">215</xref>,<xref rid="B216-cells-08-00969" ref-type="bibr">216</xref>,<xref rid="B217-cells-08-00969" ref-type="bibr">217</xref>]. Important inflammatory mediators produced by this synovitis are IL-1, TNF-&#x003b1;, IL-8, and IL-6 [<xref rid="B210-cells-08-00969" ref-type="bibr">210</xref>,<xref rid="B218-cells-08-00969" ref-type="bibr">218</xref>,<xref rid="B219-cells-08-00969" ref-type="bibr">219</xref>,<xref rid="B220-cells-08-00969" ref-type="bibr">220</xref>,<xref rid="B221-cells-08-00969" ref-type="bibr">221</xref>]. These pro-inflammatory cytokines have a direct effect on cartilage homeostasis by upregulating MMPs and other cartilage-degrading enzymes [<xref rid="B222-cells-08-00969" ref-type="bibr">222</xref>,<xref rid="B223-cells-08-00969" ref-type="bibr">223</xref>,<xref rid="B224-cells-08-00969" ref-type="bibr">224</xref>,<xref rid="B225-cells-08-00969" ref-type="bibr">225</xref>] but, importantly, also have been described to modulate TGF&#x003b2; family signaling [<xref rid="B226-cells-08-00969" ref-type="bibr">226</xref>,<xref rid="B227-cells-08-00969" ref-type="bibr">227</xref>].</p><p>For example, IL-1 can downregulate TGFBR2 on mRNA and protein expression in human articular chondrocytes [<xref rid="B226-cells-08-00969" ref-type="bibr">226</xref>]. Also, pro-inflammatory mediators produced by inflamed synovium, which was cultured in vitro (OA synovium conditioned medium), reduced <italic>Tgfbr2</italic> expression in mechanically compressed bovine cartilage explants [<xref rid="B228-cells-08-00969" ref-type="bibr">228</xref>]. IL-1 has also been described to inhibit BMP7 signaling via downregulation of the ALK2 and ALK3 receptors and inhibition of <italic>SMAD1</italic> expression [<xref rid="B229-cells-08-00969" ref-type="bibr">229</xref>]. But in contrast, IL-1 has also been described to induce <italic>BMP2</italic> and <italic>BMP7</italic> mRNA expression in chondrocytes, and a high dose of IL-1 leads to the activation of pro-BMP7 into the active form [<xref rid="B230-cells-08-00969" ref-type="bibr">230</xref>].</p><p>Next to modulation of receptor expression, inflammatory mediators can also affect SMAD-dependent signaling via various mechanisms. For instance, IL-1 can increase the expression of i-<italic>SMAD7</italic> via NF-&#x003ba;B activation in chondrocytes, which inhibits SMAD2/3 signaling [<xref rid="B231-cells-08-00969" ref-type="bibr">231</xref>]. Furthermore, TNF-&#x003b1; and IL-1 have been described to be able to decrease DNA binding activity of SMAD3/4 complexes in human OA chondrocytes via unknown mechanisms but independent of i-SMAD7 [<xref rid="B227-cells-08-00969" ref-type="bibr">227</xref>]. In addition, inflammation-induced transcription factors can compete with SMADs for co-factors. For example, SMAD3 and NF&#x003ba;B (a transcription factor downstream of TAK1) can compete for their common co-transcription factor CREB binding protein (CBP) in endothelial cells [<xref rid="B127-cells-08-00969" ref-type="bibr">127</xref>].</p><p>Recent insights provided another way of how pro-inflammatory pathways can interact with SMAD-dependent signaling, namely by post-translational modification of the linker region of SMAD proteins [<xref rid="B232-cells-08-00969" ref-type="bibr">232</xref>,<xref rid="B233-cells-08-00969" ref-type="bibr">233</xref>]. SMAD proteins consist of a N-terminal MH1 (missing in i-SMAD6 and i-SMAD7), important for DNA binding activity and nuclear importation, and a C-terminal MH2 domain, responsible for SMAD-receptor and SMAD&#x02013;SMAD interactions and gene transcription activation [<xref rid="B234-cells-08-00969" ref-type="bibr">234</xref>,<xref rid="B235-cells-08-00969" ref-type="bibr">235</xref>,<xref rid="B236-cells-08-00969" ref-type="bibr">236</xref>,<xref rid="B237-cells-08-00969" ref-type="bibr">237</xref>]. These two conserved MH1 and MH2 domains are connected via a regulatory linker domain, which can be phosphorylated on specific serine and threonine residues. This phosphorylation of the linker region regulates nuclear entry, SMAD&#x02013;protein interactions, and SMAD turnover [<xref rid="B232-cells-08-00969" ref-type="bibr">232</xref>,<xref rid="B238-cells-08-00969" ref-type="bibr">238</xref>,<xref rid="B239-cells-08-00969" ref-type="bibr">239</xref>]. For instance, mutation of the <italic>SMAD3</italic> linker resulted in strongly enhanced TGF&#x003b2;-induced responses in breast cancer cells and increased tumorigenesis during liver cancer [<xref rid="B240-cells-08-00969" ref-type="bibr">240</xref>,<xref rid="B241-cells-08-00969" ref-type="bibr">241</xref>]. Also, mutations in the linker of <italic>SMAD4</italic>, commonly found in colorectal and pancreatic cancers, result in rapid proteasomal degradation and loss of function [<xref rid="B242-cells-08-00969" ref-type="bibr">242</xref>,<xref rid="B243-cells-08-00969" ref-type="bibr">243</xref>]. These findings show that modification of the SMAD linkers greatly affect SMAD function (<xref ref-type="fig" rid="cells-08-00969-f003">Figure 3</xref>).</p><p>Phosphorylation of the serine and threonine residues in the linker domain is dependent on kinases, including MAPKs, ERK, JNK, p38, AKT, CDKs, ROCK, and GSK-3 [<xref rid="B233-cells-08-00969" ref-type="bibr">233</xref>,<xref rid="B238-cells-08-00969" ref-type="bibr">238</xref>,<xref rid="B239-cells-08-00969" ref-type="bibr">239</xref>,<xref rid="B244-cells-08-00969" ref-type="bibr">244</xref>,<xref rid="B245-cells-08-00969" ref-type="bibr">245</xref>,<xref rid="B246-cells-08-00969" ref-type="bibr">246</xref>]. In addition, dephosphorylation of the SMAD linker, dependent on phosphatases [<xref rid="B237-cells-08-00969" ref-type="bibr">237</xref>,<xref rid="B247-cells-08-00969" ref-type="bibr">247</xref>,<xref rid="B248-cells-08-00969" ref-type="bibr">248</xref>], is just as important for regulating SMAD function. Notably, many of these kinases and phosphatases are induced in chondrocytes by inflammatory mediators [<xref rid="B222-cells-08-00969" ref-type="bibr">222</xref>,<xref rid="B249-cells-08-00969" ref-type="bibr">249</xref>,<xref rid="B250-cells-08-00969" ref-type="bibr">250</xref>,<xref rid="B251-cells-08-00969" ref-type="bibr">251</xref>,<xref rid="B252-cells-08-00969" ref-type="bibr">252</xref>] present in the OA joint. This makes it likely that inflammation-induced kinases can also affect SMAD function in cartilage, thereby affecting TGF&#x003b2; and BMP signaling and, thus, a possible cause for OA. Still, the relative importance of these SMAD linker modifications in cartilage biology and OA pathogenesis is not well understood yet and warrants further research.</p><p>A (simplified) overview of SMAD modifications in the linker-domain that can alter TGF&#x003b2; signaling is depicted in <xref ref-type="fig" rid="cells-08-00969-f005">Figure 5</xref>.</p></sec></sec><sec id="sec5-cells-08-00969"><title>5. Future Perspectives</title><p>In conclusion, members of the TGF&#x003b2; family are crucial for the homeostasis of chondrocytes and, thus, of cartilage. Signaling in cartilage goes via both SMAD-dependent and SMAD-independent signaling, although both pathways are more integrated than their names suggest. Cellular context plays a large role in TGF&#x003b2; family signaling, greatly affecting its outcome, which is illustrated by, for example, the differential effects of TGF&#x003b2; and BMP7 in immature versus mature chondrocytes. How aging or inflammation provide cellular context, which regulates TGF&#x003b2; family signaling in articular cartilage, is still largely unknown. Gaining greater insights into this would help to better understand OA development and progression, and it would give leads for how to separate the beneficial effects of TGF&#x003b2; family members from their detrimental effects. This topic, thus, definitely warrants further research. Of special interest might be the interaction of SMADs with other transcription factors. Such interactions control (efficient) targeting and transcription of (potential) target genes. Altered interactions, for example due to altered SMAD linker modifications, could explain context-dependent gain and loss of function. How, for instance, the SMAD&#x02013;RUNX2 interaction is affected by aging or inflammation could be of great importance for cartilage degeneration. Closely related to this, it would be important to further study other SMAD binding partners involved in regulating chondrocyte hypertrophy such as myocyte enhancer-binding factor 2 (MEF2). This transcription factor has been shown to induce RUNX2 expression and hypertrophy in cartilage [<xref rid="B253-cells-08-00969" ref-type="bibr">253</xref>], and it has been described to interact and be inhibited by SMAD3 in muscle cells [<xref rid="B254-cells-08-00969" ref-type="bibr">254</xref>,<xref rid="B255-cells-08-00969" ref-type="bibr">255</xref>]. Identifying such interactions in articular chondrocytes can help us learn how cartilage degradation is regulated and would give leads on how to counteract this. Another topic of interest is preventing the negative impact of processes such as inflammation on TGF&#x003b2; family signaling in cartilage. For this, a better understanding of the cellular processes driving these negative effects is needed, but this hardly has been investigated until now. Especially, the relevance of inflammation-driven SMAD linker post-translational modifications as causes for disturbed TGF&#x003b2; and BMP signaling warrants attention, because this possibly will provide a new avenue of targeted therapy directed at the inhibition of cartilage degradation in OA by targeting the intracellular kinases and phosphatases responsible for these modifications.</p></sec></body><back><notes><title>Funding</title><p>This research was funded by the Dutch Arthritis Foundation (ReumaNederland), grant number 16-1-401. The APC was funded by the Dutch Arthritis Foundation (ReumaNederland) and Radboud University. </p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-cells-08-00969"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sophia Fox</surname><given-names>A.J.</given-names></name><name><surname>Bedi</surname><given-names>A.</given-names></name><name><surname>Rodeo</surname><given-names>S.A.</given-names></name></person-group><article-title>The basic science of articular cartilage: Structure, composition, and function</article-title><source>Sports Health</source><year>2009</year><volume>1</volume><fpage>461</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1177/1941738109350438</pub-id><pub-id pub-id-type="pmid">23015907</pub-id></element-citation></ref><ref id="B2-cells-08-00969"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mescher</surname><given-names>A.L.</given-names></name><name><surname>Junqueira</surname><given-names>L.C.U.A.B.H.</given-names></name></person-group><source>Junqueira&#x02019;s Basic Histology: Text and Atlas</source><edition>12th ed.</edition><publisher-name>McGraw-Hill Medical</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><publisher-loc>London, UK</publisher-loc><year>2010</year></element-citation></ref><ref id="B3-cells-08-00969"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearle</surname><given-names>A.D.</given-names></name><name><surname>Warren</surname><given-names>R.F.</given-names></name><name><surname>Rodeo</surname><given-names>S.A.</given-names></name></person-group><article-title>Basic science of articular cartilage and osteoarthritis</article-title><source>Clin. Sports Med.</source><year>2005</year><volume>24</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.csm.2004.08.007</pub-id><pub-id pub-id-type="pmid">15636773</pub-id></element-citation></ref><ref id="B4-cells-08-00969"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoulders</surname><given-names>M.D.</given-names></name><name><surname>Raines</surname><given-names>R.T.</given-names></name></person-group><article-title>Collagen structure and stability</article-title><source>Annu. Rev. Biochem.</source><year>2009</year><volume>78</volume><fpage>929</fpage><lpage>958</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.77.032207.120833</pub-id><pub-id pub-id-type="pmid">19344236</pub-id></element-citation></ref><ref id="B5-cells-08-00969"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruckner</surname><given-names>P.</given-names></name><name><surname>van der Rest</surname><given-names>M.</given-names></name></person-group><article-title>Structure and function of cartilage collagens</article-title><source>Microsc. Res. Tech.</source><year>1994</year><volume>28</volume><fpage>378</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1002/jemt.1070280504</pub-id><pub-id pub-id-type="pmid">7919525</pub-id></element-citation></ref><ref id="B6-cells-08-00969"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fraser</surname><given-names>J.R.</given-names></name><name><surname>Laurent</surname><given-names>T.C.</given-names></name><name><surname>Laurent</surname><given-names>U.B.</given-names></name></person-group><article-title>Hyaluronan: Its nature, distribution, functions and turnover</article-title><source>J. Intern. Med.</source><year>1997</year><volume>242</volume><fpage>27</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2796.1997.00170.x</pub-id><pub-id pub-id-type="pmid">9260563</pub-id></element-citation></ref><ref id="B7-cells-08-00969"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiani</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>Y.J.</given-names></name><name><surname>Yee</surname><given-names>A.J.</given-names></name><name><surname>Yang</surname><given-names>B.B.</given-names></name></person-group><article-title>Structure and function of aggrecan</article-title><source>Cell Res.</source><year>2002</year><volume>12</volume><fpage>19</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1038/sj.cr.7290106</pub-id><pub-id pub-id-type="pmid">11942407</pub-id></element-citation></ref><ref id="B8-cells-08-00969"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teshima</surname><given-names>R.</given-names></name><name><surname>Otsuka</surname><given-names>T.</given-names></name><name><surname>Takasu</surname><given-names>N.</given-names></name><name><surname>Yamagata</surname><given-names>N.</given-names></name><name><surname>Yamamoto</surname><given-names>K.</given-names></name></person-group><article-title>Structure of the most superficial layer of articular cartilage</article-title><source>J. Bone Jt. Surg. Br.</source><year>1995</year><volume>77</volume><fpage>460</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1302/0301-620X.77B3.7744937</pub-id><pub-id pub-id-type="pmid">7744937</pub-id></element-citation></ref><ref id="B9-cells-08-00969"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffery</surname><given-names>A.K.</given-names></name><name><surname>Blunn</surname><given-names>G.W.</given-names></name><name><surname>Archer</surname><given-names>C.W.</given-names></name><name><surname>Bentley</surname><given-names>G.</given-names></name></person-group><article-title>Three-dimensional collagen architecture in bovine articular cartilage</article-title><source>J. Bone Jt. Surg. Br.</source><year>1991</year><volume>73</volume><fpage>795</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1302/0301-620X.73B5.1894669</pub-id></element-citation></ref><ref id="B10-cells-08-00969"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhee</surname><given-names>D.K.</given-names></name><name><surname>Marcelino</surname><given-names>J.</given-names></name><name><surname>Baker</surname><given-names>M.</given-names></name><name><surname>Gong</surname><given-names>Y.</given-names></name><name><surname>Smits</surname><given-names>P.</given-names></name><name><surname>Lefebvre</surname><given-names>V.</given-names></name><name><surname>Jay</surname><given-names>G.D.</given-names></name><name><surname>Stewart</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Warman</surname><given-names>M.L.</given-names></name><etal/></person-group><article-title>The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth</article-title><source>J. Clin. Investig.</source><year>2005</year><volume>115</volume><fpage>622</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.1172/JCI200522263</pub-id><pub-id pub-id-type="pmid">15719068</pub-id></element-citation></ref><ref id="B11-cells-08-00969"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowman</surname><given-names>M.K.</given-names></name><name><surname>Schmidt</surname><given-names>T.A.</given-names></name><name><surname>Raghavan</surname><given-names>P.</given-names></name><name><surname>Stecco</surname><given-names>A.</given-names></name></person-group><article-title>Viscoelastic Properties of Hyaluronan in Physiological Conditions</article-title><source>F1000Res</source><year>2015</year><volume>4</volume><fpage>622</fpage><pub-id pub-id-type="doi">10.12688/f1000research.6885.1</pub-id><pub-id pub-id-type="pmid">26594344</pub-id></element-citation></ref><ref id="B12-cells-08-00969"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Kraan</surname><given-names>P.M.</given-names></name><name><surname>van den Berg</surname><given-names>W.B.</given-names></name></person-group><article-title>Chondrocyte hypertrophy and osteoarthritis: Role in initiation and progression of cartilage degeneration?</article-title><source>Osteoarthr. Cartil.</source><year>2012</year><volume>20</volume><fpage>223</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2011.12.003</pub-id><pub-id pub-id-type="pmid">22178514</pub-id></element-citation></ref><ref id="B13-cells-08-00969"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>T.D.</given-names></name><name><surname>Nickel</surname><given-names>J.</given-names></name></person-group><article-title>Promiscuity and specificity in BMP receptor activation</article-title><source>FEBS Lett.</source><year>2012</year><volume>586</volume><fpage>1846</fpage><lpage>1859</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2012.02.043</pub-id><pub-id pub-id-type="pmid">22710174</pub-id></element-citation></ref><ref id="B14-cells-08-00969"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heldin</surname><given-names>C.H.</given-names></name><name><surname>Miyazono</surname><given-names>K.</given-names></name><name><surname>ten Dijke</surname><given-names>P.</given-names></name></person-group><article-title>TGF-beta signalling from cell membrane to nucleus through SMAD proteins</article-title><source>Nature</source><year>1997</year><volume>390</volume><fpage>465</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1038/37284</pub-id><pub-id pub-id-type="pmid">9393997</pub-id></element-citation></ref><ref id="B15-cells-08-00969"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.F.</given-names></name><name><surname>Lin</surname><given-names>H.Y.</given-names></name><name><surname>Ng-Eaton</surname><given-names>E.</given-names></name><name><surname>Downward</surname><given-names>J.</given-names></name><name><surname>Lodish</surname><given-names>H.F.</given-names></name><name><surname>Weinberg</surname><given-names>R.A.</given-names></name></person-group><article-title>Expression cloning and characterization of the TGF-beta type III receptor</article-title><source>Cell</source><year>1991</year><volume>67</volume><fpage>797</fpage><lpage>805</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(91)90074-9</pub-id><pub-id pub-id-type="pmid">1657407</pub-id></element-citation></ref><ref id="B16-cells-08-00969"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Casillas</surname><given-names>F.</given-names></name><name><surname>Cheifetz</surname><given-names>S.</given-names></name><name><surname>Doody</surname><given-names>J.</given-names></name><name><surname>Andres</surname><given-names>J.L.</given-names></name><name><surname>Lane</surname><given-names>W.S.</given-names></name><name><surname>Massague</surname><given-names>J.</given-names></name></person-group><article-title>Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system</article-title><source>Cell</source><year>1991</year><volume>67</volume><fpage>785</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(91)90073-8</pub-id><pub-id pub-id-type="pmid">1657406</pub-id></element-citation></ref><ref id="B17-cells-08-00969"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheifetz</surname><given-names>S.</given-names></name><name><surname>Bellon</surname><given-names>T.</given-names></name><name><surname>Cales</surname><given-names>C.</given-names></name><name><surname>Vera</surname><given-names>S.</given-names></name><name><surname>Bernabeu</surname><given-names>C.</given-names></name><name><surname>Massague</surname><given-names>J.</given-names></name><name><surname>Letarte</surname><given-names>M.</given-names></name></person-group><article-title>Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells</article-title><source>J. Biol. Chem.</source><year>1992</year><volume>267</volume><fpage>19027</fpage><lpage>19030</lpage><pub-id pub-id-type="pmid">1326540</pub-id></element-citation></ref><ref id="B18-cells-08-00969"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siebold</surname><given-names>C.</given-names></name><name><surname>Yamashita</surname><given-names>T.</given-names></name><name><surname>Monnier</surname><given-names>P.P.</given-names></name><name><surname>Mueller</surname><given-names>B.K.</given-names></name><name><surname>Pasterkamp</surname><given-names>R.J.</given-names></name></person-group><article-title>RGMs: Structural Insights, Molecular Regulation, and Downstream Signaling</article-title><source>Trends Cell Biol.</source><year>2017</year><volume>27</volume><fpage>365</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2016.11.009</pub-id><pub-id pub-id-type="pmid">28007423</pub-id></element-citation></ref><ref id="B19-cells-08-00969"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finnson</surname><given-names>K.W.</given-names></name><name><surname>Tam</surname><given-names>B.Y.</given-names></name><name><surname>Liu</surname><given-names>K.</given-names></name><name><surname>Marcoux</surname><given-names>A.</given-names></name><name><surname>Lepage</surname><given-names>P.</given-names></name><name><surname>Roy</surname><given-names>S.</given-names></name><name><surname>Bizet</surname><given-names>A.A.</given-names></name><name><surname>Philip</surname><given-names>A.</given-names></name></person-group><article-title>Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes</article-title><source>FASEB J.</source><year>2006</year><volume>20</volume><fpage>1525</fpage><lpage>1527</lpage><pub-id pub-id-type="doi">10.1096/fj.05-5229fje</pub-id><pub-id pub-id-type="pmid">16754747</pub-id></element-citation></ref><ref id="B20-cells-08-00969"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onichtchouk</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>Y.G.</given-names></name><name><surname>Dosch</surname><given-names>R.</given-names></name><name><surname>Gawantka</surname><given-names>V.</given-names></name><name><surname>Delius</surname><given-names>H.</given-names></name><name><surname>Massague</surname><given-names>J.</given-names></name><name><surname>Niehrs</surname><given-names>C.</given-names></name></person-group><article-title>Silencing of TGF-beta signalling by the pseudoreceptor BAMBI</article-title><source>Nature</source><year>1999</year><volume>401</volume><fpage>480</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1038/46794</pub-id><pub-id pub-id-type="pmid">10519551</pub-id></element-citation></ref><ref id="B21-cells-08-00969"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zawel</surname><given-names>L.</given-names></name><name><surname>Dai</surname><given-names>J.L.</given-names></name><name><surname>Buckhaults</surname><given-names>P.</given-names></name><name><surname>Zhou</surname><given-names>S.</given-names></name><name><surname>Kinzler</surname><given-names>K.W.</given-names></name><name><surname>Vogelstein</surname><given-names>B.</given-names></name><name><surname>Kern</surname><given-names>S.E.</given-names></name></person-group><article-title>Human Smad3 and Smad4 are sequence-specific transcription activators</article-title><source>Mol. Cell</source><year>1998</year><volume>1</volume><fpage>611</fpage><lpage>617</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(00)80061-1</pub-id><pub-id pub-id-type="pmid">9660945</pub-id></element-citation></ref><ref id="B22-cells-08-00969"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kusanagi</surname><given-names>K.</given-names></name><name><surname>Inoue</surname><given-names>H.</given-names></name><name><surname>Ishidou</surname><given-names>Y.</given-names></name><name><surname>Mishima</surname><given-names>H.K.</given-names></name><name><surname>Kawabata</surname><given-names>M.</given-names></name><name><surname>Miyazono</surname><given-names>K.</given-names></name></person-group><article-title>Characterization of a bone morphogenetic protein-responsive Smad-binding element</article-title><source>Mol. Biol. Cell</source><year>2000</year><volume>11</volume><fpage>555</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1091/mbc.11.2.555</pub-id><pub-id pub-id-type="pmid">10679014</pub-id></element-citation></ref><ref id="B23-cells-08-00969"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaarenstroom</surname><given-names>T.</given-names></name><name><surname>Hill</surname><given-names>C.S.</given-names></name></person-group><article-title>TGF-beta signaling to chromatin: How Smads regulate transcription during self-renewal and differentiation</article-title><source>Semin. Cell Dev. Biol.</source><year>2014</year><volume>32</volume><fpage>107</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2014.01.009</pub-id><pub-id pub-id-type="pmid">24503509</pub-id></element-citation></ref><ref id="B24-cells-08-00969"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furumatsu</surname><given-names>T.</given-names></name><name><surname>Tsuda</surname><given-names>M.</given-names></name><name><surname>Taniguchi</surname><given-names>N.</given-names></name><name><surname>Tajima</surname><given-names>Y.</given-names></name><name><surname>Asahara</surname><given-names>H.</given-names></name></person-group><article-title>Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment</article-title><source>J. Biol. Chem.</source><year>2005</year><volume>280</volume><fpage>8343</fpage><lpage>8350</lpage><pub-id pub-id-type="doi">10.1074/jbc.M413913200</pub-id><pub-id pub-id-type="pmid">15623506</pub-id></element-citation></ref><ref id="B25-cells-08-00969"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakao</surname><given-names>A.</given-names></name><name><surname>Afrakhte</surname><given-names>M.</given-names></name><name><surname>Moren</surname><given-names>A.</given-names></name><name><surname>Nakayama</surname><given-names>T.</given-names></name><name><surname>Christian</surname><given-names>J.L.</given-names></name><name><surname>Heuchel</surname><given-names>R.</given-names></name><name><surname>Itoh</surname><given-names>S.</given-names></name><name><surname>Kawabata</surname><given-names>M.</given-names></name><name><surname>Heldin</surname><given-names>N.E.</given-names></name><name><surname>Heldin</surname><given-names>C.H.</given-names></name><etal/></person-group><article-title>Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling</article-title><source>Nature</source><year>1997</year><volume>389</volume><fpage>631</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1038/39369</pub-id><pub-id pub-id-type="pmid">9335507</pub-id></element-citation></ref><ref id="B26-cells-08-00969"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imamura</surname><given-names>T.</given-names></name><name><surname>Takase</surname><given-names>M.</given-names></name><name><surname>Nishihara</surname><given-names>A.</given-names></name><name><surname>Oeda</surname><given-names>E.</given-names></name><name><surname>Hanai</surname><given-names>J.</given-names></name><name><surname>Kawabata</surname><given-names>M.</given-names></name><name><surname>Miyazono</surname><given-names>K.</given-names></name></person-group><article-title>Smad6 inhibits signalling by the TGF-beta superfamily</article-title><source>Nature</source><year>1997</year><volume>389</volume><fpage>622</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1038/39355</pub-id><pub-id pub-id-type="pmid">9335505</pub-id></element-citation></ref><ref id="B27-cells-08-00969"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valdes</surname><given-names>A.M.</given-names></name><name><surname>Spector</surname><given-names>T.D.</given-names></name><name><surname>Tamm</surname><given-names>A.</given-names></name><name><surname>Kisand</surname><given-names>K.</given-names></name><name><surname>Doherty</surname><given-names>S.A.</given-names></name><name><surname>Dennison</surname><given-names>E.M.</given-names></name><name><surname>Mangino</surname><given-names>M.</given-names></name><name><surname>Tamm</surname><given-names>A.</given-names></name><name><surname>Kerna</surname><given-names>I.</given-names></name><name><surname>Hart</surname><given-names>D.J.</given-names></name><etal/></person-group><article-title>Genetic variation in the SMAD3 gene is associated with hip and knee osteoarthritis</article-title><source>Arthritis Rheum</source><year>2010</year><volume>62</volume><fpage>2347</fpage><lpage>2352</lpage><pub-id pub-id-type="doi">10.1002/art.27530</pub-id><pub-id pub-id-type="pmid">20506137</pub-id></element-citation></ref><ref id="B28-cells-08-00969"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aref-Eshghi</surname><given-names>E.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Hart</surname><given-names>D.</given-names></name><name><surname>Valdes</surname><given-names>A.M.</given-names></name><name><surname>Furey</surname><given-names>A.</given-names></name><name><surname>Martin</surname><given-names>G.</given-names></name><name><surname>Sun</surname><given-names>G.</given-names></name><name><surname>Rahman</surname><given-names>P.</given-names></name><name><surname>Arden</surname><given-names>N.</given-names></name><name><surname>Spector</surname><given-names>T.D.</given-names></name><etal/></person-group><article-title>SMAD3 is associated with the total burden of radiographic osteoarthritis: The Chingford study</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e97786</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0097786</pub-id><pub-id pub-id-type="pmid">24852296</pub-id></element-citation></ref><ref id="B29-cells-08-00969"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van de Laar</surname><given-names>I.M.</given-names></name><name><surname>van der Linde</surname><given-names>D.</given-names></name><name><surname>Oei</surname><given-names>E.H.</given-names></name><name><surname>Bos</surname><given-names>P.K.</given-names></name><name><surname>Bessems</surname><given-names>J.H.</given-names></name><name><surname>Bierma-Zeinstra</surname><given-names>S.M.</given-names></name><name><surname>van Meer</surname><given-names>B.L.</given-names></name><name><surname>Pals</surname><given-names>G.</given-names></name><name><surname>Oldenburg</surname><given-names>R.A.</given-names></name><name><surname>Bekkers</surname><given-names>J.A.</given-names></name><etal/></person-group><article-title>Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome</article-title><source>J. Med. Genet.</source><year>2012</year><volume>49</volume><fpage>47</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1136/jmedgenet-2011-100382</pub-id><pub-id pub-id-type="pmid">22167769</pub-id></element-citation></ref><ref id="B30-cells-08-00969"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van de Laar</surname><given-names>I.M.</given-names></name><name><surname>Oldenburg</surname><given-names>R.A.</given-names></name><name><surname>Pals</surname><given-names>G.</given-names></name><name><surname>Roos-Hesselink</surname><given-names>J.W.</given-names></name><name><surname>de Graaf</surname><given-names>B.M.</given-names></name><name><surname>Verhagen</surname><given-names>J.M.</given-names></name><name><surname>Hoedemaekers</surname><given-names>Y.M.</given-names></name><name><surname>Willemsen</surname><given-names>R.</given-names></name><name><surname>Severijnen</surname><given-names>L.A.</given-names></name><name><surname>Venselaar</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis</article-title><source>Nat. Genet.</source><year>2011</year><volume>43</volume><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1038/ng.744</pub-id><pub-id pub-id-type="pmid">21217753</pub-id></element-citation></ref><ref id="B31-cells-08-00969"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Deng</surname><given-names>C.X.</given-names></name></person-group><article-title>TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage</article-title><source>J. Cell Biol.</source><year>2001</year><volume>153</volume><fpage>35</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1083/jcb.153.1.35</pub-id><pub-id pub-id-type="pmid">11285272</pub-id></element-citation></ref><ref id="B32-cells-08-00969"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C.G.</given-names></name><name><surname>Thuillier</surname><given-names>D.</given-names></name><name><surname>Chin</surname><given-names>E.N.</given-names></name><name><surname>Alliston</surname><given-names>T.</given-names></name></person-group><article-title>Chondrocyte-intrinsic Smad3 represses Runx2-inducible matrix metalloproteinase 13 expression to maintain articular cartilage and prevent osteoarthritis</article-title><source>Arthritis Rheum</source><year>2012</year><volume>64</volume><fpage>3278</fpage><lpage>3289</lpage><pub-id pub-id-type="doi">10.1002/art.34566</pub-id><pub-id pub-id-type="pmid">22674505</pub-id></element-citation></ref><ref id="B33-cells-08-00969"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>C.M.</given-names></name><name><surname>Schwarz</surname><given-names>E.M.</given-names></name><name><surname>Reynolds</surname><given-names>P.R.</given-names></name><name><surname>Puzas</surname><given-names>J.E.</given-names></name><name><surname>Rosier</surname><given-names>R.N.</given-names></name><name><surname>O&#x02019;Keefe</surname><given-names>R.J.</given-names></name></person-group><article-title>Smad2 and 3 mediate transforming growth factor-beta1-induced inhibition of chondrocyte maturation</article-title><source>Endocrinology</source><year>2000</year><volume>141</volume><fpage>4728</fpage><lpage>4735</lpage><pub-id pub-id-type="doi">10.1210/endo.141.12.7848</pub-id><pub-id pub-id-type="pmid">11108288</pub-id></element-citation></ref><ref id="B34-cells-08-00969"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ionescu</surname><given-names>A.M.</given-names></name><name><surname>Schwarz</surname><given-names>E.M.</given-names></name><name><surname>Zuscik</surname><given-names>M.J.</given-names></name><name><surname>Drissi</surname><given-names>H.</given-names></name><name><surname>Puzas</surname><given-names>J.E.</given-names></name><name><surname>Rosier</surname><given-names>R.N.</given-names></name><name><surname>O&#x02019;Keefe</surname><given-names>R.J.</given-names></name></person-group><article-title>ATF-2 cooperates with Smad3 to mediate TGF-beta effects on chondrocyte maturation</article-title><source>Exp. Cell Res.</source><year>2003</year><volume>288</volume><fpage>198</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1016/S0014-4827(03)00181-2</pub-id><pub-id pub-id-type="pmid">12878171</pub-id></element-citation></ref><ref id="B35-cells-08-00969"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K.O.</given-names></name><name><surname>Sampson</surname><given-names>E.R.</given-names></name><name><surname>Maynard</surname><given-names>R.D.</given-names></name><name><surname>O&#x02019;Keefe</surname><given-names>R.J.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Drissi</surname><given-names>H.</given-names></name><name><surname>Rosier</surname><given-names>R.N.</given-names></name><name><surname>Hilton</surname><given-names>M.J.</given-names></name><name><surname>Zuscik</surname><given-names>M.J.</given-names></name></person-group><article-title>Ski inhibits TGF-beta/phospho-Smad3 signaling and accelerates hypertrophic differentiation in chondrocytes</article-title><source>J. Cell Biochem.</source><year>2012</year><volume>113</volume><fpage>2156</fpage><lpage>2166</lpage><pub-id pub-id-type="doi">10.1002/jcb.24089</pub-id><pub-id pub-id-type="pmid">22461172</pub-id></element-citation></ref><ref id="B36-cells-08-00969"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T.F.</given-names></name><name><surname>Gao</surname><given-names>L.</given-names></name><name><surname>Sheu</surname><given-names>T.J.</given-names></name><name><surname>Sampson</surname><given-names>E.R.</given-names></name><name><surname>Flick</surname><given-names>L.M.</given-names></name><name><surname>Konttinen</surname><given-names>Y.T.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Schwarz</surname><given-names>E.M.</given-names></name><name><surname>Zuscik</surname><given-names>M.J.</given-names></name><name><surname>Jonason</surname><given-names>J.H.</given-names></name><etal/></person-group><article-title>Aberrant hypertrophy in Smad3-deficient murine chondrocytes is rescued by restoring transforming growth factor beta-activated kinase 1/activating transcription factor 2 signaling: a potential clinical implication for osteoarthritis</article-title><source>Arthritis Rheum</source><year>2010</year><volume>62</volume><fpage>2359</fpage><lpage>2369</lpage><pub-id pub-id-type="doi">10.1002/art.27537</pub-id><pub-id pub-id-type="pmid">20506210</pub-id></element-citation></ref><ref id="B37-cells-08-00969"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>J.S.</given-names></name><name><surname>Alliston</surname><given-names>T.</given-names></name><name><surname>Delston</surname><given-names>R.</given-names></name><name><surname>Derynck</surname><given-names>R.</given-names></name></person-group><article-title>Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3</article-title><source>EMBO J.</source><year>2005</year><volume>24</volume><fpage>2543</fpage><lpage>2555</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600729</pub-id><pub-id pub-id-type="pmid">15990875</pub-id></element-citation></ref><ref id="B38-cells-08-00969"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leboy</surname><given-names>P.</given-names></name><name><surname>Grasso-Knight</surname><given-names>G.</given-names></name><name><surname>D&#x02019;Angelo</surname><given-names>M.</given-names></name><name><surname>Volk</surname><given-names>S.W.</given-names></name><name><surname>Lian</surname><given-names>J.V.</given-names></name><name><surname>Drissi</surname><given-names>H.</given-names></name><name><surname>Stein</surname><given-names>G.S.</given-names></name><name><surname>Adams</surname><given-names>S.L.</given-names></name></person-group><article-title>Smad-Runx interactions during chondrocyte maturation</article-title><source>J. Bone Jt. Surg. Am.</source><year>2001</year><volume>83-A Suppl 1</volume><issue-part>(Pt 1)</issue-part><fpage>S15</fpage><lpage>S22</lpage><pub-id pub-id-type="doi">10.2106/00004623-200100001-00003</pub-id></element-citation></ref><ref id="B39-cells-08-00969"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeda</surname><given-names>S.</given-names></name><name><surname>Bonnamy</surname><given-names>J.P.</given-names></name><name><surname>Owen</surname><given-names>M.J.</given-names></name><name><surname>Ducy</surname><given-names>P.</given-names></name><name><surname>Karsenty</surname><given-names>G.</given-names></name></person-group><article-title>Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice</article-title><source>Genes Dev.</source><year>2001</year><volume>15</volume><fpage>467</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1101/gad.845101</pub-id><pub-id pub-id-type="pmid">11230154</pub-id></element-citation></ref><ref id="B40-cells-08-00969"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enomoto</surname><given-names>H.</given-names></name><name><surname>Enomoto-Iwamoto</surname><given-names>M.</given-names></name><name><surname>Iwamoto</surname><given-names>M.</given-names></name><name><surname>Nomura</surname><given-names>S.</given-names></name><name><surname>Himeno</surname><given-names>M.</given-names></name><name><surname>Kitamura</surname><given-names>Y.</given-names></name><name><surname>Kishimoto</surname><given-names>T.</given-names></name><name><surname>Komori</surname><given-names>T.</given-names></name></person-group><article-title>Cbfa1 is a positive regulatory factor in chondrocyte maturation</article-title><source>J. Biol. Chem.</source><year>2000</year><volume>275</volume><fpage>8695</fpage><lpage>8702</lpage><pub-id pub-id-type="doi">10.1074/jbc.275.12.8695</pub-id><pub-id pub-id-type="pmid">10722711</pub-id></element-citation></ref><ref id="B41-cells-08-00969"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inada</surname><given-names>M.</given-names></name><name><surname>Yasui</surname><given-names>T.</given-names></name><name><surname>Nomura</surname><given-names>S.</given-names></name><name><surname>Miyake</surname><given-names>S.</given-names></name><name><surname>Deguchi</surname><given-names>K.</given-names></name><name><surname>Himeno</surname><given-names>M.</given-names></name><name><surname>Sato</surname><given-names>M.</given-names></name><name><surname>Yamagiwa</surname><given-names>H.</given-names></name><name><surname>Kimura</surname><given-names>T.</given-names></name><name><surname>Yasui</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Maturational disturbance of chondrocytes in Cbfa1-deficient mice</article-title><source>Dev. Dyn.</source><year>1999</year><volume>214</volume><fpage>279</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-0177(199904)214:4&#x0003c;279::AID-AJA1&#x0003e;3.0.CO;2-W</pub-id><pub-id pub-id-type="pmid">10213384</pub-id></element-citation></ref><ref id="B42-cells-08-00969"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nomura</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>E.</given-names></name></person-group><article-title>Smad2 role in mesoderm formation, left-right patterning and craniofacial development</article-title><source>Nature</source><year>1998</year><volume>393</volume><fpage>786</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1038/31693</pub-id><pub-id pub-id-type="pmid">9655392</pub-id></element-citation></ref><ref id="B43-cells-08-00969"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waldrip</surname><given-names>W.R.</given-names></name><name><surname>Bikoff</surname><given-names>E.K.</given-names></name><name><surname>Hoodless</surname><given-names>P.A.</given-names></name><name><surname>Wrana</surname><given-names>J.L.</given-names></name><name><surname>Robertson</surname><given-names>E.J.</given-names></name></person-group><article-title>Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo</article-title><source>Cell</source><year>1998</year><volume>92</volume><fpage>797</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81407-5</pub-id><pub-id pub-id-type="pmid">9529255</pub-id></element-citation></ref><ref id="B44-cells-08-00969"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinstein</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Gotay</surname><given-names>J.</given-names></name><name><surname>Deng</surname><given-names>C.X.</given-names></name></person-group><article-title>Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1998</year><volume>95</volume><fpage>9378</fpage><lpage>9383</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.16.9378</pub-id><pub-id pub-id-type="pmid">9689088</pub-id></element-citation></ref><ref id="B45-cells-08-00969"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vivian</surname><given-names>J.L.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Yee</surname><given-names>D.</given-names></name><name><surname>Schneider</surname><given-names>E.</given-names></name><name><surname>Magnuson</surname><given-names>T.</given-names></name></person-group><article-title>An allelic series of mutations in Smad2 and Smad4 identified in a genotype-based screen of N-ethyl-N- nitrosourea-mutagenized mouse embryonic stem cells</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2002</year><volume>99</volume><fpage>15542</fpage><lpage>15547</lpage><pub-id pub-id-type="doi">10.1073/pnas.242474199</pub-id><pub-id pub-id-type="pmid">12432092</pub-id></element-citation></ref><ref id="B46-cells-08-00969"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decker</surname><given-names>R.S.</given-names></name><name><surname>Koyama</surname><given-names>E.</given-names></name><name><surname>Pacifici</surname><given-names>M.</given-names></name></person-group><article-title>Genesis and morphogenesis of limb synovial joints and articular cartilage</article-title><source>Matrix Biol.</source><year>2014</year><volume>39</volume><fpage>5</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.matbio.2014.08.006</pub-id><pub-id pub-id-type="pmid">25172830</pub-id></element-citation></ref><ref id="B47-cells-08-00969"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamamoto</surname><given-names>T.</given-names></name><name><surname>Beppu</surname><given-names>H.</given-names></name><name><surname>Okada</surname><given-names>H.</given-names></name><name><surname>Kawabata</surname><given-names>M.</given-names></name><name><surname>Kitamura</surname><given-names>T.</given-names></name><name><surname>Miyazono</surname><given-names>K.</given-names></name><name><surname>Kato</surname><given-names>M.</given-names></name></person-group><article-title>Compound disruption of smad2 accelerates malignant progression of intestinal tumors in apc knockout mice</article-title><source>Cancer Res.</source><year>2002</year><volume>62</volume><fpage>5955</fpage><lpage>5961</lpage><pub-id pub-id-type="pmid">12384562</pub-id></element-citation></ref><ref id="B48-cells-08-00969"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Song</surname><given-names>B.</given-names></name><name><surname>Anbarchian</surname><given-names>T.</given-names></name><name><surname>Shirazyan</surname><given-names>A.</given-names></name><name><surname>Sadik</surname><given-names>J.E.</given-names></name><name><surname>Lyons</surname><given-names>K.M.</given-names></name></person-group><article-title>Smad2 and Smad3 Regulate Chondrocyte Proliferation and Differentiation in the Growth Plate</article-title><source>PLoS Genet.</source><year>2016</year><volume>12</volume><elocation-id>e1006352</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1006352</pub-id><pub-id pub-id-type="pmid">27741240</pub-id></element-citation></ref><ref id="B49-cells-08-00969"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lechleider</surname><given-names>R.J.</given-names></name><name><surname>Ryan</surname><given-names>J.L.</given-names></name><name><surname>Garrett</surname><given-names>L.</given-names></name><name><surname>Eng</surname><given-names>C.</given-names></name><name><surname>Deng</surname><given-names>C.</given-names></name><name><surname>Wynshaw-Boris</surname><given-names>A.</given-names></name><name><surname>Roberts</surname><given-names>A.B.</given-names></name></person-group><article-title>Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion</article-title><source>Dev. Biol.</source><year>2001</year><volume>240</volume><fpage>157</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1006/dbio.2001.0469</pub-id><pub-id pub-id-type="pmid">11784053</pub-id></element-citation></ref><ref id="B50-cells-08-00969"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>H.</given-names></name><name><surname>Huylebroeck</surname><given-names>D.</given-names></name><name><surname>Verschueren</surname><given-names>K.</given-names></name><name><surname>Guo</surname><given-names>Q.</given-names></name><name><surname>Matzuk</surname><given-names>M.M.</given-names></name><name><surname>Zwijsen</surname><given-names>A.</given-names></name></person-group><article-title>Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects</article-title><source>Development</source><year>1999</year><volume>126</volume><fpage>1631</fpage><lpage>1642</lpage><pub-id pub-id-type="pmid">10079226</pub-id></element-citation></ref><ref id="B51-cells-08-00969"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Retting</surname><given-names>K.N.</given-names></name><name><surname>Song</surname><given-names>B.</given-names></name><name><surname>Yoon</surname><given-names>B.S.</given-names></name><name><surname>Lyons</surname><given-names>K.M.</given-names></name></person-group><article-title>BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation</article-title><source>Development</source><year>2009</year><volume>136</volume><fpage>1093</fpage><lpage>1104</lpage><pub-id pub-id-type="doi">10.1242/dev.029926</pub-id><pub-id pub-id-type="pmid">19224984</pub-id></element-citation></ref><ref id="B52-cells-08-00969"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujii</surname><given-names>M.</given-names></name><name><surname>Takeda</surname><given-names>K.</given-names></name><name><surname>Imamura</surname><given-names>T.</given-names></name><name><surname>Aoki</surname><given-names>H.</given-names></name><name><surname>Sampath</surname><given-names>T.K.</given-names></name><name><surname>Enomoto</surname><given-names>S.</given-names></name><name><surname>Kawabata</surname><given-names>M.</given-names></name><name><surname>Kato</surname><given-names>M.</given-names></name><name><surname>Ichijo</surname><given-names>H.</given-names></name><name><surname>Miyazono</surname><given-names>K.</given-names></name></person-group><article-title>Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation</article-title><source>Mol. Biol. Cell</source><year>1999</year><volume>10</volume><fpage>3801</fpage><lpage>3813</lpage><pub-id pub-id-type="doi">10.1091/mbc.10.11.3801</pub-id><pub-id pub-id-type="pmid">10564272</pub-id></element-citation></ref><ref id="B53-cells-08-00969"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horiki</surname><given-names>M.</given-names></name><name><surname>Imamura</surname><given-names>T.</given-names></name><name><surname>Okamoto</surname><given-names>M.</given-names></name><name><surname>Hayashi</surname><given-names>M.</given-names></name><name><surname>Murai</surname><given-names>J.</given-names></name><name><surname>Myoui</surname><given-names>A.</given-names></name><name><surname>Ochi</surname><given-names>T.</given-names></name><name><surname>Miyazono</surname><given-names>K.</given-names></name><name><surname>Yoshikawa</surname><given-names>H.</given-names></name><name><surname>Tsumaki</surname><given-names>N.</given-names></name></person-group><article-title>Smad6/Smurf1 overexpression in cartilage delays chondrocyte hypertrophy and causes dwarfism with osteopenia</article-title><source>J. Cell Biol.</source><year>2004</year><volume>165</volume><fpage>433</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1083/jcb.200311015</pub-id><pub-id pub-id-type="pmid">15123739</pub-id></element-citation></ref><ref id="B54-cells-08-00969"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javed</surname><given-names>A.</given-names></name><name><surname>Afzal</surname><given-names>F.</given-names></name><name><surname>Bae</surname><given-names>J.S.</given-names></name><name><surname>Gutierrez</surname><given-names>S.</given-names></name><name><surname>Zaidi</surname><given-names>K.</given-names></name><name><surname>Pratap</surname><given-names>J.</given-names></name><name><surname>van Wijnen</surname><given-names>A.J.</given-names></name><name><surname>Stein</surname><given-names>J.L.</given-names></name><name><surname>Stein</surname><given-names>G.S.</given-names></name><name><surname>Lian</surname><given-names>J.B.</given-names></name></person-group><article-title>Specific residues of RUNX2 are obligatory for formation of BMP2-induced RUNX2-SMAD complex to promote osteoblast differentiation</article-title><source>Cells Tissues Organs</source><year>2009</year><volume>189</volume><fpage>133</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1159/000151719</pub-id><pub-id pub-id-type="pmid">18728344</pub-id></element-citation></ref><ref id="B55-cells-08-00969"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javed</surname><given-names>A.</given-names></name><name><surname>Bae</surname><given-names>J.S.</given-names></name><name><surname>Afzal</surname><given-names>F.</given-names></name><name><surname>Gutierrez</surname><given-names>S.</given-names></name><name><surname>Pratap</surname><given-names>J.</given-names></name><name><surname>Zaidi</surname><given-names>S.K.</given-names></name><name><surname>Lou</surname><given-names>Y.</given-names></name><name><surname>van Wijnen</surname><given-names>A.J.</given-names></name><name><surname>Stein</surname><given-names>J.L.</given-names></name><name><surname>Stein</surname><given-names>G.S.</given-names></name><etal/></person-group><article-title>Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal</article-title><source>J. Biol. Chem.</source><year>2008</year><volume>283</volume><fpage>8412</fpage><lpage>8422</lpage><pub-id pub-id-type="doi">10.1074/jbc.M705578200</pub-id><pub-id pub-id-type="pmid">18204048</pub-id></element-citation></ref><ref id="B56-cells-08-00969"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phimphilai</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Boules</surname><given-names>H.</given-names></name><name><surname>Roca</surname><given-names>H.</given-names></name><name><surname>Franceschi</surname><given-names>R.T.</given-names></name></person-group><article-title>BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype</article-title><source>J. Bone Miner. Res.</source><year>2006</year><volume>21</volume><fpage>637</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1359/jbmr.060109</pub-id><pub-id pub-id-type="pmid">16598384</pub-id></element-citation></ref><ref id="B57-cells-08-00969"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>J.S.</given-names></name><name><surname>Gutierrez</surname><given-names>S.</given-names></name><name><surname>Narla</surname><given-names>R.</given-names></name><name><surname>Pratap</surname><given-names>J.</given-names></name><name><surname>Devados</surname><given-names>R.</given-names></name><name><surname>van Wijnen</surname><given-names>A.J.</given-names></name><name><surname>Stein</surname><given-names>J.L.</given-names></name><name><surname>Stein</surname><given-names>G.S.</given-names></name><name><surname>Lian</surname><given-names>J.B.</given-names></name><name><surname>Javed</surname><given-names>A.</given-names></name></person-group><article-title>Reconstitution of Runx2/Cbfa1-null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation</article-title><source>J. Cell Biochem.</source><year>2007</year><volume>100</volume><fpage>434</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1002/jcb.21039</pub-id><pub-id pub-id-type="pmid">16927309</pub-id></element-citation></ref><ref id="B58-cells-08-00969"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kielty</surname><given-names>C.M.</given-names></name><name><surname>Kwan</surname><given-names>A.P.</given-names></name><name><surname>Holmes</surname><given-names>D.F.</given-names></name><name><surname>Schor</surname><given-names>S.L.</given-names></name><name><surname>Grant</surname><given-names>M.E.</given-names></name></person-group><article-title>Type X collagen, a product of hypertrophic chondrocytes</article-title><source>Biochem. J.</source><year>1985</year><volume>227</volume><fpage>545</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1042/bj2270545</pub-id><pub-id pub-id-type="pmid">4004779</pub-id></element-citation></ref><ref id="B59-cells-08-00969"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>M.K.</given-names></name><name><surname>Pardoux</surname><given-names>C.</given-names></name><name><surname>Hall</surname><given-names>M.C.</given-names></name><name><surname>Lee</surname><given-names>P.S.</given-names></name><name><surname>Warburton</surname><given-names>D.</given-names></name><name><surname>Qing</surname><given-names>J.</given-names></name><name><surname>Smith</surname><given-names>S.M.</given-names></name><name><surname>Derynck</surname><given-names>R.</given-names></name></person-group><article-title>TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA</article-title><source>EMBO J.</source><year>2007</year><volume>26</volume><fpage>3957</fpage><lpage>3967</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601818</pub-id><pub-id pub-id-type="pmid">17673906</pub-id></element-citation></ref><ref id="B60-cells-08-00969"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>M.</given-names></name><name><surname>Fatyol</surname><given-names>K.</given-names></name><name><surname>Jin</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>Y.E.</given-names></name></person-group><article-title>TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta</article-title><source>Mol. Cell</source><year>2008</year><volume>31</volume><fpage>918</fpage><lpage>924</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2008.09.002</pub-id><pub-id pub-id-type="pmid">18922473</pub-id></element-citation></ref><ref id="B61-cells-08-00969"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landstrom</surname><given-names>M.</given-names></name></person-group><article-title>The TAK1-TRAF6 signalling pathway</article-title><source>Int. J. Biochem. Cell Biol.</source><year>2010</year><volume>42</volume><fpage>585</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2009.12.023</pub-id><pub-id pub-id-type="pmid">20060931</pub-id></element-citation></ref><ref id="B62-cells-08-00969"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>K.</given-names></name><name><surname>Nagai</surname><given-names>S.</given-names></name><name><surname>Ninomiya-Tsuji</surname><given-names>J.</given-names></name><name><surname>Nishita</surname><given-names>M.</given-names></name><name><surname>Tamai</surname><given-names>K.</given-names></name><name><surname>Irie</surname><given-names>K.</given-names></name><name><surname>Ueno</surname><given-names>N.</given-names></name><name><surname>Nishida</surname><given-names>E.</given-names></name><name><surname>Shibuya</surname><given-names>H.</given-names></name><name><surname>Matsumoto</surname><given-names>K.</given-names></name></person-group><article-title>XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway</article-title><source>EMBO J.</source><year>1999</year><volume>18</volume><fpage>179</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1093/emboj/18.1.179</pub-id><pub-id pub-id-type="pmid">9878061</pub-id></element-citation></ref><ref id="B63-cells-08-00969"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galban</surname><given-names>S.</given-names></name><name><surname>Duckett</surname><given-names>C.S.</given-names></name></person-group><article-title>XIAP as a ubiquitin ligase in cellular signaling</article-title><source>Cell Death Differ.</source><year>2010</year><volume>17</volume><fpage>54</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1038/cdd.2009.81</pub-id><pub-id pub-id-type="pmid">19590513</pub-id></element-citation></ref><ref id="B64-cells-08-00969"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derynck</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>Y.E.</given-names></name></person-group><article-title>Smad-dependent and Smad-independent pathways in TGF-beta family signalling</article-title><source>Nature</source><year>2003</year><volume>425</volume><fpage>577</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1038/nature02006</pub-id><pub-id pub-id-type="pmid">14534577</pub-id></element-citation></ref><ref id="B65-cells-08-00969"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>H.</given-names></name><name><surname>de Caestecker</surname><given-names>M.P.</given-names></name><name><surname>Yamada</surname><given-names>Y.</given-names></name></person-group><article-title>Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells</article-title><source>J. Biol. Chem.</source><year>2001</year><volume>276</volume><fpage>14466</fpage><lpage>14473</lpage><pub-id pub-id-type="doi">10.1074/jbc.M005724200</pub-id><pub-id pub-id-type="pmid">11278290</pub-id></element-citation></ref><ref id="B66-cells-08-00969"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Tao</surname><given-names>H.</given-names></name><name><surname>Jin</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>X.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>Transforming growth factor-beta1 induces type II collagen and aggrecan expression via activation of extracellular signal-regulated kinase 1/2 and Smad2/3 signaling pathways</article-title><source>Mol. Med. Rep.</source><year>2015</year><volume>12</volume><fpage>5573</fpage><lpage>5579</lpage><pub-id pub-id-type="doi">10.3892/mmr.2015.4068</pub-id><pub-id pub-id-type="pmid">26165845</pub-id></element-citation></ref><ref id="B67-cells-08-00969"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyazaki</surname><given-names>Y.</given-names></name><name><surname>Tsukazaki</surname><given-names>T.</given-names></name><name><surname>Hirota</surname><given-names>Y.</given-names></name><name><surname>Yonekura</surname><given-names>A.</given-names></name><name><surname>Osaki</surname><given-names>M.</given-names></name><name><surname>Shindo</surname><given-names>H.</given-names></name><name><surname>Yamashita</surname><given-names>S.</given-names></name></person-group><article-title>Dexamethasone inhibition of TGF beta-induced cell growth and type II collagen mRNA expression through ERK-integrated AP-1 activity in cultured rat articular chondrocytes</article-title><source>Osteoarthr. Cartil.</source><year>2000</year><volume>8</volume><fpage>378</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1053/joca.1999.0313</pub-id><pub-id pub-id-type="pmid">10966845</pub-id></element-citation></ref><ref id="B68-cells-08-00969"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qureshi</surname><given-names>H.Y.</given-names></name><name><surname>Sylvester</surname><given-names>J.</given-names></name><name><surname>El Mabrouk</surname><given-names>M.</given-names></name><name><surname>Zafarullah</surname><given-names>M.</given-names></name></person-group><article-title>TGF-beta-induced expression of tissue inhibitor of metalloproteinases-3 gene in chondrocytes is mediated by extracellular signal-regulated kinase pathway and Sp1 transcription factor</article-title><source>J. Cell Physiol.</source><year>2005</year><volume>203</volume><fpage>345</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1002/jcp.20228</pub-id><pub-id pub-id-type="pmid">15468069</pub-id></element-citation></ref><ref id="B69-cells-08-00969"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuli</surname><given-names>R.</given-names></name><name><surname>Tuli</surname><given-names>S.</given-names></name><name><surname>Nandi</surname><given-names>S.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Manner</surname><given-names>P.A.</given-names></name><name><surname>Hozack</surname><given-names>W.J.</given-names></name><name><surname>Danielson</surname><given-names>K.G.</given-names></name><name><surname>Hall</surname><given-names>D.J.</given-names></name><name><surname>Tuan</surname><given-names>R.S.</given-names></name></person-group><article-title>Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>41227</fpage><lpage>41236</lpage><pub-id pub-id-type="doi">10.1074/jbc.M305312200</pub-id><pub-id pub-id-type="pmid">12893825</pub-id></element-citation></ref><ref id="B70-cells-08-00969"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>N.</given-names></name><name><surname>Long</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name></person-group><article-title>MEK/ERK and p38 MAPK regulate chondrogenesis of rat bone marrow mesenchymal stem cells through delicate interaction with TGF-beta1/Smads pathway</article-title><source>Cell Prolif.</source><year>2010</year><volume>43</volume><fpage>333</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2184.2010.00682.x</pub-id><pub-id pub-id-type="pmid">20590658</pub-id></element-citation></ref><ref id="B71-cells-08-00969"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bobick</surname><given-names>B.E.</given-names></name><name><surname>Kulyk</surname><given-names>W.M.</given-names></name></person-group><article-title>The MEK-ERK signaling pathway is a negative regulator of cartilage-specific gene expression in embryonic limb mesenchyme</article-title><source>J. Biol. Chem.</source><year>2004</year><volume>279</volume><fpage>4588</fpage><lpage>4595</lpage><pub-id pub-id-type="doi">10.1074/jbc.M309805200</pub-id><pub-id pub-id-type="pmid">14617631</pub-id></element-citation></ref><ref id="B72-cells-08-00969"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiao</surname><given-names>B.</given-names></name><name><surname>Padilla</surname><given-names>S.R.</given-names></name><name><surname>Benya</surname><given-names>P.D.</given-names></name></person-group><article-title>Transforming growth factor (TGF)-beta-activated kinase 1 mimics and mediates TGF-beta-induced stimulation of type II collagen synthesis in chondrocytes independent of Col2a1 transcription and Smad3 signaling</article-title><source>J. Biol. Chem.</source><year>2005</year><volume>280</volume><fpage>17562</fpage><lpage>17571</lpage><pub-id pub-id-type="doi">10.1074/jbc.M500646200</pub-id><pub-id pub-id-type="pmid">15743758</pub-id></element-citation></ref><ref id="B73-cells-08-00969"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunnell</surname><given-names>L.M.</given-names></name><name><surname>Jonason</surname><given-names>J.H.</given-names></name><name><surname>Loiselle</surname><given-names>A.E.</given-names></name><name><surname>Kohn</surname><given-names>A.</given-names></name><name><surname>Schwarz</surname><given-names>E.M.</given-names></name><name><surname>Hilton</surname><given-names>M.J.</given-names></name><name><surname>O&#x02019;Keefe</surname><given-names>R.J.</given-names></name></person-group><article-title>TAK1 regulates cartilage and joint development via the MAPK and BMP signaling pathways</article-title><source>J. Bone Miner. Res.</source><year>2010</year><volume>25</volume><fpage>1784</fpage><lpage>1797</lpage><pub-id pub-id-type="doi">10.1002/jbmr.79</pub-id><pub-id pub-id-type="pmid">20213696</pub-id></element-citation></ref><ref id="B74-cells-08-00969"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shim</surname><given-names>J.H.</given-names></name><name><surname>Greenblatt</surname><given-names>M.B.</given-names></name><name><surname>Xie</surname><given-names>M.</given-names></name><name><surname>Schneider</surname><given-names>M.D.</given-names></name><name><surname>Zou</surname><given-names>W.</given-names></name><name><surname>Zhai</surname><given-names>B.</given-names></name><name><surname>Gygi</surname><given-names>S.</given-names></name><name><surname>Glimcher</surname><given-names>L.H.</given-names></name></person-group><article-title>TAK1 is an essential regulator of BMP signalling in cartilage</article-title><source>EMBO J.</source><year>2009</year><volume>28</volume><fpage>2028</fpage><lpage>2041</lpage><pub-id pub-id-type="doi">10.1038/emboj.2009.162</pub-id><pub-id pub-id-type="pmid">19536134</pub-id></element-citation></ref><ref id="B75-cells-08-00969"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>L.</given-names></name><name><surname>Sheu</surname><given-names>T.J.</given-names></name><name><surname>Dong</surname><given-names>Y.</given-names></name><name><surname>Hoak</surname><given-names>D.M.</given-names></name><name><surname>Zuscik</surname><given-names>M.J.</given-names></name><name><surname>Schwarz</surname><given-names>E.M.</given-names></name><name><surname>Hilton</surname><given-names>M.J.</given-names></name><name><surname>O&#x02019;Keefe</surname><given-names>R.J.</given-names></name><name><surname>Jonason</surname><given-names>J.H.</given-names></name></person-group><article-title>TAK1 regulates SOX9 expression in chondrocytes and is essential for postnatal development of the growth plate and articular cartilages</article-title><source>J. Cell Sci.</source><year>2013</year><volume>126</volume><fpage>5704</fpage><lpage>5713</lpage><pub-id pub-id-type="doi">10.1242/jcs.135483</pub-id><pub-id pub-id-type="pmid">24144697</pub-id></element-citation></ref><ref id="B76-cells-08-00969"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tew</surname><given-names>S.R.</given-names></name><name><surname>Hardingham</surname><given-names>T.E.</given-names></name></person-group><article-title>Regulation of SOX9 mRNA in human articular chondrocytes involving p38 MAPK activation and mRNA stabilization</article-title><source>J. Biol. Chem.</source><year>2006</year><volume>281</volume><fpage>39471</fpage><lpage>39479</lpage><pub-id pub-id-type="doi">10.1074/jbc.M604322200</pub-id><pub-id pub-id-type="pmid">17050539</pub-id></element-citation></ref><ref id="B77-cells-08-00969"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rokutanda</surname><given-names>S.</given-names></name><name><surname>Fujita</surname><given-names>T.</given-names></name><name><surname>Kanatani</surname><given-names>N.</given-names></name><name><surname>Yoshida</surname><given-names>C.A.</given-names></name><name><surname>Komori</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Mizuno</surname><given-names>A.</given-names></name><name><surname>Komori</surname><given-names>T.</given-names></name></person-group><article-title>Akt regulates skeletal development through GSK3, mTOR, and FoxOs</article-title><source>Dev. Biol.</source><year>2009</year><volume>328</volume><fpage>78</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2009.01.009</pub-id><pub-id pub-id-type="pmid">19389373</pub-id></element-citation></ref><ref id="B78-cells-08-00969"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Jin</surname><given-names>D.</given-names></name><name><surname>Cai</surname><given-names>C.</given-names></name><name><surname>Jia</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Huang</surname><given-names>B.</given-names></name><etal/></person-group><article-title>mTORC1 regulates PTHrP to coordinate chondrocyte growth, proliferation and differentiation</article-title><source>Nat. Commun.</source><year>2016</year><volume>7</volume><fpage>11151</fpage><pub-id pub-id-type="doi">10.1038/ncomms11151</pub-id><pub-id pub-id-type="pmid">27039827</pub-id></element-citation></ref><ref id="B79-cells-08-00969"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Vasheghani</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>Y.-h.</given-names></name><name><surname>Blati</surname><given-names>M.</given-names></name><name><surname>Simeone</surname><given-names>K.</given-names></name><name><surname>Fahmi</surname><given-names>H.</given-names></name><name><surname>Lussier</surname><given-names>B.</given-names></name><name><surname>Roughley</surname><given-names>P.</given-names></name><name><surname>Lagares</surname><given-names>D.</given-names></name><name><surname>Pelletier</surname><given-names>J.-P.</given-names></name><etal/></person-group><article-title>Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis</article-title><source>Ann. Rheum. Dis.</source><year>2015</year><volume>74</volume><fpage>1432</fpage><lpage>1440</lpage><pub-id pub-id-type="doi">10.1136/annrheumdis-2013-204599</pub-id><pub-id pub-id-type="pmid">24651621</pub-id></element-citation></ref><ref id="B80-cells-08-00969"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takayama</surname><given-names>K.</given-names></name><name><surname>Kawakami</surname><given-names>Y.</given-names></name><name><surname>Kobayashi</surname><given-names>M.</given-names></name><name><surname>Greco</surname><given-names>N.</given-names></name><name><surname>Cummins</surname><given-names>J.H.</given-names></name><name><surname>Matsushita</surname><given-names>T.</given-names></name><name><surname>Kuroda</surname><given-names>R.</given-names></name><name><surname>Kurosaka</surname><given-names>M.</given-names></name><name><surname>Fu</surname><given-names>F.H.</given-names></name><name><surname>Huard</surname><given-names>J.</given-names></name></person-group><article-title>Local intra-articular injection of rapamycin delays articular cartilage degeneration in a murine model of osteoarthritis</article-title><source>Arthritis Res. Ther.</source><year>2014</year><volume>16</volume><fpage>482</fpage><pub-id pub-id-type="doi">10.1186/s13075-014-0482-4</pub-id><pub-id pub-id-type="pmid">25403236</pub-id></element-citation></ref><ref id="B81-cells-08-00969"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carames</surname><given-names>B.</given-names></name><name><surname>Hasegawa</surname><given-names>A.</given-names></name><name><surname>Taniguchi</surname><given-names>N.</given-names></name><name><surname>Miyaki</surname><given-names>S.</given-names></name><name><surname>Blanco</surname><given-names>F.J.</given-names></name><name><surname>Lotz</surname><given-names>M.</given-names></name></person-group><article-title>Autophagy activation by rapamycin reduces severity of experimental osteoarthritis</article-title><source>Ann. Rheum. Dis.</source><year>2012</year><volume>71</volume><fpage>575</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1136/annrheumdis-2011-200557</pub-id><pub-id pub-id-type="pmid">22084394</pub-id></element-citation></ref><ref id="B82-cells-08-00969"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woods</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Beier</surname><given-names>F.</given-names></name></person-group><article-title>RhoA/ROCK signaling regulates Sox9 expression and actin organization during chondrogenesis</article-title><source>J. Biol. Chem.</source><year>2005</year><volume>280</volume><fpage>11626</fpage><lpage>11634</lpage><pub-id pub-id-type="doi">10.1074/jbc.M409158200</pub-id><pub-id pub-id-type="pmid">15665004</pub-id></element-citation></ref><ref id="B83-cells-08-00969"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woods</surname><given-names>A.</given-names></name><name><surname>Beier</surname><given-names>F.</given-names></name></person-group><article-title>RhoA/ROCK signaling regulates chondrogenesis in a context-dependent manner</article-title><source>J. Biol. Chem.</source><year>2006</year><volume>281</volume><fpage>13134</fpage><lpage>13140</lpage><pub-id pub-id-type="doi">10.1074/jbc.M509433200</pub-id><pub-id pub-id-type="pmid">16565087</pub-id></element-citation></ref><ref id="B84-cells-08-00969"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haudenschild</surname><given-names>D.R.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Pang</surname><given-names>N.</given-names></name><name><surname>Lotz</surname><given-names>M.K.</given-names></name><name><surname>D&#x02019;Lima</surname><given-names>D.D.</given-names></name></person-group><article-title>Rho kinase-dependent activation of SOX9 in chondrocytes</article-title><source>Arthritis Rheum</source><year>2010</year><volume>62</volume><fpage>191</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1002/art.25051</pub-id><pub-id pub-id-type="pmid">20039424</pub-id></element-citation></ref><ref id="B85-cells-08-00969"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seyedin</surname><given-names>S.M.</given-names></name><name><surname>Thomas</surname><given-names>T.C.</given-names></name><name><surname>Thompson</surname><given-names>A.Y.</given-names></name><name><surname>Rosen</surname><given-names>D.M.</given-names></name><name><surname>Piez</surname><given-names>K.A.</given-names></name></person-group><article-title>Purification and characterization of two cartilage-inducing factors from bovine demineralized bone</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1985</year><volume>82</volume><fpage>2267</fpage><lpage>2271</lpage><pub-id pub-id-type="doi">10.1073/pnas.82.8.2267</pub-id><pub-id pub-id-type="pmid">3857579</pub-id></element-citation></ref><ref id="B86-cells-08-00969"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seyedin</surname><given-names>S.M.</given-names></name><name><surname>Thompson</surname><given-names>A.Y.</given-names></name><name><surname>Bentz</surname><given-names>H.</given-names></name><name><surname>Rosen</surname><given-names>D.M.</given-names></name><name><surname>McPherson</surname><given-names>J.M.</given-names></name><name><surname>Conti</surname><given-names>A.</given-names></name><name><surname>Siegel</surname><given-names>N.R.</given-names></name><name><surname>Galluppi</surname><given-names>G.R.</given-names></name><name><surname>Piez</surname><given-names>K.A.</given-names></name></person-group><article-title>Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta</article-title><source>J. Biol. Chem.</source><year>1986</year><volume>261</volume><fpage>5693</fpage><lpage>5695</lpage><pub-id pub-id-type="pmid">3754555</pub-id></element-citation></ref><ref id="B87-cells-08-00969"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segarini</surname><given-names>P.R.</given-names></name><name><surname>Roberts</surname><given-names>A.B.</given-names></name><name><surname>Rosen</surname><given-names>D.M.</given-names></name><name><surname>Seyedin</surname><given-names>S.M.</given-names></name></person-group><article-title>Membrane binding characteristics of two forms of transforming growth factor-beta</article-title><source>J. Biol. Chem.</source><year>1987</year><volume>262</volume><fpage>14655</fpage><lpage>14662</lpage><pub-id pub-id-type="pmid">2889729</pub-id></element-citation></ref><ref id="B88-cells-08-00969"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>Y.</given-names></name><name><surname>Schmidt</surname><given-names>D.K.</given-names></name><name><surname>Dasch</surname><given-names>J.R.</given-names></name><name><surname>Chang</surname><given-names>R.J.</given-names></name><name><surname>Glaser</surname><given-names>C.B.</given-names></name></person-group><article-title>Purification and characterization of transforming growth factor-beta 2.3 and -beta 1.2 heterodimers from bovine bone</article-title><source>J. Biol. Chem.</source><year>1992</year><volume>267</volume><fpage>2325</fpage><lpage>2328</lpage><pub-id pub-id-type="pmid">1733936</pub-id></element-citation></ref><ref id="B89-cells-08-00969"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sengle</surname><given-names>G.</given-names></name><name><surname>Ono</surname><given-names>R.N.</given-names></name><name><surname>Sasaki</surname><given-names>T.</given-names></name><name><surname>Sakai</surname><given-names>L.Y.</given-names></name></person-group><article-title>Prodomains of transforming growth factor beta (TGFbeta) superfamily members specify different functions: extracellular matrix interactions and growth factor bioavailability</article-title><source>J. Biol. Chem.</source><year>2011</year><volume>286</volume><fpage>5087</fpage><lpage>5099</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.188615</pub-id><pub-id pub-id-type="pmid">21135108</pub-id></element-citation></ref><ref id="B90-cells-08-00969"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaney Davidson</surname><given-names>E.N.</given-names></name><name><surname>Scharstuhl</surname><given-names>A.</given-names></name><name><surname>Vitters</surname><given-names>E.L.</given-names></name><name><surname>van der Kraan</surname><given-names>P.M.</given-names></name><name><surname>van den Berg</surname><given-names>W.B.</given-names></name></person-group><article-title>Reduced transforming growth factor-beta signaling in cartilage of old mice: Role in impaired repair capacity</article-title><source>Arthritis Res. Ther.</source><year>2005</year><volume>7</volume><fpage>R1338</fpage><lpage>R1347</lpage><pub-id pub-id-type="doi">10.1186/ar1833</pub-id><pub-id pub-id-type="pmid">16277687</pub-id></element-citation></ref><ref id="B91-cells-08-00969"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villiger</surname><given-names>P.M.</given-names></name><name><surname>Lotz</surname><given-names>M.</given-names></name></person-group><article-title>Differential expression of TGF beta isoforms by human articular chondrocytes in response to growth factors</article-title><source>J. Cell Physiol.</source><year>1992</year><volume>151</volume><fpage>318</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1002/jcp.1041510213</pub-id><pub-id pub-id-type="pmid">1572906</pub-id></element-citation></ref><ref id="B92-cells-08-00969"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pombo-Suarez</surname><given-names>M.</given-names></name><name><surname>Castano-Oreja</surname><given-names>M.T.</given-names></name><name><surname>Calaza</surname><given-names>M.</given-names></name><name><surname>Gomez-Reino</surname><given-names>J.</given-names></name><name><surname>Gonzalez</surname><given-names>A.</given-names></name></person-group><article-title>Differential upregulation of the three transforming growth factor beta isoforms in human osteoarthritic cartilage</article-title><source>Ann. Rheum. Dis.</source><year>2009</year><volume>68</volume><fpage>568</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1136/ard.2008.090217</pub-id><pub-id pub-id-type="pmid">18467513</pub-id></element-citation></ref><ref id="B93-cells-08-00969"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>T.I.</given-names></name><name><surname>Joyce</surname><given-names>M.E.</given-names></name><name><surname>Sobel</surname><given-names>M.E.</given-names></name><name><surname>Danielpour</surname><given-names>D.</given-names></name><name><surname>Roberts</surname><given-names>A.B.</given-names></name></person-group><article-title>Transforming growth factor-beta in calf articular cartilage organ cultures: Synthesis and distribution</article-title><source>Arch. Biochem. Biophys.</source><year>1991</year><volume>288</volume><fpage>397</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1016/0003-9861(91)90212-2</pub-id><pub-id pub-id-type="pmid">1716871</pub-id></element-citation></ref><ref id="B94-cells-08-00969"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albro</surname><given-names>M.B.</given-names></name><name><surname>Nims</surname><given-names>R.J.</given-names></name><name><surname>Cigan</surname><given-names>A.D.</given-names></name><name><surname>Yeroushalmi</surname><given-names>K.J.</given-names></name><name><surname>Shim</surname><given-names>J.J.</given-names></name><name><surname>Hung</surname><given-names>C.T.</given-names></name><name><surname>Ateshian</surname><given-names>G.A.</given-names></name></person-group><article-title>Dynamic mechanical compression of devitalized articular cartilage does not activate latent TGF-beta</article-title><source>J. Biomech.</source><year>2013</year><volume>46</volume><fpage>1433</fpage><lpage>1439</lpage><pub-id pub-id-type="doi">10.1016/j.jbiomech.2013.03.006</pub-id><pub-id pub-id-type="pmid">23540376</pub-id></element-citation></ref><ref id="B95-cells-08-00969"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maeda</surname><given-names>S.</given-names></name><name><surname>Dean</surname><given-names>D.D.</given-names></name><name><surname>Gay</surname><given-names>I.</given-names></name><name><surname>Schwartz</surname><given-names>Z.</given-names></name><name><surname>Boyan</surname><given-names>B.D.</given-names></name></person-group><article-title>Activation of latent transforming growth factor beta1 by stromelysin 1 in extracts of growth plate chondrocyte-derived matrix vesicles</article-title><source>J. Bone Miner. Res.</source><year>2001</year><volume>16</volume><fpage>1281</fpage><lpage>1290</lpage><pub-id pub-id-type="doi">10.1359/jbmr.2001.16.7.1281</pub-id><pub-id pub-id-type="pmid">11450704</pub-id></element-citation></ref><ref id="B96-cells-08-00969"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albro</surname><given-names>M.B.</given-names></name><name><surname>Cigan</surname><given-names>A.D.</given-names></name><name><surname>Nims</surname><given-names>R.J.</given-names></name><name><surname>Yeroushalmi</surname><given-names>K.J.</given-names></name><name><surname>Oungoulian</surname><given-names>S.R.</given-names></name><name><surname>Hung</surname><given-names>C.T.</given-names></name><name><surname>Ateshian</surname><given-names>G.A.</given-names></name></person-group><article-title>Shearing of synovial fluid activates latent TGF-beta</article-title><source>Osteoarthr. Cartil.</source><year>2012</year><volume>20</volume><fpage>1374</fpage><lpage>1382</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2012.07.006</pub-id><pub-id pub-id-type="pmid">22858668</pub-id></element-citation></ref><ref id="B97-cells-08-00969"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jobling</surname><given-names>M.F.</given-names></name><name><surname>Mott</surname><given-names>J.D.</given-names></name><name><surname>Finnegan</surname><given-names>M.T.</given-names></name><name><surname>Jurukovski</surname><given-names>V.</given-names></name><name><surname>Erickson</surname><given-names>A.C.</given-names></name><name><surname>Walian</surname><given-names>P.J.</given-names></name><name><surname>Taylor</surname><given-names>S.E.</given-names></name><name><surname>Ledbetter</surname><given-names>S.</given-names></name><name><surname>Lawrence</surname><given-names>C.M.</given-names></name><name><surname>Rifkin</surname><given-names>D.B.</given-names></name><etal/></person-group><article-title>Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species</article-title><source>Radiat. Res.</source><year>2006</year><volume>166</volume><fpage>839</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1667/RR0695.1</pub-id><pub-id pub-id-type="pmid">17149983</pub-id></element-citation></ref><ref id="B98-cells-08-00969"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madej</surname><given-names>W.</given-names></name><name><surname>van Caam</surname><given-names>A.</given-names></name><name><surname>Blaney Davidson</surname><given-names>E.N.</given-names></name><name><surname>van der Kraan</surname><given-names>P.M.</given-names></name><name><surname>Buma</surname><given-names>P.</given-names></name></person-group><article-title>Physiological and excessive mechanical compression of articular cartilage activates Smad2/3P signaling</article-title><source>Osteoarthr. Cartil.</source><year>2014</year><volume>22</volume><fpage>1018</fpage><lpage>1025</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2014.04.024</pub-id><pub-id pub-id-type="pmid">24795273</pub-id></element-citation></ref><ref id="B99-cells-08-00969"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finnson</surname><given-names>K.W.</given-names></name><name><surname>Parker</surname><given-names>W.L.</given-names></name><name><surname>ten Dijke</surname><given-names>P.</given-names></name><name><surname>Thorikay</surname><given-names>M.</given-names></name><name><surname>Philip</surname><given-names>A.</given-names></name></person-group><article-title>ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes</article-title><source>J. Bone Miner. Res.</source><year>2008</year><volume>23</volume><fpage>896</fpage><lpage>906</lpage><pub-id pub-id-type="doi">10.1359/jbmr.080209</pub-id><pub-id pub-id-type="pmid">18333754</pub-id></element-citation></ref><ref id="B100-cells-08-00969"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaney Davidson</surname><given-names>E.N.</given-names></name><name><surname>Remst</surname><given-names>D.F.</given-names></name><name><surname>Vitters</surname><given-names>E.L.</given-names></name><name><surname>van Beuningen</surname><given-names>H.M.</given-names></name><name><surname>Blom</surname><given-names>A.B.</given-names></name><name><surname>Goumans</surname><given-names>M.J.</given-names></name><name><surname>van den Berg</surname><given-names>W.B.</given-names></name><name><surname>van der Kraan</surname><given-names>P.M.</given-names></name></person-group><article-title>Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice</article-title><source>J. Immunol.</source><year>2009</year><volume>182</volume><fpage>7937</fpage><lpage>7945</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0803991</pub-id><pub-id pub-id-type="pmid">19494318</pub-id></element-citation></ref><ref id="B101-cells-08-00969"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Beuningen</surname><given-names>H.M.</given-names></name><name><surname>van der Kraan</surname><given-names>P.M.</given-names></name><name><surname>Arntz</surname><given-names>O.J.</given-names></name><name><surname>van den Berg</surname><given-names>W.B.</given-names></name></person-group><article-title>Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint</article-title><source>Lab. Investig.</source><year>1994</year><volume>71</volume><fpage>279</fpage><lpage>290</lpage><pub-id pub-id-type="pmid">8078307</pub-id></element-citation></ref><ref id="B102-cells-08-00969"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Beuningen</surname><given-names>H.M.</given-names></name><name><surname>Glansbeek</surname><given-names>H.L.</given-names></name><name><surname>van der Kraan</surname><given-names>P.M.</given-names></name><name><surname>van den Berg</surname><given-names>W.B.</given-names></name></person-group><article-title>Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation</article-title><source>Osteoarthr. Cartil.</source><year>1998</year><volume>6</volume><fpage>306</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1053/joca.1998.0129</pub-id><pub-id pub-id-type="pmid">10197165</pub-id></element-citation></ref><ref id="B103-cells-08-00969"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>T.I.</given-names></name><name><surname>Roberts</surname><given-names>A.B.</given-names></name></person-group><article-title>Transforming growth factor beta regulates the metabolism of proteoglycans in bovine cartilage organ cultures</article-title><source>J. Biol. Chem.</source><year>1988</year><volume>263</volume><fpage>12828</fpage><lpage>12831</lpage><pub-id pub-id-type="pmid">3166454</pub-id></element-citation></ref><ref id="B104-cells-08-00969"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malemud</surname><given-names>C.J.</given-names></name><name><surname>Killeen</surname><given-names>W.</given-names></name><name><surname>Hering</surname><given-names>T.M.</given-names></name><name><surname>Purchio</surname><given-names>A.F.</given-names></name></person-group><article-title>Enhanced sulfated-proteoglycan core protein synthesis by incubation of rabbit chondrocytes with recombinant transforming growth factor-beta 1</article-title><source>J. Cell Physiol.</source><year>1991</year><volume>149</volume><fpage>152</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1002/jcp.1041490119</pub-id><pub-id pub-id-type="pmid">1939343</pub-id></element-citation></ref><ref id="B105-cells-08-00969"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Kraan</surname><given-names>P.</given-names></name><name><surname>Vitters</surname><given-names>E.</given-names></name><name><surname>van den Berg</surname><given-names>W.</given-names></name></person-group><article-title>Differential effect of transforming growth factor beta on freshly isolated and cultured articular chondrocytes</article-title><source>J. Rheumatol.</source><year>1992</year><volume>19</volume><fpage>140</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">1556677</pub-id></element-citation></ref><ref id="B106-cells-08-00969"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redini</surname><given-names>F.</given-names></name><name><surname>Galera</surname><given-names>P.</given-names></name><name><surname>Mauviel</surname><given-names>A.</given-names></name><name><surname>Loyau</surname><given-names>G.</given-names></name><name><surname>Pujol</surname><given-names>J.P.</given-names></name></person-group><article-title>Transforming growth factor beta stimulates collagen and glycosaminoglycan biosynthesis in cultured rabbit articular chondrocytes</article-title><source>FEBS Lett.</source><year>1988</year><volume>234</volume><fpage>172</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1016/0014-5793(88)81327-9</pub-id><pub-id pub-id-type="pmid">3164687</pub-id></element-citation></ref><ref id="B107-cells-08-00969"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galera</surname><given-names>P.</given-names></name><name><surname>Vivien</surname><given-names>D.</given-names></name><name><surname>Pronost</surname><given-names>S.</given-names></name><name><surname>Bonaventure</surname><given-names>J.</given-names></name><name><surname>Redini</surname><given-names>F.</given-names></name><name><surname>Loyau</surname><given-names>G.</given-names></name><name><surname>Pujol</surname><given-names>J.P.</given-names></name></person-group><article-title>Transforming growth factor-beta 1 (TGF-beta 1) up-regulation of collagen type II in primary cultures of rabbit articular chondrocytes (RAC) involves increased mRNA levels without affecting mRNA stability and procollagen processing</article-title><source>J. Cell Physiol.</source><year>1992</year><volume>153</volume><fpage>596</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1002/jcp.1041530322</pub-id><pub-id pub-id-type="pmid">1447320</pub-id></element-citation></ref><ref id="B108-cells-08-00969"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Recklies</surname><given-names>A.D.</given-names></name><name><surname>Baillargeon</surname><given-names>L.</given-names></name><name><surname>White</surname><given-names>C.</given-names></name></person-group><article-title>Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes</article-title><source>Arthritis Rheum</source><year>1998</year><volume>41</volume><fpage>997</fpage><lpage>1006</lpage><pub-id pub-id-type="doi">10.1002/1529-0131(199806)41:6&#x0003c;997::AID-ART6&#x0003e;3.0.CO;2-G</pub-id><pub-id pub-id-type="pmid">9627009</pub-id></element-citation></ref><ref id="B109-cells-08-00969"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motaung</surname><given-names>S.C.</given-names></name><name><surname>Di Cesare</surname><given-names>P.E.</given-names></name><name><surname>Reddi</surname><given-names>A.H.</given-names></name></person-group><article-title>Differential response of cartilage oligomeric matrix protein (COMP) to morphogens of bone morphogenetic protein/transforming growth factor-beta family in the surface, middle and deep zones of articular cartilage</article-title><source>J. Tissue Eng. Regen. Med.</source><year>2011</year><volume>5</volume><fpage>e87</fpage><lpage>e96</lpage><pub-id pub-id-type="doi">10.1002/term.358</pub-id><pub-id pub-id-type="pmid">21604381</pub-id></element-citation></ref><ref id="B110-cells-08-00969"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iozzo</surname><given-names>R.V.</given-names></name><name><surname>Pillarisetti</surname><given-names>J.</given-names></name><name><surname>Sharma</surname><given-names>B.</given-names></name><name><surname>Murdoch</surname><given-names>A.D.</given-names></name><name><surname>Danielson</surname><given-names>K.G.</given-names></name><name><surname>Uitto</surname><given-names>J.</given-names></name><name><surname>Mauviel</surname><given-names>A.</given-names></name></person-group><article-title>Structural and functional characterization of the human perlecan gene promoter. Transcriptional activation by transforming growth factor-beta via a nuclear factor 1-binding element</article-title><source>J. Biol. Chem.</source><year>1997</year><volume>272</volume><fpage>5219</fpage><lpage>5228</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.8.5219</pub-id><pub-id pub-id-type="pmid">9030592</pub-id></element-citation></ref><ref id="B111-cells-08-00969"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burton-Wurster</surname><given-names>N.</given-names></name><name><surname>Lust</surname><given-names>G.</given-names></name></person-group><article-title>Fibronectin and proteoglycan synthesis in long term cultures of cartilage explants in Ham&#x02019;s F12 supplemented with insulin and calcium: effects of the addition of TGF-beta</article-title><source>Arch. Biochem. Biophys.</source><year>1990</year><volume>283</volume><fpage>27</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/0003-9861(90)90607-Z</pub-id><pub-id pub-id-type="pmid">2241173</pub-id></element-citation></ref><ref id="B112-cells-08-00969"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>T.I.</given-names></name></person-group><article-title>Transforming growth factor-beta 1 stimulates synthesis of proteoglycan aggregates in calf articular cartilage organ cultures</article-title><source>Arch. Biochem. Biophys.</source><year>1991</year><volume>286</volume><fpage>99</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/0003-9861(91)90013-9</pub-id><pub-id pub-id-type="pmid">1910291</pub-id></element-citation></ref><ref id="B113-cells-08-00969"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niikura</surname><given-names>T.</given-names></name><name><surname>Reddi</surname><given-names>A.H.</given-names></name></person-group><article-title>Differential regulation of lubricin/superficial zone protein by transforming growth factor beta/bone morphogenetic protein superfamily members in articular chondrocytes and synoviocytes</article-title><source>Arthritis Rheum</source><year>2007</year><volume>56</volume><fpage>2312</fpage><lpage>2321</lpage><pub-id pub-id-type="doi">10.1002/art.22659</pub-id><pub-id pub-id-type="pmid">17599751</pub-id></element-citation></ref><ref id="B114-cells-08-00969"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Kraan</surname><given-names>P.M.</given-names></name><name><surname>Vitters</surname><given-names>E.L.</given-names></name><name><surname>van den Berg</surname><given-names>W.B.</given-names></name></person-group><article-title>Inhibition of proteoglycan synthesis by transforming growth factor beta in anatomically intact articular cartilage of murine patellae</article-title><source>Ann. Rheum. Dis.</source><year>1992</year><volume>51</volume><fpage>643</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1136/ard.51.5.643</pub-id><pub-id pub-id-type="pmid">1616330</pub-id></element-citation></ref><ref id="B115-cells-08-00969"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glansbeek</surname><given-names>H.L.</given-names></name><name><surname>van der Kraan</surname><given-names>P.M.</given-names></name><name><surname>Vitters</surname><given-names>E.L.</given-names></name><name><surname>van den Berg</surname><given-names>W.B.</given-names></name></person-group><article-title>Correlation of the size of type II transforming growth factor beta (TGF-beta) receptor with TGF-beta responses of isolated bovine articular chondrocytes</article-title><source>Ann. Rheum. Dis.</source><year>1993</year><volume>52</volume><fpage>812</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1136/ard.52.11.812</pub-id><pub-id pub-id-type="pmid">8250612</pub-id></element-citation></ref><ref id="B116-cells-08-00969"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chadjichristos</surname><given-names>C.</given-names></name><name><surname>Ghayor</surname><given-names>C.</given-names></name><name><surname>Herrouin</surname><given-names>J.F.</given-names></name><name><surname>Ala-Kokko</surname><given-names>L.</given-names></name><name><surname>Suske</surname><given-names>G.</given-names></name><name><surname>Pujol</surname><given-names>J.P.</given-names></name><name><surname>Galera</surname><given-names>P.</given-names></name></person-group><article-title>Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-beta 1) in articular chondrocytes involves SP3/SP1 ratio</article-title><source>J. Biol. Chem.</source><year>2002</year><volume>277</volume><fpage>43903</fpage><lpage>43917</lpage><pub-id pub-id-type="doi">10.1074/jbc.M206111200</pub-id><pub-id pub-id-type="pmid">12186868</pub-id></element-citation></ref><ref id="B117-cells-08-00969"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Keefe</surname><given-names>R.J.</given-names></name><name><surname>Puzas</surname><given-names>J.E.</given-names></name><name><surname>Brand</surname><given-names>J.S.</given-names></name><name><surname>Rosier</surname><given-names>R.N.</given-names></name></person-group><article-title>Effects of transforming growth factor-beta on matrix synthesis by chick growth plate chondrocytes</article-title><source>Endocrinology</source><year>1988</year><volume>122</volume><fpage>2953</fpage><lpage>2961</lpage><pub-id pub-id-type="doi">10.1210/endo-122-6-2953</pub-id><pub-id pub-id-type="pmid">3163548</pub-id></element-citation></ref><ref id="B118-cells-08-00969"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vivien</surname><given-names>D.</given-names></name><name><surname>Galera</surname><given-names>P.</given-names></name><name><surname>Lebrun</surname><given-names>E.</given-names></name><name><surname>Loyau</surname><given-names>G.</given-names></name><name><surname>Pujol</surname><given-names>J.P.</given-names></name></person-group><article-title>Differential effects of transforming growth factor-beta and epidermal growth factor on the cell cycle of cultured rabbit articular chondrocytes</article-title><source>J. Cell Physiol.</source><year>1990</year><volume>143</volume><fpage>534</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1002/jcp.1041430319</pub-id><pub-id pub-id-type="pmid">2358472</pub-id></element-citation></ref><ref id="B119-cells-08-00969"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Beuningen</surname><given-names>H.M.</given-names></name><name><surname>Glansbeek</surname><given-names>H.L.</given-names></name><name><surname>van der Kraan</surname><given-names>P.M.</given-names></name><name><surname>van den Berg</surname><given-names>W.B.</given-names></name></person-group><article-title>Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections</article-title><source>Osteoarthr. Cartil.</source><year>2000</year><volume>8</volume><fpage>25</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1053/joca.1999.0267</pub-id><pub-id pub-id-type="pmid">10607496</pub-id></element-citation></ref><ref id="B120-cells-08-00969"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Beuningen</surname><given-names>H.M.</given-names></name><name><surname>van der Kraan</surname><given-names>P.M.</given-names></name><name><surname>Arntz</surname><given-names>O.J.</given-names></name><name><surname>van den Berg</surname><given-names>W.B.</given-names></name></person-group><article-title>Protection from interleukin 1 induced destruction of articular cartilage by transforming growth factor beta: studies in anatomically intact cartilage in vitro and in vivo</article-title><source>Ann. Rheum. Dis.</source><year>1993</year><volume>52</volume><fpage>185</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1136/ard.52.3.185</pub-id><pub-id pub-id-type="pmid">8484670</pub-id></element-citation></ref><ref id="B121-cells-08-00969"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Beuningen</surname><given-names>H.M.</given-names></name><name><surname>van der Kraan</surname><given-names>P.M.</given-names></name><name><surname>Arntz</surname><given-names>O.J.</given-names></name><name><surname>van den Berg</surname><given-names>W.B.</given-names></name></person-group><article-title>In vivo protection against interleukin-1-induced articular cartilage damage by transforming growth factor-beta 1: age-related differences</article-title><source>Ann. Rheum. Dis.</source><year>1994</year><volume>53</volume><fpage>593</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1136/ard.53.9.593</pub-id><pub-id pub-id-type="pmid">7979598</pub-id></element-citation></ref><ref id="B122-cells-08-00969"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>N.</given-names></name><name><surname>Rieneck</surname><given-names>K.</given-names></name><name><surname>van der Kraan</surname><given-names>P.M.</given-names></name><name><surname>van Beuningen</surname><given-names>H.M.</given-names></name><name><surname>Vitters</surname><given-names>E.L.</given-names></name><name><surname>Bendtzen</surname><given-names>K.</given-names></name><name><surname>van den Berg</surname><given-names>W.B.</given-names></name></person-group><article-title>Elucidation of IL-1/TGF-beta interactions in mouse chondrocyte cell line by genome-wide gene expression</article-title><source>Osteoarthr. Cartil.</source><year>2005</year><volume>13</volume><fpage>426</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2004.12.010</pub-id><pub-id pub-id-type="pmid">15882566</pub-id></element-citation></ref><ref id="B123-cells-08-00969"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redini</surname><given-names>F.</given-names></name><name><surname>Mauviel</surname><given-names>A.</given-names></name><name><surname>Pronost</surname><given-names>S.</given-names></name><name><surname>Loyau</surname><given-names>G.</given-names></name><name><surname>Pujol</surname><given-names>J.P.</given-names></name></person-group><article-title>Transforming growth factor beta exerts opposite effects from interleukin-1 beta on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression</article-title><source>Arthritis Rheum</source><year>1993</year><volume>36</volume><fpage>44</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1002/art.1780360108</pub-id><pub-id pub-id-type="pmid">8424835</pub-id></element-citation></ref><ref id="B124-cells-08-00969"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glansbeek</surname><given-names>H.L.</given-names></name><name><surname>van Beuningen</surname><given-names>H.M.</given-names></name><name><surname>Vitters</surname><given-names>E.L.</given-names></name><name><surname>van der Kraan</surname><given-names>P.M.</given-names></name><name><surname>van den Berg</surname><given-names>W.B.</given-names></name></person-group><article-title>Stimulation of articular cartilage repair in established arthritis by local administration of transforming growth factor-beta into murine knee joints</article-title><source>Lab. Investig.</source><year>1998</year><volume>78</volume><fpage>133</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">9484711</pub-id></element-citation></ref><ref id="B125-cells-08-00969"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pronost</surname><given-names>S.</given-names></name><name><surname>Segond</surname><given-names>N.</given-names></name><name><surname>Macro</surname><given-names>M.</given-names></name><name><surname>Redini</surname><given-names>F.</given-names></name><name><surname>Penfornis</surname><given-names>H.</given-names></name><name><surname>Jullienne</surname><given-names>A.</given-names></name><name><surname>Moukhtar</surname><given-names>M.S.</given-names></name><name><surname>Pujol</surname><given-names>J.P.</given-names></name></person-group><article-title>Modulation of interleukin-1 receptor expression by transforming growth factor-beta in cultured rabbit articular chondrocytes: analysis by reverse transcription-polymerase chain reaction</article-title><source>Osteoarthr. Cartil.</source><year>1995</year><volume>3</volume><fpage>147</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1016/S1063-4584(05)80049-4</pub-id><pub-id pub-id-type="pmid">8581744</pub-id></element-citation></ref><ref id="B126-cells-08-00969"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiegertjes</surname><given-names>R.</given-names></name><name><surname>van Caam</surname><given-names>A.</given-names></name><name><surname>van Beuningen</surname><given-names>H.</given-names></name><name><surname>Koenders</surname><given-names>M.</given-names></name><name><surname>van Lent</surname><given-names>P.</given-names></name><name><surname>van der Kraan</surname><given-names>P.</given-names></name><name><surname>van de Loo</surname><given-names>F.</given-names></name><name><surname>Blaney Davidson</surname><given-names>E.</given-names></name></person-group><article-title>TGF-beta dampens IL-6 signaling in articular chondrocytes by decreasing IL-6 receptor expression</article-title><source>Osteoarthr. Cartil.</source><year>2019</year></element-citation></ref><ref id="B127-cells-08-00969"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiou</surname><given-names>S.R.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Westerhoff</surname><given-names>M.</given-names></name><name><surname>Lu</surname><given-names>L.</given-names></name><name><surname>Petrof</surname><given-names>E.O.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Claud</surname><given-names>E.C.</given-names></name></person-group><article-title>Oral administration of transforming growth factor-beta1 (TGF-beta1) protects the immature gut from injury via Smad protein-dependent suppression of epithelial nuclear factor kappaB (NF-kappaB) signaling and proinflammatory cytokine production</article-title><source>J. Biol. Chem.</source><year>2013</year><volume>288</volume><fpage>34757</fpage><lpage>34766</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.503946</pub-id><pub-id pub-id-type="pmid">24129565</pub-id></element-citation></ref><ref id="B128-cells-08-00969"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiChiara</surname><given-names>M.R.</given-names></name><name><surname>Kiely</surname><given-names>J.M.</given-names></name><name><surname>Gimbrone</surname><given-names>M.A.</given-names><suffix>Jr.</suffix></name><name><surname>Lee</surname><given-names>M.E.</given-names></name><name><surname>Perrella</surname><given-names>M.A.</given-names></name><name><surname>Topper</surname><given-names>J.N.</given-names></name></person-group><article-title>Inhibition of E-selectin gene expression by transforming growth factor beta in endothelial cells involves coactivator integration of Smad and nuclear factor kappaB-mediated signals</article-title><source>J. Exp. Med.</source><year>2000</year><volume>192</volume><fpage>695</fpage><lpage>704</lpage><pub-id pub-id-type="doi">10.1084/jem.192.5.695</pub-id><pub-id pub-id-type="pmid">10974035</pub-id></element-citation></ref><ref id="B129-cells-08-00969"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T.F.</given-names></name><name><surname>Darowish</surname><given-names>M.</given-names></name><name><surname>Zuscik</surname><given-names>M.J.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Schwarz</surname><given-names>E.M.</given-names></name><name><surname>Rosier</surname><given-names>R.N.</given-names></name><name><surname>Drissi</surname><given-names>H.</given-names></name><name><surname>O&#x02019;Keefe</surname><given-names>R.J.</given-names></name></person-group><article-title>Smad3-deficient chondrocytes have enhanced BMP signaling and accelerated differentiation</article-title><source>J. Bone Miner. Res.</source><year>2006</year><volume>21</volume><fpage>4</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1359/JBMR.050911</pub-id><pub-id pub-id-type="pmid">16355269</pub-id></element-citation></ref><ref id="B130-cells-08-00969"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Jin</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Im</surname><given-names>H.J.</given-names></name><name><surname>O&#x02019;Keefe</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name></person-group><article-title>Deletion of the transforming growth factor beta receptor type II gene in articular chondrocytes leads to a progressive osteoarthritis-like phenotype in mice</article-title><source>Arthritis Rheum</source><year>2013</year><volume>65</volume><fpage>3107</fpage><lpage>3119</lpage><pub-id pub-id-type="doi">10.1002/art.38122</pub-id><pub-id pub-id-type="pmid">23982761</pub-id></element-citation></ref><ref id="B131-cells-08-00969"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serra</surname><given-names>R.</given-names></name><name><surname>Johnson</surname><given-names>M.</given-names></name><name><surname>Filvaroff</surname><given-names>E.H.</given-names></name><name><surname>LaBorde</surname><given-names>J.</given-names></name><name><surname>Sheehan</surname><given-names>D.M.</given-names></name><name><surname>Derynck</surname><given-names>R.</given-names></name><name><surname>Moses</surname><given-names>H.L.</given-names></name></person-group><article-title>Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis</article-title><source>J. Cell Biol.</source><year>1997</year><volume>139</volume><fpage>541</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1083/jcb.139.2.541</pub-id><pub-id pub-id-type="pmid">9334355</pub-id></element-citation></ref><ref id="B132-cells-08-00969"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sueyoshi</surname><given-names>T.</given-names></name><name><surname>Yamamoto</surname><given-names>K.</given-names></name><name><surname>Akiyama</surname><given-names>H.</given-names></name></person-group><article-title>Conditional deletion of Tgfbr2 in hypertrophic chondrocytes delays terminal chondrocyte differentiation</article-title><source>Matrix Biol.</source><year>2012</year><volume>31</volume><fpage>352</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1016/j.matbio.2012.07.002</pub-id><pub-id pub-id-type="pmid">22885149</pub-id></element-citation></ref><ref id="B133-cells-08-00969"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>R.</given-names></name><name><surname>Mian</surname><given-names>M.</given-names></name><name><surname>Fu</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>J.Y.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>L.</given-names></name></person-group><article-title>Attenuation of the progression of articular cartilage degeneration by inhibition of TGF-beta1 signaling in a mouse model of osteoarthritis</article-title><source>Am. J. Pathol.</source><year>2015</year><volume>185</volume><fpage>2875</fpage><lpage>2885</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2015.07.003</pub-id><pub-id pub-id-type="pmid">26355014</pub-id></element-citation></ref><ref id="B134-cells-08-00969"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitsugi</surname><given-names>S.</given-names></name><name><surname>Ariyoshi</surname><given-names>W.</given-names></name><name><surname>Okinaga</surname><given-names>T.</given-names></name><name><surname>Kaneuji</surname><given-names>T.</given-names></name><name><surname>Kataoka</surname><given-names>Y.</given-names></name><name><surname>Takahashi</surname><given-names>T.</given-names></name><name><surname>Nishihara</surname><given-names>T.</given-names></name></person-group><article-title>Mechanisms involved in inhibition of chondrogenesis by activin-A</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2012</year><volume>420</volume><fpage>380</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2012.03.003</pub-id><pub-id pub-id-type="pmid">22425773</pub-id></element-citation></ref><ref id="B135-cells-08-00969"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermansson</surname><given-names>M.</given-names></name><name><surname>Sawaji</surname><given-names>Y.</given-names></name><name><surname>Bolton</surname><given-names>M.</given-names></name><name><surname>Alexander</surname><given-names>S.</given-names></name><name><surname>Wallace</surname><given-names>A.</given-names></name><name><surname>Begum</surname><given-names>S.</given-names></name><name><surname>Wait</surname><given-names>R.</given-names></name><name><surname>Saklatvala</surname><given-names>J.</given-names></name></person-group><article-title>Proteomic analysis of articular cartilage shows increased type II collagen synthesis in osteoarthritis and expression of inhibin betaA (activin A), a regulatory molecule for chondrocytes</article-title><source>J. Biol. Chem.</source><year>2004</year><volume>279</volume><fpage>43514</fpage><lpage>43521</lpage><pub-id pub-id-type="doi">10.1074/jbc.M407041200</pub-id><pub-id pub-id-type="pmid">15292256</pub-id></element-citation></ref><ref id="B136-cells-08-00969"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>S.</given-names></name><name><surname>Watt</surname><given-names>F.</given-names></name><name><surname>Sawaji</surname><given-names>Y.</given-names></name><name><surname>Hermansson</surname><given-names>M.</given-names></name><name><surname>Saklatvala</surname><given-names>J.</given-names></name></person-group><article-title>Activin A is an anticatabolic autocrine cytokine in articular cartilage whose production is controlled by fibroblast growth factor 2 and NF-kappaB</article-title><source>Arthritis Rheum</source><year>2007</year><volume>56</volume><fpage>3715</fpage><lpage>3725</lpage><pub-id pub-id-type="doi">10.1002/art.22953</pub-id><pub-id pub-id-type="pmid">17968943</pub-id></element-citation></ref><ref id="B137-cells-08-00969"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tardif</surname><given-names>G.</given-names></name><name><surname>Hum</surname><given-names>D.</given-names></name><name><surname>Pelletier</surname><given-names>J.P.</given-names></name><name><surname>Boileau</surname><given-names>C.</given-names></name><name><surname>Ranger</surname><given-names>P.</given-names></name><name><surname>Martel-Pelletier</surname><given-names>J.</given-names></name></person-group><article-title>Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts</article-title><source>Arthritis Rheum</source><year>2004</year><volume>50</volume><fpage>2521</fpage><lpage>2530</lpage><pub-id pub-id-type="doi">10.1002/art.20441</pub-id><pub-id pub-id-type="pmid">15334466</pub-id></element-citation></ref><ref id="B138-cells-08-00969"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tardif</surname><given-names>G.</given-names></name><name><surname>Pelletier</surname><given-names>J.P.</given-names></name><name><surname>Boileau</surname><given-names>C.</given-names></name><name><surname>Martel-Pelletier</surname><given-names>J.</given-names></name></person-group><article-title>The BMP antagonists follistatin and gremlin in normal and early osteoarthritic cartilage: An immunohistochemical study</article-title><source>Osteoarthr. Cartil.</source><year>2009</year><volume>17</volume><fpage>263</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2008.06.022</pub-id><pub-id pub-id-type="pmid">18691909</pub-id></element-citation></ref><ref id="B139-cells-08-00969"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flechtenmacher</surname><given-names>J.</given-names></name><name><surname>Huch</surname><given-names>K.</given-names></name><name><surname>Thonar</surname><given-names>E.J.</given-names></name><name><surname>Mollenhauer</surname><given-names>J.A.</given-names></name><name><surname>Davies</surname><given-names>S.R.</given-names></name><name><surname>Schmid</surname><given-names>T.M.</given-names></name><name><surname>Puhl</surname><given-names>W.</given-names></name><name><surname>Sampath</surname><given-names>T.K.</given-names></name><name><surname>Aydelotte</surname><given-names>M.B.</given-names></name><name><surname>Kuettner</surname><given-names>K.E.</given-names></name></person-group><article-title>Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes</article-title><source>Arthritis Rheum</source><year>1996</year><volume>39</volume><fpage>1896</fpage><lpage>1904</lpage><pub-id pub-id-type="doi">10.1002/art.1780391117</pub-id><pub-id pub-id-type="pmid">8912513</pub-id></element-citation></ref><ref id="B140-cells-08-00969"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luyten</surname><given-names>F.P.</given-names></name><name><surname>Chen</surname><given-names>P.</given-names></name><name><surname>Paralkar</surname><given-names>V.</given-names></name><name><surname>Reddi</surname><given-names>A.H.</given-names></name></person-group><article-title>Recombinant bone morphogenetic protein-4, transforming growth factor-beta 1, and activin A enhance the cartilage phenotype of articular chondrocytes in vitro</article-title><source>Exp. Cell Res.</source><year>1994</year><volume>210</volume><fpage>224</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1006/excr.1994.1033</pub-id><pub-id pub-id-type="pmid">8299720</pub-id></element-citation></ref><ref id="B141-cells-08-00969"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>A.L.</given-names></name><name><surname>Fang</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Leslie</surname><given-names>M.P.</given-names></name><name><surname>Chang</surname><given-names>E.</given-names></name><name><surname>Di Cesare</surname><given-names>P.E.</given-names></name></person-group><article-title>Expression of bone morphogenetic proteins, receptors, and tissue inhibitors in human fetal, adult, and osteoarthritic articular cartilage</article-title><source>J. Orthop. Res.</source><year>2004</year><volume>22</volume><fpage>1188</fpage><lpage>1192</lpage><pub-id pub-id-type="doi">10.1016/j.orthres.2004.02.013</pub-id><pub-id pub-id-type="pmid">15475196</pub-id></element-citation></ref><ref id="B142-cells-08-00969"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Caam</surname><given-names>A.</given-names></name><name><surname>Madej</surname><given-names>W.</given-names></name><name><surname>Thijssen</surname><given-names>E.</given-names></name><name><surname>Garcia de Vinuesa</surname><given-names>A.</given-names></name><name><surname>van den Berg</surname><given-names>W.</given-names></name><name><surname>Goumans</surname><given-names>M.J.</given-names></name><name><surname>Ten Dijke</surname><given-names>P.</given-names></name><name><surname>Blaney Davidson</surname><given-names>E.</given-names></name><name><surname>van der Kraan</surname><given-names>P.M.</given-names></name></person-group><article-title>Expression of TGFbeta-family signalling components in ageing cartilage: Age-related loss of TGFbeta and BMP receptors</article-title><source>Osteoarthr. Cartil.</source><year>2016</year></element-citation></ref><ref id="B143-cells-08-00969"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bragdon</surname><given-names>B.</given-names></name><name><surname>Moseychuk</surname><given-names>O.</given-names></name><name><surname>Saldanha</surname><given-names>S.</given-names></name><name><surname>King</surname><given-names>D.</given-names></name><name><surname>Julian</surname><given-names>J.</given-names></name><name><surname>Nohe</surname><given-names>A.</given-names></name></person-group><article-title>Bone morphogenetic proteins: A critical review</article-title><source>Cell Signal</source><year>2011</year><volume>23</volume><fpage>609</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2010.10.003</pub-id><pub-id pub-id-type="pmid">20959140</pub-id></element-citation></ref><ref id="B144-cells-08-00969"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sengle</surname><given-names>G.</given-names></name><name><surname>Ono</surname><given-names>R.N.</given-names></name><name><surname>Lyons</surname><given-names>K.M.</given-names></name><name><surname>Bachinger</surname><given-names>H.P.</given-names></name><name><surname>Sakai</surname><given-names>L.Y.</given-names></name></person-group><article-title>A new model for growth factor activation: Type II receptors compete with the prodomain for BMP-7</article-title><source>J. Mol. Biol.</source><year>2008</year><volume>381</volume><fpage>1025</fpage><lpage>1039</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2008.06.074</pub-id><pub-id pub-id-type="pmid">18621057</pub-id></element-citation></ref><ref id="B145-cells-08-00969"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aykul</surname><given-names>S.</given-names></name><name><surname>Martinez-Hackert</surname><given-names>E.</given-names></name></person-group><article-title>Transforming Growth Factor-beta Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding</article-title><source>J. Biol. Chem.</source><year>2016</year><volume>291</volume><fpage>10792</fpage><lpage>10804</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.713487</pub-id><pub-id pub-id-type="pmid">26961869</pub-id></element-citation></ref><ref id="B146-cells-08-00969"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pregizer</surname><given-names>S.K.</given-names></name><name><surname>Mortlock</surname><given-names>D.P.</given-names></name></person-group><article-title>Dynamics and cellular localization of Bmp2, Bmp4, and Noggin transcription in the postnatal mouse skeleton</article-title><source>J. Bone Miner. Res.</source><year>2015</year><volume>30</volume><fpage>64</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1002/jbmr.2313</pub-id><pub-id pub-id-type="pmid">25043193</pub-id></element-citation></ref><ref id="B147-cells-08-00969"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hills</surname><given-names>R.L.</given-names></name><name><surname>Belanger</surname><given-names>L.M.</given-names></name><name><surname>Morris</surname><given-names>E.A.</given-names></name></person-group><article-title>Bone morphogenetic protein 9 is a potent anabolic factor for juvenile bovine cartilage, but not adult cartilage</article-title><source>J. Orthop. Res.</source><year>2005</year><volume>23</volume><fpage>611</fpage><lpage>617</lpage><pub-id pub-id-type="doi">10.1016/j.orthres.2004.12.009</pub-id><pub-id pub-id-type="pmid">15885482</pub-id></element-citation></ref><ref id="B148-cells-08-00969"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaney Davidson</surname><given-names>E.N.</given-names></name><name><surname>Vitters</surname><given-names>E.L.</given-names></name><name><surname>van Lent</surname><given-names>P.L.</given-names></name><name><surname>van de Loo</surname><given-names>F.A.</given-names></name><name><surname>van den Berg</surname><given-names>W.B.</given-names></name><name><surname>van der Kraan</surname><given-names>P.M.</given-names></name></person-group><article-title>Elevated extracellular matrix production and degradation upon bone morphogenetic protein-2 (BMP-2) stimulation point toward a role for BMP-2 in cartilage repair and remodeling</article-title><source>Arthritis Res. Ther.</source><year>2007</year><volume>9</volume><fpage>R102</fpage><pub-id pub-id-type="doi">10.1186/ar2305</pub-id><pub-id pub-id-type="pmid">17922907</pub-id></element-citation></ref><ref id="B149-cells-08-00969"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Lin</surname><given-names>X.</given-names></name><name><surname>Hu</surname><given-names>N.</given-names></name><name><surname>Liao</surname><given-names>J.Y.</given-names></name><name><surname>Lin</surname><given-names>L.B.</given-names></name><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Hu</surname><given-names>Z.M.</given-names></name><name><surname>Liang</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>W.</given-names></name><etal/></person-group><article-title>BMP2 induces chondrogenic differentiation, osteogenic differentiation and endochondral ossification in stem cells</article-title><source>Cell Tissue Res.</source><year>2016</year><pub-id pub-id-type="doi">10.1007/s00441-016-2403-0</pub-id></element-citation></ref><ref id="B150-cells-08-00969"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaney Davidson</surname><given-names>E.N.</given-names></name><name><surname>Vitters</surname><given-names>E.L.</given-names></name><name><surname>Bennink</surname><given-names>M.B.</given-names></name><name><surname>van Lent</surname><given-names>P.L.</given-names></name><name><surname>van Caam</surname><given-names>A.P.</given-names></name><name><surname>Blom</surname><given-names>A.B.</given-names></name><name><surname>van den Berg</surname><given-names>W.B.</given-names></name><name><surname>van de Loo</surname><given-names>F.A.</given-names></name><name><surname>van der Kraan</surname><given-names>P.M.</given-names></name></person-group><article-title>Inducible chondrocyte-specific overexpression of BMP2 in young mice results in severe aggravation of osteophyte formation in experimental OA without altering cartilage damage</article-title><source>Ann. Rheum. Dis.</source><year>2015</year><volume>74</volume><fpage>1257</fpage><lpage>1264</lpage><pub-id pub-id-type="doi">10.1136/annrheumdis-2013-204528</pub-id><pub-id pub-id-type="pmid">24448347</pub-id></element-citation></ref><ref id="B151-cells-08-00969"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaneko</surname><given-names>K.</given-names></name><name><surname>Higuchi</surname><given-names>C.</given-names></name><name><surname>Kunugiza</surname><given-names>Y.</given-names></name><name><surname>Yoshida</surname><given-names>K.</given-names></name><name><surname>Sakai</surname><given-names>T.</given-names></name><name><surname>Yoshikawa</surname><given-names>H.</given-names></name><name><surname>Nakata</surname><given-names>K.</given-names></name></person-group><article-title>Hyaluronan inhibits BMP-induced osteoblast differentiation</article-title><source>FEBS Lett.</source><year>2015</year><volume>589</volume><fpage>447</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2014.12.031</pub-id><pub-id pub-id-type="pmid">25592835</pub-id></element-citation></ref><ref id="B152-cells-08-00969"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klammert</surname><given-names>U.</given-names></name><name><surname>Mueller</surname><given-names>T.D.</given-names></name><name><surname>Hellmann</surname><given-names>T.V.</given-names></name><name><surname>Wuerzler</surname><given-names>K.K.</given-names></name><name><surname>Kotzsch</surname><given-names>A.</given-names></name><name><surname>Schliermann</surname><given-names>A.</given-names></name><name><surname>Schmitz</surname><given-names>W.</given-names></name><name><surname>Kuebler</surname><given-names>A.C.</given-names></name><name><surname>Sebald</surname><given-names>W.</given-names></name><name><surname>Nickel</surname><given-names>J.</given-names></name></person-group><article-title>GDF-5 can act as a context-dependent BMP-2 antagonist</article-title><source>BMC Biol.</source><year>2015</year><volume>13</volume><elocation-id>77</elocation-id><pub-id pub-id-type="doi">10.1186/s12915-015-0183-8</pub-id><pub-id pub-id-type="pmid">26385096</pub-id></element-citation></ref><ref id="B153-cells-08-00969"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>S.C.</given-names></name><name><surname>Hoang</surname><given-names>B.</given-names></name><name><surname>Thomas</surname><given-names>J.T.</given-names></name><name><surname>Vukicevic</surname><given-names>S.</given-names></name><name><surname>Luyten</surname><given-names>F.P.</given-names></name><name><surname>Ryba</surname><given-names>N.J.</given-names></name><name><surname>Kozak</surname><given-names>C.A.</given-names></name><name><surname>Reddi</surname><given-names>A.H.</given-names></name><name><surname>Moos</surname><given-names>M.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-beta superfamily predominantly expressed in long bones during human embryonic development</article-title><source>J. Biol. Chem.</source><year>1994</year><volume>269</volume><fpage>28227</fpage><lpage>28234</lpage><pub-id pub-id-type="pmid">7961761</pub-id></element-citation></ref><ref id="B154-cells-08-00969"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erlacher</surname><given-names>L.</given-names></name><name><surname>Ng</surname><given-names>C.K.</given-names></name><name><surname>Ullrich</surname><given-names>R.</given-names></name><name><surname>Krieger</surname><given-names>S.</given-names></name><name><surname>Luyten</surname><given-names>F.P.</given-names></name></person-group><article-title>Presence of cartilage-derived morphogenetic proteins in articular cartilage and enhancement of matrix replacement in vitro</article-title><source>Arthritis Rheum</source><year>1998</year><volume>41</volume><fpage>263</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1002/1529-0131(199802)41:2&#x0003c;263::AID-ART10&#x0003e;3.0.CO;2-5</pub-id><pub-id pub-id-type="pmid">9485084</pub-id></element-citation></ref><ref id="B155-cells-08-00969"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bobacz</surname><given-names>K.</given-names></name><name><surname>Gruber</surname><given-names>R.</given-names></name><name><surname>Soleiman</surname><given-names>A.</given-names></name><name><surname>Graninger</surname><given-names>W.B.</given-names></name><name><surname>Luyten</surname><given-names>F.P.</given-names></name><name><surname>Erlacher</surname><given-names>L.</given-names></name></person-group><article-title>Cartilage-derived morphogenetic protein-1 and -2 are endogenously expressed in healthy and osteoarthritic human articular chondrocytes and stimulate matrix synthesis</article-title><source>Osteoarthr. Cartil.</source><year>2002</year><volume>10</volume><fpage>394</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1053/joca.2002.0522</pub-id><pub-id pub-id-type="pmid">12027540</pub-id></element-citation></ref><ref id="B156-cells-08-00969"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chubinskaya</surname><given-names>S.</given-names></name><name><surname>Merrihew</surname><given-names>C.</given-names></name><name><surname>Cs-Szabo</surname><given-names>G.</given-names></name><name><surname>Mollenhauer</surname><given-names>J.</given-names></name><name><surname>McCartney</surname><given-names>J.</given-names></name><name><surname>Rueger</surname><given-names>D.C.</given-names></name><name><surname>Kuettner</surname><given-names>K.E.</given-names></name></person-group><article-title>Human articular chondrocytes express osteogenic protein-1</article-title><source>J. Histochem. Cytochem.</source><year>2000</year><volume>48</volume><fpage>239</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1177/002215540004800209</pub-id><pub-id pub-id-type="pmid">10639490</pub-id></element-citation></ref><ref id="B157-cells-08-00969"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muehleman</surname><given-names>C.</given-names></name><name><surname>Kuettner</surname><given-names>K.E.</given-names></name><name><surname>Rueger</surname><given-names>D.C.</given-names></name><name><surname>Ten Dijke</surname><given-names>P.</given-names></name><name><surname>Chubinskaya</surname><given-names>S.</given-names></name></person-group><article-title>Immunohistochemical localization of osteogenetic protein (OP-1) and its receptors in rabbit articular cartilage</article-title><source>J. Histochem. Cytochem.</source><year>2002</year><volume>50</volume><fpage>1341</fpage><lpage>1350</lpage><pub-id pub-id-type="doi">10.1177/002215540205001007</pub-id><pub-id pub-id-type="pmid">12364567</pub-id></element-citation></ref><ref id="B158-cells-08-00969"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>R.S.</given-names></name><name><surname>Andhare</surname><given-names>R.A.</given-names></name><name><surname>Rousche</surname><given-names>K.T.</given-names></name><name><surname>Knudson</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Grossfield</surname><given-names>J.B.</given-names></name><name><surname>Thomas</surname><given-names>R.O.</given-names></name><name><surname>Hollingsworth</surname><given-names>R.E.</given-names></name><name><surname>Knudson</surname><given-names>C.B.</given-names></name></person-group><article-title>CD44 modulates Smad1 activation in the BMP-7 signaling pathway</article-title><source>J. Cell Biol.</source><year>2004</year><volume>166</volume><fpage>1081</fpage><lpage>1091</lpage><pub-id pub-id-type="doi">10.1083/jcb.200402138</pub-id><pub-id pub-id-type="pmid">15452148</pub-id></element-citation></ref><ref id="B159-cells-08-00969"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andhare</surname><given-names>R.A.</given-names></name><name><surname>Takahashi</surname><given-names>N.</given-names></name><name><surname>Knudson</surname><given-names>W.</given-names></name><name><surname>Knudson</surname><given-names>C.B.</given-names></name></person-group><article-title>Hyaluronan promotes the chondrocyte response to BMP-7</article-title><source>Osteoarthr. Cartil.</source><year>2009</year><volume>17</volume><fpage>906</fpage><lpage>916</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2008.12.007</pub-id><pub-id pub-id-type="pmid">19195913</pub-id></element-citation></ref><ref id="B160-cells-08-00969"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>N.</given-names></name><name><surname>Knudson</surname><given-names>W.</given-names></name><name><surname>Askew</surname><given-names>E.B.</given-names></name><name><surname>Veluci</surname><given-names>R.</given-names></name><name><surname>Knudson</surname><given-names>C.B.</given-names></name></person-group><article-title>CD44 and hyaluronan promote the bone morphogenetic protein 7 signaling response in murine chondrocytes</article-title><source>Arthritis Rheumatol.</source><year>2014</year><volume>66</volume><fpage>1547</fpage><lpage>1558</lpage><pub-id pub-id-type="doi">10.1002/art.38388</pub-id><pub-id pub-id-type="pmid">24497488</pub-id></element-citation></ref><ref id="B161-cells-08-00969"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soder</surname><given-names>S.</given-names></name><name><surname>Hakimiyan</surname><given-names>A.</given-names></name><name><surname>Rueger</surname><given-names>D.C.</given-names></name><name><surname>Kuettner</surname><given-names>K.E.</given-names></name><name><surname>Aigner</surname><given-names>T.</given-names></name><name><surname>Chubinskaya</surname><given-names>S.</given-names></name></person-group><article-title>Antisense inhibition of osteogenic protein 1 disturbs human articular cartilage integrity</article-title><source>Arthritis Rheum</source><year>2005</year><volume>52</volume><fpage>468</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1002/art.20856</pub-id><pub-id pub-id-type="pmid">15693015</pub-id></element-citation></ref><ref id="B162-cells-08-00969"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishida</surname><given-names>Y.</given-names></name><name><surname>Knudson</surname><given-names>C.B.</given-names></name><name><surname>Eger</surname><given-names>W.</given-names></name><name><surname>Kuettner</surname><given-names>K.E.</given-names></name><name><surname>Knudson</surname><given-names>W.</given-names></name></person-group><article-title>Osteogenic protein 1 stimulates cells-associated matrix assembly by normal human articular chondrocytes: up-regulation of hyaluronan synthase, CD44, and aggrecan</article-title><source>Arthritis Rheum</source><year>2000</year><volume>43</volume><fpage>206</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1002/1529-0131(200001)43:1&#x0003c;206::AID-ANR25&#x0003e;3.0.CO;2-1</pub-id><pub-id pub-id-type="pmid">10643717</pub-id></element-citation></ref><ref id="B163-cells-08-00969"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huch</surname><given-names>K.</given-names></name><name><surname>Wilbrink</surname><given-names>B.</given-names></name><name><surname>Flechtenmacher</surname><given-names>J.</given-names></name><name><surname>Koepp</surname><given-names>H.E.</given-names></name><name><surname>Aydelotte</surname><given-names>M.B.</given-names></name><name><surname>Sampath</surname><given-names>T.K.</given-names></name><name><surname>Kuettner</surname><given-names>K.E.</given-names></name><name><surname>Mollenhauer</surname><given-names>J.</given-names></name><name><surname>Thonar</surname><given-names>E.J.</given-names></name></person-group><article-title>Effects of recombinant human osteogenic protein 1 on the production of proteoglycan, prostaglandin E2, and interleukin-1 receptor antagonist by human articular chondrocytes cultured in the presence of interleukin-1beta</article-title><source>Arthritis Rheum</source><year>1997</year><volume>40</volume><fpage>2157</fpage><lpage>2161</lpage><pub-id pub-id-type="doi">10.1002/art.1780401209</pub-id><pub-id pub-id-type="pmid">9416852</pub-id></element-citation></ref><ref id="B164-cells-08-00969"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chubinskaya</surname><given-names>S.</given-names></name><name><surname>Segalite</surname><given-names>D.</given-names></name><name><surname>Pikovsky</surname><given-names>D.</given-names></name><name><surname>Hakimiyan</surname><given-names>A.A.</given-names></name><name><surname>Rueger</surname><given-names>D.C.</given-names></name></person-group><article-title>Effects induced by BMPS in cultures of human articular chondrocytes: Comparative studies</article-title><source>Growth Factors</source><year>2008</year><volume>26</volume><fpage>275</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1080/08977190802291733</pub-id><pub-id pub-id-type="pmid">18651287</pub-id></element-citation></ref><ref id="B165-cells-08-00969"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bobacz</surname><given-names>K.</given-names></name><name><surname>Sunk</surname><given-names>I.G.</given-names></name><name><surname>Hofstaetter</surname><given-names>J.G.</given-names></name><name><surname>Amoyo</surname><given-names>L.</given-names></name><name><surname>Toma</surname><given-names>C.D.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name><name><surname>Weichhart</surname><given-names>T.</given-names></name><name><surname>Saemann</surname><given-names>M.</given-names></name><name><surname>Smolen</surname><given-names>J.S.</given-names></name></person-group><article-title>Toll-like receptors and chondrocytes: The lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7</article-title><source>Arthritis Rheum</source><year>2007</year><volume>56</volume><fpage>1880</fpage><lpage>1893</lpage><pub-id pub-id-type="doi">10.1002/art.22637</pub-id><pub-id pub-id-type="pmid">17530716</pub-id></element-citation></ref><ref id="B166-cells-08-00969"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Im</surname><given-names>H.J.</given-names></name><name><surname>Pacione</surname><given-names>C.</given-names></name><name><surname>Chubinskaya</surname><given-names>S.</given-names></name><name><surname>Van Wijnen</surname><given-names>A.J.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Loeser</surname><given-names>R.F.</given-names></name></person-group><article-title>Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment- and interleukin-1beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>25386</fpage><lpage>25394</lpage><pub-id pub-id-type="doi">10.1074/jbc.M302048200</pub-id><pub-id pub-id-type="pmid">12734180</pub-id></element-citation></ref><ref id="B167-cells-08-00969"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abula</surname><given-names>K.</given-names></name><name><surname>Muneta</surname><given-names>T.</given-names></name><name><surname>Miyatake</surname><given-names>K.</given-names></name><name><surname>Yamada</surname><given-names>J.</given-names></name><name><surname>Matsukura</surname><given-names>Y.</given-names></name><name><surname>Inoue</surname><given-names>M.</given-names></name><name><surname>Sekiya</surname><given-names>I.</given-names></name><name><surname>Graf</surname><given-names>D.</given-names></name><name><surname>Economides</surname><given-names>A.N.</given-names></name><name><surname>Rosen</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Elimination of BMP7 from the developing limb mesenchyme leads to articular cartilage degeneration and synovial inflammation with increased age</article-title><source>FEBS Lett.</source><year>2015</year><volume>589</volume><fpage>1240</fpage><lpage>1248</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2015.04.004</pub-id><pub-id pub-id-type="pmid">25889639</pub-id></element-citation></ref><ref id="B168-cells-08-00969"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurtig</surname><given-names>M.</given-names></name><name><surname>Chubinskaya</surname><given-names>S.</given-names></name><name><surname>Dickey</surname><given-names>J.</given-names></name><name><surname>Rueger</surname><given-names>D.</given-names></name></person-group><article-title>BMP-7 protects against progression of cartilage degeneration after impact injury</article-title><source>J. Orthop. Res.</source><year>2009</year><volume>27</volume><fpage>602</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1002/jor.20787</pub-id><pub-id pub-id-type="pmid">18985691</pub-id></element-citation></ref><ref id="B169-cells-08-00969"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badlani</surname><given-names>N.</given-names></name><name><surname>Inoue</surname><given-names>A.</given-names></name><name><surname>Healey</surname><given-names>R.</given-names></name><name><surname>Coutts</surname><given-names>R.</given-names></name><name><surname>Amiel</surname><given-names>D.</given-names></name></person-group><article-title>The protective effect of OP-1 on articular cartilage in the development of osteoarthritis</article-title><source>Osteoarthr. Cartil.</source><year>2008</year><volume>16</volume><fpage>600</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2007.09.009</pub-id><pub-id pub-id-type="pmid">17977753</pub-id></element-citation></ref><ref id="B170-cells-08-00969"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>M.</given-names></name><name><surname>Muneta</surname><given-names>T.</given-names></name><name><surname>Ju</surname><given-names>Y.J.</given-names></name><name><surname>Mochizuki</surname><given-names>T.</given-names></name><name><surname>Sekiya</surname><given-names>I.</given-names></name></person-group><article-title>Weekly intra-articular injections of bone morphogenetic protein-7 inhibits osteoarthritis progression</article-title><source>Arthritis Res. Ther.</source><year>2008</year><volume>10</volume><fpage>R118</fpage><pub-id pub-id-type="doi">10.1186/ar2521</pub-id><pub-id pub-id-type="pmid">18826579</pub-id></element-citation></ref><ref id="B171-cells-08-00969"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>A.C.</given-names></name><name><surname>Rodrigo</surname><given-names>J.J.</given-names></name><name><surname>Reddi</surname><given-names>A.H.</given-names></name><name><surname>Curtiss</surname><given-names>S.</given-names></name><name><surname>Grotkopp</surname><given-names>E.</given-names></name><name><surname>Chiu</surname><given-names>M.</given-names></name></person-group><article-title>Microfracture and bone morphogenetic protein 7 (BMP-7) synergistically stimulate articular cartilage repair</article-title><source>Osteoarthr. Cartil.</source><year>2006</year><volume>14</volume><fpage>1126</fpage><lpage>1135</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2006.04.004</pub-id><pub-id pub-id-type="pmid">16765606</pub-id></element-citation></ref><ref id="B172-cells-08-00969"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spiro</surname><given-names>A.S.</given-names></name><name><surname>Beil</surname><given-names>F.T.</given-names></name><name><surname>Baranowsky</surname><given-names>A.</given-names></name><name><surname>Barvencik</surname><given-names>F.</given-names></name><name><surname>Schilling</surname><given-names>A.F.</given-names></name><name><surname>Nguyen</surname><given-names>K.</given-names></name><name><surname>Khadem</surname><given-names>S.</given-names></name><name><surname>Seitz</surname><given-names>S.</given-names></name><name><surname>Rueger</surname><given-names>J.M.</given-names></name><name><surname>Schinke</surname><given-names>T.</given-names></name><etal/></person-group><article-title>BMP-7-induced ectopic bone formation and fracture healing is impaired by systemic NSAID application in C57BL/6-mice</article-title><source>J. Orthop. Res.</source><year>2010</year><volume>28</volume><fpage>785</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1002/jor.21044</pub-id><pub-id pub-id-type="pmid">20063306</pub-id></element-citation></ref><ref id="B173-cells-08-00969"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>D.J.</given-names></name><name><surname>Pike</surname><given-names>M.C.</given-names></name><name><surname>Jonas</surname><given-names>B.L.</given-names></name><name><surname>Kissin</surname><given-names>E.</given-names></name><name><surname>Krop</surname><given-names>J.</given-names></name><name><surname>McAlindon</surname><given-names>T.</given-names></name></person-group><article-title>Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis</article-title><source>BMC Musculoskelet Disord.</source><year>2010</year><volume>11</volume><elocation-id>232</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2474-11-232</pub-id><pub-id pub-id-type="pmid">20932341</pub-id></element-citation></ref><ref id="B174-cells-08-00969"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>P.</given-names></name><name><surname>Vukicevic</surname><given-names>S.</given-names></name><name><surname>Sampath</surname><given-names>T.K.</given-names></name><name><surname>Luyten</surname><given-names>F.P.</given-names></name></person-group><article-title>Bovine articular chondrocytes do not undergo hypertrophy when cultured in the presence of serum and osteogenic protein-1</article-title><source>Biochem. Biophys. Res. Commun.</source><year>1993</year><volume>197</volume><fpage>1253</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1993.2612</pub-id><pub-id pub-id-type="pmid">8280141</pub-id></element-citation></ref><ref id="B175-cells-08-00969"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caron</surname><given-names>M.M.</given-names></name><name><surname>Emans</surname><given-names>P.J.</given-names></name><name><surname>Cremers</surname><given-names>A.</given-names></name><name><surname>Surtel</surname><given-names>D.A.</given-names></name><name><surname>Coolsen</surname><given-names>M.M.</given-names></name><name><surname>van Rhijn</surname><given-names>L.W.</given-names></name><name><surname>Welting</surname><given-names>T.J.</given-names></name></person-group><article-title>Hypertrophic differentiation during chondrogenic differentiation of progenitor cells is stimulated by BMP-2 but suppressed by BMP-7</article-title><source>Osteoarthr. Cartil.</source><year>2013</year><volume>21</volume><fpage>604</fpage><lpage>613</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2013.01.009</pub-id><pub-id pub-id-type="pmid">23353668</pub-id></element-citation></ref><ref id="B176-cells-08-00969"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haaijman</surname><given-names>A.</given-names></name><name><surname>D&#x02019;Souza</surname><given-names>R.N.</given-names></name><name><surname>Bronckers</surname><given-names>A.L.</given-names></name><name><surname>Goei</surname><given-names>S.W.</given-names></name><name><surname>Burger</surname><given-names>E.H.</given-names></name></person-group><article-title>OP-1 (BMP-7) affects mRNA expression of type I, II, X collagen, and matrix Gla protein in ossifying long bones in vitro</article-title><source>J. Bone Miner. Res.</source><year>1997</year><volume>12</volume><fpage>1815</fpage><lpage>1823</lpage><pub-id pub-id-type="doi">10.1359/jbmr.1997.12.11.1815</pub-id><pub-id pub-id-type="pmid">9383686</pub-id></element-citation></ref><ref id="B177-cells-08-00969"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caron</surname><given-names>M.M.</given-names></name><name><surname>Emans</surname><given-names>P.J.</given-names></name><name><surname>Surtel</surname><given-names>D.A.</given-names></name><name><surname>van der Kraan</surname><given-names>P.M.</given-names></name><name><surname>van Rhijn</surname><given-names>L.W.</given-names></name><name><surname>Welting</surname><given-names>T.J.</given-names></name></person-group><article-title>BAPX-1/NKX-3.2 acts as a chondrocyte hypertrophy molecular switch in osteoarthritis</article-title><source>Arthritis Rheumatol.</source><year>2015</year><volume>67</volume><fpage>2944</fpage><lpage>2956</lpage><pub-id pub-id-type="doi">10.1002/art.39293</pub-id><pub-id pub-id-type="pmid">26245691</pub-id></element-citation></ref><ref id="B178-cells-08-00969"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erlacher</surname><given-names>L.</given-names></name><name><surname>McCartney</surname><given-names>J.</given-names></name><name><surname>Piek</surname><given-names>E.</given-names></name><name><surname>ten Dijke</surname><given-names>P.</given-names></name><name><surname>Yanagishita</surname><given-names>M.</given-names></name><name><surname>Oppermann</surname><given-names>H.</given-names></name><name><surname>Luyten</surname><given-names>F.P.</given-names></name></person-group><article-title>Cartilage-derived morphogenetic proteins and osteogenic protein-1 differentially regulate osteogenesis</article-title><source>J. Bone Miner. Res.</source><year>1998</year><volume>13</volume><fpage>383</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1359/jbmr.1998.13.3.383</pub-id><pub-id pub-id-type="pmid">9525338</pub-id></element-citation></ref><ref id="B179-cells-08-00969"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>P.</given-names></name><name><surname>Vukicevic</surname><given-names>S.</given-names></name><name><surname>Sampath</surname><given-names>T.K.</given-names></name><name><surname>Luyten</surname><given-names>F.P.</given-names></name></person-group><article-title>Osteogenic protein-1 promotes growth and maturation of chick sternal chondrocytes in serum-free cultures</article-title><source>J. Cell Sci.</source><year>1995</year><volume>108</volume><issue-part>Pt 1</issue-part><fpage>105</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">7738088</pub-id></element-citation></ref><ref id="B180-cells-08-00969"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bobacz</surname><given-names>K.</given-names></name><name><surname>Gruber</surname><given-names>R.</given-names></name><name><surname>Soleiman</surname><given-names>A.</given-names></name><name><surname>Erlacher</surname><given-names>L.</given-names></name><name><surname>Smolen</surname><given-names>J.S.</given-names></name><name><surname>Graninger</surname><given-names>W.B.</given-names></name></person-group><article-title>Expression of bone morphogenetic protein 6 in healthy and osteoarthritic human articular chondrocytes and stimulation of matrix synthesis in vitro</article-title><source>Arthritis Rheum</source><year>2003</year><volume>48</volume><fpage>2501</fpage><lpage>2508</lpage><pub-id pub-id-type="doi">10.1002/art.11248</pub-id><pub-id pub-id-type="pmid">13130469</pub-id></element-citation></ref><ref id="B181-cells-08-00969"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilsson</surname><given-names>O.</given-names></name><name><surname>Parker</surname><given-names>E.A.</given-names></name><name><surname>Hegde</surname><given-names>A.</given-names></name><name><surname>Chau</surname><given-names>M.</given-names></name><name><surname>Barnes</surname><given-names>K.M.</given-names></name><name><surname>Baron</surname><given-names>J.</given-names></name></person-group><article-title>Gradients in bone morphogenetic protein-related gene expression across the growth plate</article-title><source>J. Endocrinol.</source><year>2007</year><volume>193</volume><fpage>75</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1677/joe.1.07099</pub-id><pub-id pub-id-type="pmid">17400805</pub-id></element-citation></ref><ref id="B182-cells-08-00969"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>H.</given-names></name><name><surname>Akiyama</surname><given-names>H.</given-names></name><name><surname>Shigeno</surname><given-names>C.</given-names></name><name><surname>Nakamura</surname><given-names>T.</given-names></name></person-group><article-title>Bone morphogenetic protein-6 and parathyroid hormone-related protein coordinately regulate the hypertrophic conversion in mouse clonal chondrogenic EC cells, ATDC5</article-title><source>Biochim. Biophys. Acta</source><year>1999</year><volume>1451</volume><fpage>263</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1016/S0167-4889(99)00100-7</pub-id><pub-id pub-id-type="pmid">10556581</pub-id></element-citation></ref><ref id="B183-cells-08-00969"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bidart</surname><given-names>M.</given-names></name><name><surname>Ricard</surname><given-names>N.</given-names></name><name><surname>Levet</surname><given-names>S.</given-names></name><name><surname>Samson</surname><given-names>M.</given-names></name><name><surname>Mallet</surname><given-names>C.</given-names></name><name><surname>David</surname><given-names>L.</given-names></name><name><surname>Subileau</surname><given-names>M.</given-names></name><name><surname>Tillet</surname><given-names>E.</given-names></name><name><surname>Feige</surname><given-names>J.J.</given-names></name><name><surname>Bailly</surname><given-names>S.</given-names></name></person-group><article-title>BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain</article-title><source>Cell Mol. Life Sci.</source><year>2012</year><volume>69</volume><fpage>313</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">21710321</pub-id></element-citation></ref><ref id="B184-cells-08-00969"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blunk</surname><given-names>T.</given-names></name><name><surname>Sieminski</surname><given-names>A.L.</given-names></name><name><surname>Appel</surname><given-names>B.</given-names></name><name><surname>Croft</surname><given-names>C.</given-names></name><name><surname>Courter</surname><given-names>D.L.</given-names></name><name><surname>Chieh</surname><given-names>J.J.</given-names></name><name><surname>Goepferich</surname><given-names>A.</given-names></name><name><surname>Khurana</surname><given-names>J.S.</given-names></name><name><surname>Gooch</surname><given-names>K.J.</given-names></name></person-group><article-title>Bone morphogenetic protein 9: A potent modulator of cartilage development in vitro</article-title><source>Growth Factors</source><year>2003</year><volume>21</volume><fpage>71</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1080/0897719031000148822</pub-id><pub-id pub-id-type="pmid">14626354</pub-id></element-citation></ref><ref id="B185-cells-08-00969"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luu</surname><given-names>H.H.</given-names></name><name><surname>Song</surname><given-names>W.X.</given-names></name><name><surname>Luo</surname><given-names>X.</given-names></name><name><surname>Manning</surname><given-names>D.</given-names></name><name><surname>Luo</surname><given-names>J.</given-names></name><name><surname>Deng</surname><given-names>Z.L.</given-names></name><name><surname>Sharff</surname><given-names>K.A.</given-names></name><name><surname>Montag</surname><given-names>A.G.</given-names></name><name><surname>Haydon</surname><given-names>R.C.</given-names></name><name><surname>He</surname><given-names>T.C.</given-names></name></person-group><article-title>Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells</article-title><source>J. Orthop. Res.</source><year>2007</year><volume>25</volume><fpage>665</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1002/jor.20359</pub-id><pub-id pub-id-type="pmid">17290432</pub-id></element-citation></ref><ref id="B186-cells-08-00969"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Caam</surname><given-names>A.</given-names></name><name><surname>Blaney Davidson</surname><given-names>E.</given-names></name><name><surname>Garcia de Vinuesa</surname><given-names>A.</given-names></name><name><surname>van Geffen</surname><given-names>E.</given-names></name><name><surname>van den Berg</surname><given-names>W.</given-names></name><name><surname>Goumans</surname><given-names>M.J.</given-names></name><name><surname>Ten Dijke</surname><given-names>P.</given-names></name><name><surname>van der Kraan</surname><given-names>P.</given-names></name></person-group><article-title>The high affinity ALK1-ligand BMP9 induces a hypertrophy-like state in chondrocytes that is antagonized by TGFbeta1</article-title><source>Osteoarthr. Cartil.</source><year>2015</year><volume>23</volume><fpage>985</fpage><lpage>995</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2015.02.007</pub-id><pub-id pub-id-type="pmid">25681563</pub-id></element-citation></ref><ref id="B187-cells-08-00969"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>Y.</given-names></name><name><surname>Mabuchi</surname><given-names>A.</given-names></name><name><surname>Shi</surname><given-names>D.</given-names></name><name><surname>Kubo</surname><given-names>T.</given-names></name><name><surname>Takatori</surname><given-names>Y.</given-names></name><name><surname>Saito</surname><given-names>S.</given-names></name><name><surname>Fujioka</surname><given-names>M.</given-names></name><name><surname>Sudo</surname><given-names>A.</given-names></name><name><surname>Uchida</surname><given-names>A.</given-names></name><name><surname>Yamamoto</surname><given-names>S.</given-names></name><etal/></person-group><article-title>A functional polymorphism in the 5&#x02032; UTR of GDF5 is associated with susceptibility to osteoarthritis</article-title><source>Nat. Genet.</source><year>2007</year><volume>39</volume><fpage>529</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1038/2005</pub-id><pub-id pub-id-type="pmid">17384641</pub-id></element-citation></ref><ref id="B188-cells-08-00969"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ratnayake</surname><given-names>M.</given-names></name><name><surname>Ploger</surname><given-names>F.</given-names></name><name><surname>Santibanez-Koref</surname><given-names>M.</given-names></name><name><surname>Loughlin</surname><given-names>J.</given-names></name></person-group><article-title>Human chondrocytes respond discordantly to the protein encoded by the osteoarthritis susceptibility gene GDF5</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e86590</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0086590</pub-id><pub-id pub-id-type="pmid">24466161</pub-id></element-citation></ref><ref id="B189-cells-08-00969"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>J.A.</given-names></name><name><surname>Buckwalter</surname><given-names>J.A.</given-names></name></person-group><article-title>Aging, articular cartilage chondrocyte senescence and osteoarthritis</article-title><source>Biogerontology</source><year>2002</year><volume>3</volume><fpage>257</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1023/A:1020185404126</pub-id><pub-id pub-id-type="pmid">12237562</pub-id></element-citation></ref><ref id="B190-cells-08-00969"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chubinskaya</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>B.</given-names></name><name><surname>Merrihew</surname><given-names>C.</given-names></name><name><surname>Heretis</surname><given-names>K.</given-names></name><name><surname>Rueger</surname><given-names>D.C.</given-names></name><name><surname>Kuettner</surname><given-names>K.E.</given-names></name></person-group><article-title>Age-related changes in cartilage endogenous osteogenic protein-1 (OP-1)</article-title><source>Biochim. Biophys. Acta</source><year>2002</year><volume>1588</volume><fpage>126</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1016/S0925-4439(02)00158-8</pub-id><pub-id pub-id-type="pmid">12385776</pub-id></element-citation></ref><ref id="B191-cells-08-00969"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iqbal</surname><given-names>J.</given-names></name><name><surname>Dudhia</surname><given-names>J.</given-names></name><name><surname>Bird</surname><given-names>J.L.</given-names></name><name><surname>Bayliss</surname><given-names>M.T.</given-names></name></person-group><article-title>Age-related effects of TGF-beta on proteoglycan synthesis in equine articular cartilage</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2000</year><volume>274</volume><fpage>467</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2000.3167</pub-id><pub-id pub-id-type="pmid">10913361</pub-id></element-citation></ref><ref id="B192-cells-08-00969"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loeser</surname><given-names>R.F.</given-names></name><name><surname>Im</surname><given-names>H.J.</given-names></name><name><surname>Richardson</surname><given-names>B.</given-names></name><name><surname>Lu</surname><given-names>Q.</given-names></name><name><surname>Chubinskaya</surname><given-names>S.</given-names></name></person-group><article-title>Methylation of the OP-1 promoter: Potential role in the age-related decline in OP-1 expression in cartilage</article-title><source>Osteoarthr. Cartil.</source><year>2009</year><volume>17</volume><fpage>513</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2008.08.003</pub-id><pub-id pub-id-type="pmid">18829350</pub-id></element-citation></ref><ref id="B193-cells-08-00969"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loeser</surname><given-names>R.F.</given-names></name><name><surname>Gandhi</surname><given-names>U.</given-names></name><name><surname>Long</surname><given-names>D.L.</given-names></name><name><surname>Yin</surname><given-names>W.</given-names></name><name><surname>Chubinskaya</surname><given-names>S.</given-names></name></person-group><article-title>Aging and oxidative stress reduce the response of human articular chondrocytes to insulin-like growth factor 1 and osteogenic protein 1</article-title><source>Arthritis Rheumatol.</source><year>2014</year><volume>66</volume><fpage>2201</fpage><lpage>2209</lpage><pub-id pub-id-type="doi">10.1002/art.38641</pub-id><pub-id pub-id-type="pmid">24664641</pub-id></element-citation></ref><ref id="B194-cells-08-00969"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Luo</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Leung</surname><given-names>V.Y.</given-names></name><name><surname>Wen</surname><given-names>C.</given-names></name><name><surname>Shah</surname><given-names>M.F.</given-names></name><name><surname>Pan</surname><given-names>H.</given-names></name><name><surname>Chiu</surname><given-names>K.</given-names></name><name><surname>Cao</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Cartilage degeneration and excessive subchondral bone formation in spontaneous osteoarthritis involves altered TGF-beta signaling</article-title><source>J. Orthop. Res.</source><year>2016</year><volume>34</volume><fpage>763</fpage><lpage>770</lpage><pub-id pub-id-type="doi">10.1002/jor.23079</pub-id><pub-id pub-id-type="pmid">26496668</pub-id></element-citation></ref><ref id="B195-cells-08-00969"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauge</surname><given-names>C.</given-names></name><name><surname>Girard</surname><given-names>N.</given-names></name><name><surname>Lhuissier</surname><given-names>E.</given-names></name><name><surname>Bazille</surname><given-names>C.</given-names></name><name><surname>Boumediene</surname><given-names>K.</given-names></name></person-group><article-title>Regulation and Role of TGFbeta Signaling Pathway in Aging and Osteoarthritis Joints</article-title><source>Aging Dis.</source><year>2014</year><volume>5</volume><fpage>394</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">25489490</pub-id></element-citation></ref><ref id="B196-cells-08-00969"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>W.</given-names></name><name><surname>Young</surname><given-names>D.A.</given-names></name><name><surname>Rowan</surname><given-names>A.D.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Cawston</surname><given-names>T.E.</given-names></name><name><surname>Proctor</surname><given-names>C.J.</given-names></name></person-group><article-title>Oxidative changes and signalling pathways are pivotal in initiating age-related changes in articular cartilage</article-title><source>Ann. Rheum. Dis.</source><year>2016</year><volume>75</volume><fpage>449</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1136/annrheumdis-2014-206295</pub-id><pub-id pub-id-type="pmid">25475114</pub-id></element-citation></ref><ref id="B197-cells-08-00969"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hjelmeland</surname><given-names>A.B.</given-names></name><name><surname>Schilling</surname><given-names>S.H.</given-names></name><name><surname>Guo</surname><given-names>X.</given-names></name><name><surname>Quarles</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>X.F.</given-names></name></person-group><article-title>Loss of Smad3-mediated negative regulation of Runx2 activity leads to an alteration in cell fate determination</article-title><source>Mol. Cell Biol.</source><year>2005</year><volume>25</volume><fpage>9460</fpage><lpage>9468</lpage><pub-id pub-id-type="doi">10.1128/MCB.25.21.9460-9468.2005</pub-id><pub-id pub-id-type="pmid">16227596</pub-id></element-citation></ref><ref id="B198-cells-08-00969"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>L.</given-names></name><name><surname>Baek</surname><given-names>H.J.</given-names></name><name><surname>Karsenty</surname><given-names>G.</given-names></name><name><surname>Justice</surname><given-names>M.J.</given-names></name></person-group><article-title>Filamin B represses chondrocyte hypertrophy in a Runx2/Smad3-dependent manner</article-title><source>J. Cell Biol.</source><year>2007</year><volume>178</volume><fpage>121</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1083/jcb.200703113</pub-id><pub-id pub-id-type="pmid">17606870</pub-id></element-citation></ref><ref id="B199-cells-08-00969"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Responte</surname><given-names>D.J.</given-names></name><name><surname>Lee</surname><given-names>J.K.</given-names></name><name><surname>Hu</surname><given-names>J.C.</given-names></name><name><surname>Athanasiou</surname><given-names>K.A.</given-names></name></person-group><article-title>Biomechanics-driven chondrogenesis: From embryo to adult</article-title><source>FASEB J.</source><year>2012</year><volume>26</volume><fpage>3614</fpage><lpage>3624</lpage><pub-id pub-id-type="doi">10.1096/fj.12-207241</pub-id><pub-id pub-id-type="pmid">22673579</pub-id></element-citation></ref><ref id="B200-cells-08-00969"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname><given-names>J.</given-names></name><name><surname>Perera</surname><given-names>P.</given-names></name><name><surname>Rath</surname><given-names>B.</given-names></name><name><surname>Agarwal</surname><given-names>S.</given-names></name></person-group><article-title>Dynamic regulation of bone morphogenetic proteins in engineered osteochondral constructs by biomechanical stimulation</article-title><source>Tissue Eng. Part A</source><year>2013</year><volume>19</volume><fpage>783</fpage><lpage>792</lpage><pub-id pub-id-type="doi">10.1089/ten.tea.2012.0103</pub-id><pub-id pub-id-type="pmid">23198877</pub-id></element-citation></ref><ref id="B201-cells-08-00969"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madej</surname><given-names>W.</given-names></name><name><surname>van Caam</surname><given-names>A.</given-names></name><name><surname>Blaney Davidson</surname><given-names>E.</given-names></name><name><surname>Buma</surname><given-names>P.</given-names></name><name><surname>van der Kraan</surname><given-names>P.M.</given-names></name></person-group><article-title>Unloading results in rapid loss of TGFbeta signaling in articular cartilage: Role of loading-induced TGFbeta signaling in maintenance of articular chondrocyte phenotype?</article-title><source>Osteoarthr. Cartil.</source><year>2016</year><volume>24</volume><fpage>1807</fpage><lpage>1815</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2016.05.018</pub-id><pub-id pub-id-type="pmid">27268943</pub-id></element-citation></ref><ref id="B202-cells-08-00969"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinterwimmer</surname><given-names>S.</given-names></name><name><surname>Krammer</surname><given-names>M.</given-names></name><name><surname>Krotz</surname><given-names>M.</given-names></name><name><surname>Glaser</surname><given-names>C.</given-names></name><name><surname>Baumgart</surname><given-names>R.</given-names></name><name><surname>Reiser</surname><given-names>M.</given-names></name><name><surname>Eckstein</surname><given-names>F.</given-names></name></person-group><article-title>Cartilage atrophy in the knees of patients after seven weeks of partial load bearing</article-title><source>Arthritis Rheum</source><year>2004</year><volume>50</volume><fpage>2516</fpage><lpage>2520</lpage><pub-id pub-id-type="doi">10.1002/art.20378</pub-id><pub-id pub-id-type="pmid">15334465</pub-id></element-citation></ref><ref id="B203-cells-08-00969"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nomura</surname><given-names>M.</given-names></name><name><surname>Sakitani</surname><given-names>N.</given-names></name><name><surname>Iwasawa</surname><given-names>H.</given-names></name><name><surname>Kohara</surname><given-names>Y.</given-names></name><name><surname>Takano</surname><given-names>S.</given-names></name><name><surname>Wakimoto</surname><given-names>Y.</given-names></name><name><surname>Kuroki</surname><given-names>H.</given-names></name><name><surname>Moriyama</surname><given-names>H.</given-names></name></person-group><article-title>Thinning of articular cartilage after joint unloading or immobilization. An experimental investigation of the pathogenesis in mice</article-title><source>Osteoarthr. Cartil.</source><year>2017</year><volume>25</volume><fpage>727</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2016.11.013</pub-id><pub-id pub-id-type="pmid">27916560</pub-id></element-citation></ref><ref id="B204-cells-08-00969"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madej</surname><given-names>W.</given-names></name><name><surname>van Caam</surname><given-names>A.</given-names></name><name><surname>Davidson</surname><given-names>E.N.</given-names></name><name><surname>Hannink</surname><given-names>G.</given-names></name><name><surname>Buma</surname><given-names>P.</given-names></name><name><surname>van der Kraan</surname><given-names>P.M.</given-names></name></person-group><article-title>Ageing is associated with reduction of mechanically-induced activation of Smad2/3P signaling in articular cartilage</article-title><source>Osteoarthr. Cartil.</source><year>2016</year><volume>24</volume><fpage>146</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2015.07.018</pub-id><pub-id pub-id-type="pmid">26247611</pub-id></element-citation></ref><ref id="B205-cells-08-00969"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>I.J.</given-names></name><name><surname>Worthington</surname><given-names>S.</given-names></name><name><surname>Felson</surname><given-names>D.T.</given-names></name><name><surname>Jurmain</surname><given-names>R.D.</given-names></name><name><surname>Wren</surname><given-names>K.T.</given-names></name><name><surname>Maijanen</surname><given-names>H.</given-names></name><name><surname>Woods</surname><given-names>R.J.</given-names></name><name><surname>Lieberman</surname><given-names>D.E.</given-names></name></person-group><article-title>Knee osteoarthritis has doubled in prevalence since the mid-20th century</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2017</year><volume>114</volume><fpage>9332</fpage><lpage>9336</lpage><pub-id pub-id-type="doi">10.1073/pnas.1703856114</pub-id><pub-id pub-id-type="pmid">28808025</pub-id></element-citation></ref><ref id="B206-cells-08-00969"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iijima</surname><given-names>H.</given-names></name><name><surname>Ito</surname><given-names>A.</given-names></name><name><surname>Nagai</surname><given-names>M.</given-names></name><name><surname>Tajino</surname><given-names>J.</given-names></name><name><surname>Yamaguchi</surname><given-names>S.</given-names></name><name><surname>Kiyan</surname><given-names>W.</given-names></name><name><surname>Nakahata</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Aoyama</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Physiological exercise loading suppresses post-traumatic osteoarthritis progression via an increase in bone morphogenetic proteins expression in an experimental rat knee model</article-title><source>Osteoarthr. Cartil.</source><year>2017</year><volume>25</volume><fpage>964</fpage><lpage>975</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2016.12.008</pub-id><pub-id pub-id-type="pmid">27965139</pub-id></element-citation></ref><ref id="B207-cells-08-00969"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>S.H.</given-names></name><name><surname>Mori</surname><given-names>D.</given-names></name><name><surname>Kobayashi</surname><given-names>H.</given-names></name><name><surname>Mori</surname><given-names>Y.</given-names></name><name><surname>Nakamoto</surname><given-names>H.</given-names></name><name><surname>Okada</surname><given-names>K.</given-names></name><name><surname>Taniguchi</surname><given-names>Y.</given-names></name><name><surname>Sugita</surname><given-names>S.</given-names></name><name><surname>Yano</surname><given-names>F.</given-names></name><name><surname>Chung</surname><given-names>U.I.</given-names></name><etal/></person-group><article-title>Excessive mechanical loading promotes osteoarthritis through the gremlin-1-NF-kappaB pathway</article-title><source>Nat. Commun.</source><year>2019</year><volume>10</volume><fpage>1442</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-09491-5</pub-id><pub-id pub-id-type="pmid">30926814</pub-id></element-citation></ref><ref id="B208-cells-08-00969"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henao-Murillo</surname><given-names>L.</given-names></name><name><surname>Ito</surname><given-names>K.</given-names></name><name><surname>van Donkelaar</surname><given-names>C.C.</given-names></name></person-group><article-title>Collagen Damage Location in Articular Cartilage Differs if Damage is Caused by Excessive Loading Magnitude or Rate</article-title><source>Ann. Biomed. Eng.</source><year>2018</year><volume>46</volume><fpage>605</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1007/s10439-018-1986-x</pub-id><pub-id pub-id-type="pmid">29423727</pub-id></element-citation></ref><ref id="B209-cells-08-00969"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scanzello</surname><given-names>C.R.</given-names></name><name><surname>Goldring</surname><given-names>S.R.</given-names></name></person-group><article-title>The role of synovitis in osteoarthritis pathogenesis</article-title><source>Bone</source><year>2012</year><volume>51</volume><fpage>249</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1016/j.bone.2012.02.012</pub-id><pub-id pub-id-type="pmid">22387238</pub-id></element-citation></ref><ref id="B210-cells-08-00969"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>W.H.</given-names></name><name><surname>Lepus</surname><given-names>C.M.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Raghu</surname><given-names>H.</given-names></name><name><surname>Mao</surname><given-names>R.</given-names></name><name><surname>Lindstrom</surname><given-names>T.M.</given-names></name><name><surname>Sokolove</surname><given-names>J.</given-names></name></person-group><article-title>Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis</article-title><source>Nat. Rev. Rheumatol.</source><year>2016</year><volume>12</volume><fpage>580</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1038/nrrheum.2016.136</pub-id><pub-id pub-id-type="pmid">27539668</pub-id></element-citation></ref><ref id="B211-cells-08-00969"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Agostino</surname><given-names>M.A.</given-names></name><name><surname>Conaghan</surname><given-names>P.</given-names></name><name><surname>Le Bars</surname><given-names>M.</given-names></name><name><surname>Baron</surname><given-names>G.</given-names></name><name><surname>Grassi</surname><given-names>W.</given-names></name><name><surname>Martin-Mola</surname><given-names>E.</given-names></name><name><surname>Wakefield</surname><given-names>R.</given-names></name><name><surname>Brasseur</surname><given-names>J.L.</given-names></name><name><surname>So</surname><given-names>A.</given-names></name><name><surname>Backhaus</surname><given-names>M.</given-names></name><etal/></person-group><article-title>EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: Prevalence of inflammation in osteoarthritis</article-title><source>Ann. Rheum. Dis.</source><year>2005</year><volume>64</volume><fpage>1703</fpage><lpage>1709</lpage><pub-id pub-id-type="doi">10.1136/ard.2005.037994</pub-id><pub-id pub-id-type="pmid">15878903</pub-id></element-citation></ref><ref id="B212-cells-08-00969"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>K.</given-names></name><name><surname>Grainger</surname><given-names>A.</given-names></name><name><surname>Niu</surname><given-names>J.</given-names></name><name><surname>Clancy</surname><given-names>M.</given-names></name><name><surname>Guermazi</surname><given-names>A.</given-names></name><name><surname>Crema</surname><given-names>M.</given-names></name><name><surname>Hughes</surname><given-names>L.</given-names></name><name><surname>Buckwalter</surname><given-names>J.</given-names></name><name><surname>Wooley</surname><given-names>A.</given-names></name><name><surname>Nevitt</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Relation of synovitis to knee pain using contrast-enhanced MRIs</article-title><source>Ann. Rheum. Dis.</source><year>2010</year><volume>69</volume><fpage>1779</fpage><lpage>1783</lpage><pub-id pub-id-type="doi">10.1136/ard.2009.121426</pub-id><pub-id pub-id-type="pmid">20472593</pub-id></element-citation></ref><ref id="B213-cells-08-00969"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokolove</surname><given-names>J.</given-names></name><name><surname>Lepus</surname><given-names>C.M.</given-names></name></person-group><article-title>Role of inflammation in the pathogenesis of osteoarthritis: Latest findings and interpretations</article-title><source>Ther. Adv. Musculoskelet Dis.</source><year>2013</year><volume>5</volume><fpage>77</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1177/1759720X12467868</pub-id><pub-id pub-id-type="pmid">23641259</pub-id></element-citation></ref><ref id="B214-cells-08-00969"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guermazi</surname><given-names>A.</given-names></name><name><surname>Roemer</surname><given-names>F.W.</given-names></name><name><surname>Hayashi</surname><given-names>D.</given-names></name><name><surname>Crema</surname><given-names>M.D.</given-names></name><name><surname>Niu</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Marra</surname><given-names>M.D.</given-names></name><name><surname>Katur</surname><given-names>A.</given-names></name><name><surname>Lynch</surname><given-names>J.A.</given-names></name><name><surname>El-Khoury</surname><given-names>G.Y.</given-names></name><etal/></person-group><article-title>Assessment of synovitis with contrast-enhanced MRI using a whole-joint semiquantitative scoring system in people with, or at high risk of, knee osteoarthritis: the MOST study</article-title><source>Ann. Rheum. Dis.</source><year>2011</year><volume>70</volume><fpage>805</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1136/ard.2010.139618</pub-id><pub-id pub-id-type="pmid">21187293</pub-id></element-citation></ref><ref id="B215-cells-08-00969"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pessler</surname><given-names>F.</given-names></name><name><surname>Dai</surname><given-names>L.</given-names></name><name><surname>Diaz-Torne</surname><given-names>C.</given-names></name><name><surname>Gomez-Vaquero</surname><given-names>C.</given-names></name><name><surname>Paessler</surname><given-names>M.E.</given-names></name><name><surname>Zheng</surname><given-names>D.H.</given-names></name><name><surname>Einhorn</surname><given-names>E.</given-names></name><name><surname>Range</surname><given-names>U.</given-names></name><name><surname>Scanzello</surname><given-names>C.</given-names></name><name><surname>Schumacher</surname><given-names>H.R.</given-names></name></person-group><article-title>The synovitis of &#x0201c;non-inflammatory&#x0201d; orthopaedic arthropathies: A quantitative histological and immunohistochemical analysis</article-title><source>Ann. Rheum. Dis.</source><year>2008</year><volume>67</volume><fpage>1184</fpage><lpage>1187</lpage><pub-id pub-id-type="doi">10.1136/ard.2008.087775</pub-id><pub-id pub-id-type="pmid">18203762</pub-id></element-citation></ref><ref id="B216-cells-08-00969"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldring</surname><given-names>M.B.</given-names></name><name><surname>Goldring</surname><given-names>S.R.</given-names></name></person-group><article-title>Osteoarthritis</article-title><source>J. Cell Physiol.</source><year>2007</year><volume>213</volume><fpage>626</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1002/jcp.21258</pub-id><pub-id pub-id-type="pmid">17786965</pub-id></element-citation></ref><ref id="B217-cells-08-00969"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bondeson</surname><given-names>J.</given-names></name><name><surname>Blom</surname><given-names>A.B.</given-names></name><name><surname>Wainwright</surname><given-names>S.</given-names></name><name><surname>Hughes</surname><given-names>C.</given-names></name><name><surname>Caterson</surname><given-names>B.</given-names></name><name><surname>van den Berg</surname><given-names>W.B.</given-names></name></person-group><article-title>The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis</article-title><source>Arthritis Rheum</source><year>2010</year><volume>62</volume><fpage>647</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1002/art.27290</pub-id><pub-id pub-id-type="pmid">20187160</pub-id></element-citation></ref><ref id="B218-cells-08-00969"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapoor</surname><given-names>M.</given-names></name><name><surname>Martel-Pelletier</surname><given-names>J.</given-names></name><name><surname>Lajeunesse</surname><given-names>D.</given-names></name><name><surname>Pelletier</surname><given-names>J.P.</given-names></name><name><surname>Fahmi</surname><given-names>H.</given-names></name></person-group><article-title>Role of proinflammatory cytokines in the pathophysiology of osteoarthritis</article-title><source>Nat. Rev. Rheumatol.</source><year>2011</year><volume>7</volume><fpage>33</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1038/nrrheum.2010.196</pub-id><pub-id pub-id-type="pmid">21119608</pub-id></element-citation></ref><ref id="B219-cells-08-00969"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wojdasiewicz</surname><given-names>P.</given-names></name><name><surname>Poniatowski</surname><given-names>L.A.</given-names></name><name><surname>Szukiewicz</surname><given-names>D.</given-names></name></person-group><article-title>The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis</article-title><source>Mediators Inflamm.</source><year>2014</year><volume>2014</volume><fpage>561459</fpage><pub-id pub-id-type="doi">10.1155/2014/561459</pub-id><pub-id pub-id-type="pmid">24876674</pub-id></element-citation></ref><ref id="B220-cells-08-00969"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sellam</surname><given-names>J.</given-names></name><name><surname>Berenbaum</surname><given-names>F.</given-names></name></person-group><article-title>The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis</article-title><source>Nat. Rev. Rheumatol.</source><year>2010</year><volume>6</volume><fpage>625</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1038/nrrheum.2010.159</pub-id><pub-id pub-id-type="pmid">20924410</pub-id></element-citation></ref><ref id="B221-cells-08-00969"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laavola</surname><given-names>M.</given-names></name><name><surname>Leppanen</surname><given-names>T.</given-names></name><name><surname>Hamalainen</surname><given-names>M.</given-names></name><name><surname>Vuolteenaho</surname><given-names>K.</given-names></name><name><surname>Moilanen</surname><given-names>T.</given-names></name><name><surname>Nieminen</surname><given-names>R.</given-names></name><name><surname>Moilanen</surname><given-names>E.</given-names></name></person-group><article-title>IL-6 in Osteoarthritis: Effects of Pine Stilbenoids</article-title><source>Molecules</source><year>2018</year><volume>24</volume><elocation-id>109</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24010109</pub-id></element-citation></ref><ref id="B222-cells-08-00969"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Legendre</surname><given-names>F.</given-names></name><name><surname>Bogdanowicz</surname><given-names>P.</given-names></name><name><surname>Boumediene</surname><given-names>K.</given-names></name><name><surname>Pujol</surname><given-names>J.P.</given-names></name></person-group><article-title>Role of interleukin 6 (IL-6)/IL-6R-induced signal tranducers and activators of transcription and mitogen-activated protein kinase/extracellular</article-title><source>J. Rheumatol.</source><year>2005</year><volume>32</volume><fpage>1307</fpage><lpage>1316</lpage><pub-id pub-id-type="pmid">15996070</pub-id></element-citation></ref><ref id="B223-cells-08-00969"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>J.H.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Shin</surname><given-names>Y.</given-names></name><name><surname>Rhee</surname><given-names>J.</given-names></name><name><surname>Chun</surname><given-names>C.H.</given-names></name><name><surname>Chun</surname><given-names>J.S.</given-names></name></person-group><article-title>Interleukin-6 plays an essential role in hypoxia-inducible factor 2alpha-induced experimental osteoarthritic cartilage destruction in mice</article-title><source>Arthritis Rheum</source><year>2011</year><volume>63</volume><fpage>2732</fpage><lpage>2743</lpage><pub-id pub-id-type="doi">10.1002/art.30451</pub-id><pub-id pub-id-type="pmid">21590680</pub-id></element-citation></ref><ref id="B224-cells-08-00969"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cortial</surname><given-names>D.</given-names></name><name><surname>Gouttenoire</surname><given-names>J.</given-names></name><name><surname>Rousseau</surname><given-names>C.F.</given-names></name><name><surname>Ronziere</surname><given-names>M.C.</given-names></name><name><surname>Piccardi</surname><given-names>N.</given-names></name><name><surname>Msika</surname><given-names>P.</given-names></name><name><surname>Herbage</surname><given-names>D.</given-names></name><name><surname>Mallein-Gerin</surname><given-names>F.</given-names></name><name><surname>Freyria</surname><given-names>A.M.</given-names></name></person-group><article-title>Activation by IL-1 of bovine articular chondrocytes in culture within a 3D collagen-based scaffold. An in vitro model to address the effect of compounds with therapeutic potential in osteoarthritis</article-title><source>Osteoarthr. Cartil.</source><year>2006</year><volume>14</volume><fpage>631</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2006.01.008</pub-id><pub-id pub-id-type="pmid">16527498</pub-id></element-citation></ref><ref id="B225-cells-08-00969"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>J.C.</given-names></name><name><surname>Martel-Pelletier</surname><given-names>J.</given-names></name><name><surname>Pelletier</surname><given-names>J.P.</given-names></name></person-group><article-title>The role of cytokines in osteoarthritis pathophysiology</article-title><source>Biorheology</source><year>2002</year><volume>39</volume><fpage>237</fpage><lpage>246</lpage><pub-id pub-id-type="pmid">12082286</pub-id></element-citation></ref><ref id="B226-cells-08-00969"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauge</surname><given-names>C.</given-names></name><name><surname>Legendre</surname><given-names>F.</given-names></name><name><surname>Leclercq</surname><given-names>S.</given-names></name><name><surname>Elissalde</surname><given-names>J.M.</given-names></name><name><surname>Pujol</surname><given-names>J.P.</given-names></name><name><surname>Galera</surname><given-names>P.</given-names></name><name><surname>Boumediene</surname><given-names>K.</given-names></name></person-group><article-title>Interleukin-1beta impairment of transforming growth factor beta1 signaling by down-regulation of transforming growth factor beta receptor type II and up-regulation of Smad7 in human articular chondrocytes</article-title><source>Arthritis Rheum</source><year>2007</year><volume>56</volume><fpage>3020</fpage><lpage>3032</lpage><pub-id pub-id-type="doi">10.1002/art.22840</pub-id><pub-id pub-id-type="pmid">17763417</pub-id></element-citation></ref><ref id="B227-cells-08-00969"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roman-Blas</surname><given-names>J.A.</given-names></name><name><surname>Stokes</surname><given-names>D.G.</given-names></name><name><surname>Jimenez</surname><given-names>S.A.</given-names></name></person-group><article-title>Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes</article-title><source>Osteoarthr. Cartil.</source><year>2007</year><volume>15</volume><fpage>1367</fpage><lpage>1377</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2007.04.011</pub-id><pub-id pub-id-type="pmid">17604656</pub-id></element-citation></ref><ref id="B228-cells-08-00969"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madej</surname><given-names>W.</given-names></name><name><surname>Buma</surname><given-names>P.</given-names></name><name><surname>van der Kraan</surname><given-names>P.</given-names></name></person-group><article-title>Inflammatory conditions partly impair the mechanically mediated activation of Smad2/3 signaling in articular cartilage</article-title><source>Arthritis Res. Ther.</source><year>2016</year><volume>18</volume><fpage>146</fpage><pub-id pub-id-type="doi">10.1186/s13075-016-1038-6</pub-id><pub-id pub-id-type="pmid">27334538</pub-id></element-citation></ref><ref id="B229-cells-08-00969"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elshaier</surname><given-names>A.M.</given-names></name><name><surname>Hakimiyan</surname><given-names>A.A.</given-names></name><name><surname>Rappoport</surname><given-names>L.</given-names></name><name><surname>Rueger</surname><given-names>D.C.</given-names></name><name><surname>Chubinskaya</surname><given-names>S.</given-names></name></person-group><article-title>Effect of interleukin-1beta on osteogenic protein 1-induced signaling in adult human articular chondrocytes</article-title><source>Arthritis Rheum</source><year>2009</year><volume>60</volume><fpage>143</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1002/art.24151</pub-id><pub-id pub-id-type="pmid">19116903</pub-id></element-citation></ref><ref id="B230-cells-08-00969"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merrihew</surname><given-names>C.</given-names></name><name><surname>Soeder</surname><given-names>S.</given-names></name><name><surname>Rueger</surname><given-names>D.C.</given-names></name><name><surname>Kuettner</surname><given-names>K.E.</given-names></name><name><surname>Chubinskaya</surname><given-names>S.</given-names></name></person-group><article-title>Modulation of endogenous osteogenic protein-1 (OP-1) by interleukin-1 in adult human articular cartilage</article-title><source>J. Bone Jt. Surg. Am.</source><year>2003</year><volume>85-A Suppl 3</volume><fpage>67</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.2106/00004623-200300003-00012</pub-id></element-citation></ref><ref id="B231-cells-08-00969"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauge</surname><given-names>C.</given-names></name><name><surname>Attia</surname><given-names>J.</given-names></name><name><surname>Leclercq</surname><given-names>S.</given-names></name><name><surname>Pujol</surname><given-names>J.P.</given-names></name><name><surname>Galera</surname><given-names>P.</given-names></name><name><surname>Boumediene</surname><given-names>K.</given-names></name></person-group><article-title>Interleukin-1beta up-regulation of Smad7 via NF-kappaB activation in human chondrocytes</article-title><source>Arthritis Rheum</source><year>2008</year><volume>58</volume><fpage>221</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1002/art.23154</pub-id><pub-id pub-id-type="pmid">18163503</pub-id></element-citation></ref><ref id="B232-cells-08-00969"><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuzaki</surname><given-names>K.</given-names></name></person-group><article-title>Smad phospho-isoforms direct context-dependent TGF-beta signaling</article-title><source>Cytokine Growth Factor Rev.</source><year>2013</year><volume>24</volume><fpage>385</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1016/j.cytogfr.2013.06.002</pub-id><pub-id pub-id-type="pmid">23871609</pub-id></element-citation></ref><ref id="B233-cells-08-00969"><label>233.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamato</surname><given-names>D.</given-names></name><name><surname>Burch</surname><given-names>M.L.</given-names></name><name><surname>Piva</surname><given-names>T.J.</given-names></name><name><surname>Rezaei</surname><given-names>H.B.</given-names></name><name><surname>Rostam</surname><given-names>M.A.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Zheng</surname><given-names>W.</given-names></name><name><surname>Little</surname><given-names>P.J.</given-names></name><name><surname>Osman</surname><given-names>N.</given-names></name></person-group><article-title>Transforming growth factor-beta signalling: Role and consequences of Smad linker region phosphorylation</article-title><source>Cell Signal</source><year>2013</year><volume>25</volume><fpage>2017</fpage><lpage>2024</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2013.06.001</pub-id><pub-id pub-id-type="pmid">23770288</pub-id></element-citation></ref><ref id="B234-cells-08-00969"><label>234.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massague</surname><given-names>J.</given-names></name></person-group><article-title>TGF-beta signal transduction</article-title><source>Annu. Rev. Biochem.</source><year>1998</year><volume>67</volume><fpage>753</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.67.1.753</pub-id><pub-id pub-id-type="pmid">9759503</pub-id></element-citation></ref><ref id="B235-cells-08-00969"><label>235.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y.</given-names></name></person-group><article-title>Structural insights on Smad function in TGFbeta signaling</article-title><source>Bioessays</source><year>2001</year><volume>23</volume><fpage>223</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1002/1521-1878(200103)23:3&#x0003c;223::AID-BIES1032&#x0003e;3.0.CO;2-U</pub-id><pub-id pub-id-type="pmid">11223879</pub-id></element-citation></ref><ref id="B236-cells-08-00969"><label>236.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>C.S.</given-names></name></person-group><article-title>Nucleocytoplasmic shuttling of Smad proteins</article-title><source>Cell Res.</source><year>2009</year><volume>19</volume><fpage>36</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1038/cr.2008.325</pub-id><pub-id pub-id-type="pmid">19114992</pub-id></element-citation></ref><ref id="B237-cells-08-00969"><label>237.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sapkota</surname><given-names>G.</given-names></name><name><surname>Knockaert</surname><given-names>M.</given-names></name><name><surname>Alarcon</surname><given-names>C.</given-names></name><name><surname>Montalvo</surname><given-names>E.</given-names></name><name><surname>Brivanlou</surname><given-names>A.H.</given-names></name><name><surname>Massague</surname><given-names>J.</given-names></name></person-group><article-title>Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways</article-title><source>J. Biol. Chem.</source><year>2006</year><volume>281</volume><fpage>40412</fpage><lpage>40419</lpage><pub-id pub-id-type="doi">10.1074/jbc.M610172200</pub-id><pub-id pub-id-type="pmid">17085434</pub-id></element-citation></ref><ref id="B238-cells-08-00969"><label>238.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuzaki</surname><given-names>K.</given-names></name></person-group><article-title>Smad phosphoisoform signaling specificity: The right place at the right time</article-title><source>Carcinogenesis</source><year>2011</year><volume>32</volume><fpage>1578</fpage><lpage>1588</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgr172</pub-id><pub-id pub-id-type="pmid">21798854</pub-id></element-citation></ref><ref id="B239-cells-08-00969"><label>239.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millet</surname><given-names>C.</given-names></name><name><surname>Yamashita</surname><given-names>M.</given-names></name><name><surname>Heller</surname><given-names>M.</given-names></name><name><surname>Yu</surname><given-names>L.R.</given-names></name><name><surname>Veenstra</surname><given-names>T.D.</given-names></name><name><surname>Zhang</surname><given-names>Y.E.</given-names></name></person-group><article-title>A negative feedback control of transforming growth factor-beta signaling by glycogen synthase kinase 3-mediated Smad3 linker phosphorylation at Ser-204</article-title><source>J. Biol. Chem.</source><year>2009</year><volume>284</volume><fpage>19808</fpage><lpage>19816</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.016667</pub-id><pub-id pub-id-type="pmid">19458083</pub-id></element-citation></ref><ref id="B240-cells-08-00969"><label>240.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>E.</given-names></name><name><surname>Sato</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>R.J.</given-names></name><name><surname>Kwak</surname><given-names>M.K.</given-names></name><name><surname>Naka</surname><given-names>K.</given-names></name><name><surname>Gim</surname><given-names>J.</given-names></name><name><surname>Kadota</surname><given-names>M.</given-names></name><name><surname>Tang</surname><given-names>B.</given-names></name><name><surname>Flanders</surname><given-names>K.C.</given-names></name><name><surname>Kim</surname><given-names>T.A.</given-names></name><etal/></person-group><article-title>Definition of smad3 phosphorylation events that affect malignant and metastatic behaviors in breast cancer cells</article-title><source>Cancer Res.</source><year>2014</year><volume>74</volume><fpage>6139</fpage><lpage>6149</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-14-0803</pub-id><pub-id pub-id-type="pmid">25205100</pub-id></element-citation></ref><ref id="B241-cells-08-00969"><label>241.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murata</surname><given-names>M.</given-names></name><name><surname>Yoshida</surname><given-names>K.</given-names></name><name><surname>Yamaguchi</surname><given-names>T.</given-names></name><name><surname>Matsuzaki</surname><given-names>K.</given-names></name></person-group><article-title>Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma</article-title><source>World J. Gastroenterol.</source><year>2014</year><volume>20</volume><fpage>15018</fpage><lpage>15027</lpage><pub-id pub-id-type="doi">10.3748/wjg.v20.i41.15018</pub-id><pub-id pub-id-type="pmid">25386050</pub-id></element-citation></ref><ref id="B242-cells-08-00969"><label>242.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demagny</surname><given-names>H.</given-names></name><name><surname>De Robertis</surname><given-names>E.M.</given-names></name></person-group><article-title>Point mutations in the tumor suppressor Smad4/DPC4 enhance its phosphorylation by GSK3 and reversibly inactivate TGF-beta signaling</article-title><source>Mol. Cell Oncol</source><year>2016</year><volume>3</volume><fpage>e1025181</fpage><pub-id pub-id-type="doi">10.1080/23723556.2015.1025181</pub-id><pub-id pub-id-type="pmid">27308538</pub-id></element-citation></ref><ref id="B243-cells-08-00969"><label>243.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demagny</surname><given-names>H.</given-names></name><name><surname>Araki</surname><given-names>T.</given-names></name><name><surname>De Robertis</surname><given-names>E.M.</given-names></name></person-group><article-title>The tumor suppressor Smad4/DPC4 is regulated by phosphorylations that integrate FGF, Wnt, and TGF-beta signaling</article-title><source>Cell Rep.</source><year>2014</year><volume>9</volume><fpage>688</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.09.020</pub-id><pub-id pub-id-type="pmid">25373906</pub-id></element-citation></ref><ref id="B244-cells-08-00969"><label>244.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heldin</surname><given-names>C.H.</given-names></name><name><surname>Moustakas</surname><given-names>A.</given-names></name></person-group><article-title>Role of Smads in TGFbeta signaling</article-title><source>Cell Tissue Res.</source><year>2012</year><volume>347</volume><fpage>21</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1007/s00441-011-1190-x</pub-id><pub-id pub-id-type="pmid">21643690</pub-id></element-citation></ref><ref id="B245-cells-08-00969"><label>245.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekimoto</surname><given-names>G.</given-names></name><name><surname>Matsuzaki</surname><given-names>K.</given-names></name><name><surname>Yoshida</surname><given-names>K.</given-names></name><name><surname>Mori</surname><given-names>S.</given-names></name><name><surname>Murata</surname><given-names>M.</given-names></name><name><surname>Seki</surname><given-names>T.</given-names></name><name><surname>Matsui</surname><given-names>H.</given-names></name><name><surname>Fujisawa</surname><given-names>J.</given-names></name><name><surname>Okazaki</surname><given-names>K.</given-names></name></person-group><article-title>Reversible Smad-dependent signaling between tumor suppression and oncogenesis</article-title><source>Cancer Res.</source><year>2007</year><volume>67</volume><fpage>5090</fpage><lpage>5096</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-4629</pub-id><pub-id pub-id-type="pmid">17545585</pub-id></element-citation></ref><ref id="B246-cells-08-00969"><label>246.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>J.S.</given-names></name><name><surname>Ramasamy</surname><given-names>T.S.</given-names></name><name><surname>Murphy</surname><given-names>N.</given-names></name><name><surname>Holt</surname><given-names>M.K.</given-names></name><name><surname>Czapiewski</surname><given-names>R.</given-names></name><name><surname>Wei</surname><given-names>S.K.</given-names></name><name><surname>Cui</surname><given-names>W.</given-names></name></person-group><article-title>PI3K/mTORC2 regulates TGF-beta/Activin signalling by modulating Smad2/3 activity via linker phosphorylation</article-title><source>Nat. Commun.</source><year>2015</year><volume>6</volume><fpage>7212</fpage><pub-id pub-id-type="doi">10.1038/ncomms8212</pub-id><pub-id pub-id-type="pmid">25998442</pub-id></element-citation></ref><ref id="B247-cells-08-00969"><label>247.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruce</surname><given-names>D.L.</given-names></name><name><surname>Sapkota</surname><given-names>G.P.</given-names></name></person-group><article-title>Phosphatases in SMAD regulation</article-title><source>FEBS Lett.</source><year>2012</year><volume>586</volume><fpage>1897</fpage><lpage>1905</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2012.02.001</pub-id><pub-id pub-id-type="pmid">22576046</pub-id></element-citation></ref><ref id="B248-cells-08-00969"><label>248.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Feng</surname><given-names>X.H.</given-names></name></person-group><article-title>Regulation of TGF-beta signalling by protein phosphatases</article-title><source>Biochem. J.</source><year>2010</year><volume>430</volume><fpage>191</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1042/BJ20100427</pub-id><pub-id pub-id-type="pmid">20704570</pub-id></element-citation></ref><ref id="B249-cells-08-00969"><label>249.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saklatvala</surname><given-names>J.</given-names></name></person-group><article-title>Inflammatory signaling in cartilage: MAPK and NF-kappaB pathways in chondrocytes and the use of inhibitors for research into pathogenesis and therapy of osteoarthritis</article-title><source>Curr. Drug Targets</source><year>2007</year><volume>8</volume><fpage>305</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.2174/138945007779940115</pub-id><pub-id pub-id-type="pmid">17305508</pub-id></element-citation></ref><ref id="B250-cells-08-00969"><label>250.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Djouad</surname><given-names>F.</given-names></name><name><surname>Rackwitz</surname><given-names>L.</given-names></name><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>Janjanin</surname><given-names>S.</given-names></name><name><surname>Tuan</surname><given-names>R.S.</given-names></name></person-group><article-title>ERK1/2 activation induced by inflammatory cytokines compromises effective host tissue integration of engineered cartilage</article-title><source>Tissue Eng. Part A</source><year>2009</year><volume>15</volume><fpage>2825</fpage><lpage>2835</lpage><pub-id pub-id-type="doi">10.1089/ten.tea.2008.0663</pub-id><pub-id pub-id-type="pmid">19243242</pub-id></element-citation></ref><ref id="B251-cells-08-00969"><label>251.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geng</surname><given-names>Y.</given-names></name><name><surname>Valbracht</surname><given-names>J.</given-names></name><name><surname>Lotz</surname><given-names>M.</given-names></name></person-group><article-title>Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes</article-title><source>J. Clin. Investig.</source><year>1996</year><volume>98</volume><fpage>2425</fpage><lpage>2430</lpage><pub-id pub-id-type="doi">10.1172/JCI119056</pub-id><pub-id pub-id-type="pmid">8941662</pub-id></element-citation></ref><ref id="B252-cells-08-00969"><label>252.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manley</surname><given-names>G.C.A.</given-names></name><name><surname>Stokes</surname><given-names>C.A.</given-names></name><name><surname>Marsh</surname><given-names>E.K.</given-names></name><name><surname>Sabroe</surname><given-names>I.</given-names></name><name><surname>Parker</surname><given-names>L.C.</given-names></name></person-group><article-title>DUSP10 Negatively Regulates the Inflammatory Response to Rhinovirus through Interleukin-1beta Signaling</article-title><source>J. Virol.</source><year>2019</year><volume>93</volume></element-citation></ref><ref id="B253-cells-08-00969"><label>253.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>M.A.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Czubryt</surname><given-names>M.P.</given-names></name><name><surname>Phan</surname><given-names>J.</given-names></name><name><surname>McAnally</surname><given-names>D.</given-names></name><name><surname>Qi</surname><given-names>X.</given-names></name><name><surname>Shelton</surname><given-names>J.M.</given-names></name><name><surname>Richardson</surname><given-names>J.A.</given-names></name><name><surname>Bassel-Duby</surname><given-names>R.</given-names></name><name><surname>Olson</surname><given-names>E.N.</given-names></name></person-group><article-title>MEF2C transcription factor controls chondrocyte hypertrophy and bone development</article-title><source>Dev. Cell</source><year>2007</year><volume>12</volume><fpage>377</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2007.02.004</pub-id><pub-id pub-id-type="pmid">17336904</pub-id></element-citation></ref><ref id="B254-cells-08-00969"><label>254.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinn</surname><given-names>Z.A.</given-names></name><name><surname>Yang</surname><given-names>C.C.</given-names></name><name><surname>Wrana</surname><given-names>J.L.</given-names></name><name><surname>McDermott</surname><given-names>J.C.</given-names></name></person-group><article-title>Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins</article-title><source>Nucleic Acids Res.</source><year>2001</year><volume>29</volume><fpage>732</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.1093/nar/29.3.732</pub-id><pub-id pub-id-type="pmid">11160896</pub-id></element-citation></ref><ref id="B255-cells-08-00969"><label>255.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Kang</surname><given-names>J.S.</given-names></name><name><surname>Derynck</surname><given-names>R.</given-names></name></person-group><article-title>TGF-beta-activated Smad3 represses MEF2-dependent transcription in myogenic differentiation</article-title><source>EMBO J.</source><year>2004</year><volume>23</volume><fpage>1557</fpage><lpage>1566</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600179</pub-id><pub-id pub-id-type="pmid">15044954</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="cells-08-00969-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Appearance and structure of adult (bovine) articular cartilage. Note that the orientation of collagen fibrils differs per zone, from parallel in the superficial zone to perpendicular in the deep zone. Scale bar = 100 &#x000b5;m.</p></caption><graphic xlink:href="cells-08-00969-g001"/></fig><fig id="cells-08-00969-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Transforming growth factor &#x003b2; (TGF&#x003b2;) family SMAD-dependent signaling. Ligand binding induces the formation of a receptor complex containing a type I and type II receptors. Type III receptors stabilize and facilitate the binding of TGF&#x003b2; to the receptor complex, which recruits a receptor SMAD (R-SMAD). The R-SMAD is subsequently phosphorylated on its C-terminal domain, and a complex is formed with the common SMAD4 (co-SMAD4). This complex translocates to the nucleus where it can bind transcription factors, like SOX9 and RUNX2, and activates transcription. The activation of SMAD2/3 signaling results in anti-hypertrophic and anti-inflammatory function, whereas activation of SMAD1/5/9 signaling is associated with pro-hypertrophic regulation of the extracellular matrix and maturation of the cartilage. Other important target genes are the inhibitory SMADs, <italic>SMAD6</italic> and <italic>SMAD7,</italic> whose expression provides the cell with a negative feedback mechanism. ACVR2 = Activin type-2 receptor, ALK = ALK tyrosine kinase receptor, BMP = Bone morphogenetic protein, BMPR = Bone morphogenetic protein receptor, GDF2 = Growth differentiation factor 2, MH(1/2) = MAD homology (1/2) domain, RGM = Repulsive guidance molecule, RUNX2 = Runt-related transcription factor 2, SOX9 = Transcription factor SOX9, TGFBR = TGF&#x003b2; receptor</p></caption><graphic xlink:href="cells-08-00969-g002"/></fig><fig id="cells-08-00969-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Transforming growth factor &#x003b2; (TGF&#x003b2;) family SMAD-independent signaling. Ligand binding induces the formation of a receptor complex. This complex can initiate SMAD-independent signaling via activation of adaptor proteins, e.g., SHC1 and TRAF6. This activation results in initiation of the ERK and TAK signaling cascades, culminating in the activation of MAPKAPK2, p38, JNK, and NF&#x003ba;b. These pathways induce transcription and translation and regulate diverse cellular processes. AKT = RAC-alpha serine/threonine-protein kinase, AP-1 = Activator protein 1, ATF2 = Cyclic AMP-dependent transcription factor ATF-2, CEBP&#x003b2; = CCAAT/enhancer-binding protein &#x003b2;, ERK = Mitogen-activated protein kinase 3, GRB2 = Growth factor receptor-bound protein 2, HSP27 = Heat shock protein beta-1, IkBa = NF-kappa-B inhibitor alpha, IKK = Inhibitor of nuclear factor kappa-B kinase, JNK = c-Jun N-terminal kinase, MAP2K = Dual specificity mitogen-activated protein kinase kinase 1, MAPKAPK = MAP kinase-activated protein kinase, MEF2 = Myocyte-specific enhancer factor 2A, MKK = Dual specificity mitogen-activated protein kinase kinase, cMYC = Myc proto-oncogene protein, NEMO = NF-kappa-B essential modulator, NF&#x003ba;b = nuclear factor kappa-light-chain-enhancer of activated B cells, p38 = p38 mitogen-activated protein kinases, PI3K = Phosphatidylinositol 3-kinase, RAF = RAF proto-oncogene serine/threonine-protein kinase, RAS = GTPase HRas, SHC1 = SHC-transforming protein 1, SOS = Son of sevenless homolog 1, SP-1 = Sp1 transcription factor, TAB = TGF-beta-activated kinase 1 and MAP3K7-binding protein 1, TAK1 = TGF&#x003b2;-activated kinase 1, TCFs = ternary complex factors, TRAF6 = TNF receptor-associated factor 6, and XIAP = E3 ubiquitin-protein ligase XIAP.</p></caption><graphic xlink:href="cells-08-00969-g003"/></fig><fig id="cells-08-00969-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Effects of the different Transforming Growth Factor &#x003b2; (TGF&#x003b2;) family members on articular cartilage biology and osteoarthritis (OA) development. On the left healthy articular cartilage is depicted, on the right osteoarthritic cartilage. The middle depicts how TGF&#x003b2; family members regulate matrix turnover, chondrocyte proliferation, hypertrophy-like differentiation, and inflammation. An imbalance in these effects of TGF&#x003b2; family members because of age- and/or inflammation-related changes contributes to OA development. ADAMTS5 = A disintegrin and metalloproteinase with thrombospondin motifs 5, ALPL = Alkaline phosphatase tissue-nonspecific isozyme, BAPX-1 = Homeobox protein Nkx-3.2, BMP = Bone morphogenetic protein, GDF = Growth differentiation factor, IL = interleukin, MMP = matrix metalloproteinase, NF&#x003ba;b = nuclear factor kappa-light-chain-enhancer of activated B cells, PRG4 = proteoglycan 4, RUNX2 = Runt-related transcription factor 2, SOX9 = Transcription factor SOX-9, and STAT3 = Signal transducer and activator of transcription 3.</p></caption><graphic xlink:href="cells-08-00969-g004"/></fig><fig id="cells-08-00969-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>SMAD linker modifications alter Transforming growth factor &#x003b2; (TGF&#x003b2;) signaling. The SMAD proteins consist of a MH1 and MH2 domain, connected with a non-conserved linker domain. Threonine and serine residues in the linker domain can be modulated by protein kinases and phosphatases like mitogen-activated protein kinases (MAPKs), c-Jun N-terminal kinases (JNK), and Glycogen synthase kinase 3 (GSK-3). These kinases can be activated by growth factors and inflammatory mediators. This process greatly affects SMAD function and leads to altered TGF&#x003b2; signaling.</p></caption><graphic xlink:href="cells-08-00969-g005"/></fig></floats-group></article>